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Inflammation in the female genital tract (FGT) is associated with increased HIV-1 viral 
replication, HIV-1 transmission and HIV-1 acquisition. The optimal commensal Lactobacillus 
bacterial species is associated with reduced inflammation in the FGT and dampened immune 
responses to non-optimal bacteria in vitro. Using a transcriptomics approach, this research 
aimed to investigate gene expression patterns in the FGT of HIV-infected women compared 
to peripheral blood. Furthermore, transcriptomics was used to investigate interactions 
between different vaginal Lactobacillus species and the host to elucidate its 
immunomodulatory mechanisms.  
Cervical cytobrushes and blood samples were collected from chronically HIV-infected South 
African women. Cervical and peripheral blood mononuclear cells (CMCs and PBMCs) were 
isolated and mRNA was extracted for microarray analysis using the Illumina HumanHT-12 v3 
Expression BeadChip system. Eight Lactobacillus isolates, two of each L. jensenii, L. 
mucosae, L. crispatus and L. vaginalis species were included in this study. The effects of these 
lactobacilli on cytokine production by vaginal epithelial (VK2) cells stimulated with Gardnerella 
vaginalis (ATCC 14018) were tested in vitro, RNA was extracted and used for Affymetrix 
Genechip whole transcript microarray analysis.  
This study found that significantly over-expressed genes in CMCs compared to PBMCs were 
mapped to proinflammatory signaling pathways (including Nuclear factor kappa B (NFκB), 
Tumor necrosis factor (TNF), Toll-like receptor (TLR) and Nucleotide-binding and 
oligomerization domain (NOD)-like receptor). Concurrently, a signature of reduced potential 
for adaptive immunity was observed in CMCs compared to PBMCs, as evidenced by 
underrepresentation of the T cell receptor signaling and natural killer cell mediated cytotoxicity 
pathways. G. vaginalis induced a potent proinflammatory cytokine response by VK2 cells in 
vitro. Over-expressed genes in G. vaginalis-stimulated VK2 cells compared to unstimulated 
VK2 cells were mapped to inflammatory signalling pathways. In contrast, 3/8 Lactobacillus 
isolates, including two L. mucosae and one L. vaginalis species, reduced inflammatory 
cytokine production by VK2 cells in response to G. vaginalis and were thus termed “cytokine-
suppressive”. Several genes, 7/8 of which are involved in inflammation, were downregulated 
in VK2 cells co-cultured with lactobacilli and G. vaginalis in combination compared to co-
culture with G. vaginalis only. Futhermore, when gene expression changes were investigated 
in cells cultured with cytokine-suppresive lactobacilli versus non-cytokine-suppressive 
lactobacilli, it was found that SAMD9L, DDX58, IFIT1 gene expression was downregulated 
exclusively in VK2 cells co-cultured with cytokine-suppressive lactobacilli and G. vaginalis 
compared to co-culture with G. vaginalis only.  
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The findings of this study have identified distinct gene expression patterns in the FGT 
compared to peripheral blood. Furthermore, key genes that may play a critical role in the 
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Chapter 1: Introduction 
The maintenance of health in the female genital tract (FGT) involves the microbiome, epithelial 
cell barrier and immune system  (1). A Lactobacillus-dominated vaginal microbiome has long 
been considered optimal (2), by producing lactic acid, hydrogen peroxide and bacteriocins, 
and hence creating an unfavourable environment for pathogens (3–8). In contrast, bacterial 
vaginosis (BV) occurs when lactobacilli are replaced by a diverse population of non-optimal 
bacteria (9). BV is highly prevalent, with 30-40% of women in sub-Saharan Africa having this 
condition (10). BV is associated with increased inflammation in the FGT that subsequently 
increases susceptibility to Human Immunodeficiency Virus (HIV) acquisition and may reduce 
the efficacy of some forms of antiretroviral pre-exposure prophylaxis (11–15). In addition, BV 
is associated with poor reproductive health outcomes, including preterm birth, pelvic 
inflammatory disease (PID) and infertility (16). Induction of the inflammatory cascade plays a 
critical role in the onset of labour (17,18) and thus, modulation of inflammatory responses by 
vaginal bacteria likely has an important influence on pregnancy outcomes. The condition may 
present with symptoms, however most cases are asymptomatic (19,20). Therefore, it is 
possible for BV to be unnoticed and thus not treated, allowing persistent inflammation in the 
FGT, and causing these women to be particularly vulnerable to HIV infection, as well as poor 
reproductive health outcomes. On the other hand, Lactobacillus species play a critical role in 
regulating inflammatory responses in the FGT and women with Lactobacillus dominated FGTs 
are at low risk of HIV infection (21).  
Given the prevalence of HIV in South Africa in particular (22), our knowledge of biological 
factors that increase acquisition risk in this population, are a necessity in combating this 
epidemic. Furthermore, adverse reproductive outcomes are highly prevalent in sub-Saharan 
Africa, with a preterm birth rate of 28.2% (23) and many children born preternaturally have 
lifelong health sequalae (24). Moreover, PID is associated with infertility (25). A study by 
Haggerty et al. (2016) (26) found an association between endometrial BV-associated bacteria 
and recurrent PID, and women who tested positive for PID were more likely to develop 
infertility in a United States cohort of women. Thus, an improved understanding of the 
biological factors that increase poor reproductive outcomes is imperative to reduce the 
prevalence of PID, preterm birth and infertility.   
It is possible that the immunoregulatory ability of Lactobacillus spp. (27–29) may be harnessed 
to reduce susceptibility to HIV acquisition. Improving our understanding of the underlying 
immunomodulatory mechanisms of these commensal bacteria, will inform on biomedical 
intervention strategies for preventing HIV and adverse reproductive outcomes.  
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Using transcriptomics, the aims of this thesis were to describe microbial pattern recognition 
and inflammatory signalling pathways in the FGT and to determine the mechanisms underlying 
the anti-inflammatory effect of Lactobacillus spp. in the FGT.  
 
1.1 The vaginal microbiome in optimal and non-optimal states  
An optimal vaginal microbiome consists of predominantly Lactobacillus spp., vaginal pH lower 
than 4.5 and low levels of BV-associated bacteria (9). One of the primary mechanisms by 
which vaginal Lactobacillus spp. inhibit the growth of pathogenic microorganisms is via the 
production of lactic acid that is responsible for the low pH associated with an optimal state (3–
6). In addition, Lactobacillus spp. inhibit the adhesion of BV-associated bacteria to the 
epithelium of the FGT and produce bacteriocins and hydrogen peroxide, although the role of 
the latter is controversial (3,7,27,30) (Figure 1). The Lactobacillus spp. L. crispatus, L. iners, 
L. jensenii and L. gasseri were identified as predominant vaginal lactobacilli from South African 
women (31). A more recent cohort study by Jespers et al. (2017) (32), including women from 
Kenya, Rawanda and South Africa, identified the same species in the vaginal microbiomes of 
these women. The study also found that women with an abundance of L. crispatus, had low 
levels of L. iners and vice versa. A recent study by Campisciano et al. (2018) (33) found that 
L. iners was the dominant Lactobacillus spp. isolated from Caucasian women with BV. L. iners 
is associated with increased risk of conversion from an optimal to a non-optimal vaginal 
microbiome (34) and acquisition of sexually transmitted infections (STIs) (35). In contrast, L. 
crispatus has been identified in women considered to have optimal vaginal microbiota (33). 
Furthermore, L. crispatus, L. jensenii and L. gasseri have antagonistic activity against BV-
associated bacteria (36). Thus, a vaginal microbiome dominated by Lactobacillus spp. confers 
an optimal state to the host; however, the ability to maintain this state is largely influenced by 
the specific sp. which predominates.  
An imbalance in the vaginal microbiome occurs when there is a decreased abundance of 
Lactobacillus spp., increased vaginal pH above 4.5 and the outgrowth of potentially 
pathogenic anaerobic microorganisms, such as Gardnerella, Prevotella, Mobiluncus and 
Atopobium spp. (9,33), resulting in BV.  Nugent scoring by Gram stain and microscopy is the 
gold standard for diagnosis of BV and is used to determine whether the vaginal microbiome is 
optimal (predominantly lactobacilli; score: 0-3), intermediate (some lactobacilli and some 
Gram variable coccobacilli and Mobiluncus; score: 4-6) or BV (few to no lactobacilli with 
abundant Gram variable coccobacilli and Mobiluncus; 7-10) (37). BV has been described as 
a polymicrobial condition (38) and its exact aetiology is not fully understood. However, 
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Gardnerella vaginalis has been found to be a key BV-associated bacterium and it is commonly 
isolated from the vaginal tracts of women with BV (32,39,40). However, G. vaginalis is also 
isolated from women with intermediate vaginal microbiomes (33) and those with optimal states 
(41,42). Four subtypes of G. vaginalis have been identified, of which clade one, two and three 
are prevalent in women with BV and clade four is prevalent in women without BV (43). It has 
been suggested that G. vaginalis is an early colonizer of the vaginal tract involved in the 
progression to BV and promotes the colonization and growth of other BV-associated bacteria 
(44). This pathogenic property has been attributed to its ability to self-aggregate which 
produces a robust biofilm (45). G. vaginalis strains may display varying pathogenic potential 
in the FGT, as genes which encode biofilm components, antimicrobial resistance and virulence 
factors, are strain specific. Furthermore, G. vaginalis strains isolated from women with BV are 
more virulent in vitro compared to those isolated from women with non-optimal vaginal 
microbiomes (46). Therefore, G. vaginalis is an important BV-associated bacterium and an 
improved understanding of its pathogenicity in the FGT, together with the host immune 
















1.2 The innate immune response in the FGT 
The interplay between the microbiome and the immune system allows for the defence against 
pathogens, while maintaining tolerance to commensal bacteria and allogeneic sperm (47). An 
intricate network of receptors, intracellular signalling mechanisms and cytokines function 
together to initiate host defences against pathogens (48). Cytokines are chemical messengers 
which regulate the innate and adaptive immune systems (49). Pro-inflammatory cytokines, 
such as interleukin (IL)-1α and IL-1β, IL-6, IL-8, and tumor necrosis factor alpha (TNFα), 
function to promote an inflammatory response via vasodilation and recruitment of immune 
cells to the site of infection or tissue damage (50).  The pleotropic IL-1 cytokine family has pro-
inflammatory, immunoregulatory and haematopoietic functions, as well as promoting the 
development of Th17 helper T cells (51). Both IL-1α and IL-1β initiates downstream signalling 
in various cell types by binding to the IL-1 receptor (IL-1R) (51), however, IL-1α also contains 
a nuclear localisation site enabling it to promote  
 
proinflammatory gene transcription independently of the IL-1R (52). In contrast, the IL-1R 
antagonist (IL-1RA) is an anti-inflammatory cytokine which competes for the IL-1R, thus 
reducing inflammation (51,52). The IL-6 cytokine binds the IL-6 receptor and the 
transmembrane glycoprotein130 (gp130) to induce intracellular signalling which initiates the 
acute phase inflammatory response, causing the neutralization of pathogens and minimizing 
Figure 1: Implications of the vaginal microbiome in optimal and non-optimal states. A) Depicts an optimal vaginal 
microbiome with lactobacilli abundance, lactate production, low pH, hydrogen peroxide production and bacteriocins which 
inhibit the outgrowth of BV-associated bacteria. Consequently, inflammation and HIV-1 susceptibility are reduced. B) Depicts 
a non-optimal vaginal microbiome, with the outgrowth of BV-associated bacteria, reduced lactobacilli, lactate and hydrogen 
peroxide production, increased pH and reduced bacteriocins. Consequently, inflammation and HIV-1 susceptibility are 
increased. HIV-1: Human Immunodeficiency Virus-1.  
15 
 
tissue damage (53). The chemokine IL-8 is a potent chemoattractant and activator of 
neutrophils at infection sites, which combat invading pathogens (51,54). Macrophage 
inflammatory protein (MIP)-1α is a chemokine which functions to recruit and activate T 
lymphocytes and monocytes (55) . The structurally similar chemokine MIP-1β functions in 
neutrophil chemotaxis, as well as T cell activation and recruitment, resulting in proliferation, 
IL-2 secretion and IL-2 cell receptor expression (56). The chemokine MIP-3α is responsible 
for the chemotaxis of immature dendritic cells, memory T cells and B cells, and is involved in 
the formation of lymphoid mucosal tissues (57). Interferon gamma inducible protein 10 (IP-10) 
is a chemokine secreted by cells stimulated by interferons and lipopolysaccharides (LPS), 
which recruits activated T cells (58). 
 
1.2.1 Mucosal barrier of the FGT 
The mucosal barrier of the FGT provides a robust protective layer to infection. A single layer 
of columnar epithelial cells lines the upper FGT, while a multi-layered non-keratinized stratified 
squamous epithelium lines the lower FGT (49). In addition, a layer of mucus inhibits direct 
contact of pathogens with the epithelium and contains mucins composed of glycosylated 
proteins, which trap pathogens and prevent their entry (49). Intraepithelial immune cells such 
as T cells, macrophages, dendritic cells, natural killer cells and neutrophils are present in the 
epithelial layer to combat potential invading microorganisms (59). 
 
1.2.2 Pathogen detection in the FGT 
In addition to providing a physical barrier to infection, epithelial cells of the FGT play a crucial 
role in pathogen detection via their pattern recognition receptors (PRR). These receptors 
detect pathogens by recognizing conserved molecular structures, known as pathogen- 
associated molecular patterns (PAMPs) (60). In addition, PRRs detect danger associated 
molecular patterns (DAMPs) which are released by damaged tissue (61). Bacterial PAMPS 
include LPS, flagellin, peptidoglycan and bacterial nucleic acid structures, while viral PAMPS 
are double or single stranded RNA or viral DNA (62). 
Toll-like receptors (TLRs) were the first class of PRRs to be identified. Ten different TLRs have 
been identified in humans, which recognize diverse pathogen classes (60). They are either 
located on the cell surface or intracellularly (63). TLR1 and 2 recognize peptidoglycan and 
lipoproteins of Gram-positive bacteria, whereas TLR4 recognizes LPS in the cell wall of Gram-
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negative bacteria (60). Immune cells such as neutrophils, macrophages and dendritic cells, 
as well as dermal endothelial and mucosal epithelial cells, express TLRs, as they are involved 
in the first line of defence against invading pathogens (64). Fazeli et al. (2005) (65) detected 
TLR1-6 in epithelia from different regions of the FGT, however, TLR4 was not detected in 
vaginal and cervical epithelia. Similarly, Fichorova et al. (2002) (66) found that cervical and 
vaginal epithelial cells did not express TLR4 in vitro. However, Zariffard et al. (2005) (67) found 
higher expression of TLR4 and TLR2 mRNA in cells obtained from cervicovaginal lavage 
(CVL) samples of women with BV compared to cervical mucosal tissue. The authors thus 
concluded that these TLRs were expressed in the FGT, although TLR4 may have been 
expressed by immune cells present in the lumen and not epithelial cells.  
Other classes of PRRs include C-type lectins receptors (CLRs), Retinoic acid inducible (RIG-
I)-like receptors and nucleotide oligomerization domain (NOD)-like receptors (NLRs) (62). 
Langerhans cells, myeloid dendritic cells and macrophages isolated from endocervical tissue 
have been found to express CLRs (68). CLRs are widely known for the recognition of fungal 
microbes (69). Vaginal candidiasis is a common condition caused by the fungal spp. Candida 
albicans (70). CLRs are important in the detection of this pathogen and polymorphisms in 
these receptors are associated with recurrent vulvovaginal candidiasis (71,72), as well as 
recurrent BV (72). RIG-I receptors recognize viral RNA (73). Sathe & Reddy (2014) (74) found 
that these are key receptors intracellularly expressed by endocervical epithelial cells and are 
important for anti-viral immune responses. NLRs are intracellular proteins which function as 
scaffolding proteins involved in signalling cascades which trigger inflammatory pathways (75). 
They recognize Gram-negative and Gram-positive bacteria by detection of peptidoglycan, a 
major component of bacterial cell walls (75).  
 
1.2.3 Downstream inflammatory networks  
The activation of PRRs initiates intracellular signalling cascades which activate inflammatory 
pathways of a cell (76). The main inflammatory pathways activated by PRRs are the nuclear 
factor kappa light-chain-enhancer of activated B cells (NF-κB ) pathway and the mitogen 
activated protein (MAP) kinase pathway (63).  
After TLR detection of a microbial PAMP, an adaptor molecule myeloid differentiation primary 
response 88 (MyD88), is recruited to the TLR. MyD88 then associates with the cytoplasmic 
domain of the receptor and mediates signal transduction (63). Thereafter, a series of 
phosphorylation, ubiquitination and protein-protein interactions occur to activate downstream 
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signal transduction pathways. These signals result in the activation of transcription factors 
necessary for the regulation of genes involved in inflammation (63). The NF-κB pathway is an 
example of a downstream inflammatory network.  
The NF-κB complex consists of p50 and p65 subunits bound to inhibitor of κB (IκBα) in its 
inactive state in the cytoplasm. Upon PRR activation by PAMPS, IκB kinase (IKK) is activated 
and phosphorylates IκBα which results in its dissociation from NF-κB, ubiquitination and 
degradation. The NF-κB complex is then able to translocate into the nucleus and induce 
specific gene expression, many of these being pro-inflammatory cytokines (77).  
Similarly, the MAP kinase pathway involves sequential signalling steps which culminate to 
induce pro-inflammatory cytokine production. The pathway includes MAP kinases which 
propagate signals from the cell surface to the nucleus (78). The p38 MAP kinase pathway is 
associated with inflammation, being activated by extracellular stimuli including cytokines and 
pathogens which activate p38 via TLRs (79,80). Following this extracellular stimulus, 
phosphorylation of MAP kinase isoforms activates the p38 MAP kinase, resulting in production 
of inflammatory mediators for the recruitment and activation of leukocytes (78). 
 
1.3 BV-associated bacteria cause inflammation in the FGT  
BV and the inflammation caused by BV-associated bacteria increase risk of HIV acquisition in 
women, as well as HIV transmission to uninfected partners (81,82). BV has been associated 
with increased inflammatory mediators and immune cells in the FGT (33,83,84) and 
biomarkers of damage to the epithelium of the vaginal mucosa (85). In contrast, some 
chemokines are downregulated (83) which may suggest a tolerogenic mechanism used by 
pathogenic bacteria to persist in the FGT. Recent studies have found that G. vaginalis 
specifically induces pro-inflammatory cytokine production. Santos et al. (2018) (86) found that 
HeLa cells stimulated with G. vaginalis induced the production of TNF-α, IL-1β, IL-6 and IL-8 
in vitro. Similarly, an in vivo study by Sierra et al. (2018) (87) found high levels of IL-6 in the 
cervicovaginal fluid (CVF) and increased expression of IL-1β, IL-8 and IL-10 in the cervices of 
pregnant mice inoculated intravaginally with G. vaginalis compared to the control group.  
Inflammation caused by BV may increase HIV risk by increasing recruitment of HIV target 
cells, including CD4+ T cells, macrophages and dendritic cells, into the FGT (81). Interestingly, 
Campisciano et al. (2018) (33) found that G. vaginalis abundance correlated with IL-15 in a 
cohort of Italian Caucasian women. Studies have found that IL-15 is involved in the activation 
(88) and proliferation (89) of CD4+ T cells in vitro. Thus, increased concentrations of this 
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cytokine may be an important factor in the persistence of HIV target cells in FGTs with 
microbiomes dominated by G. vaginalis.  
FGT inflammation also influences susceptibility to different HIV viral phenotypes, as pre-
infection genital tract inflammation is associated with increased acquisition of less infectious 
HIV variants (90). Furthermore, following activation by inflammatory cytokines, NF-κB  binds 
to the long terminal repeat (LTR) situated in the HIV promoter to initiate HIV replication (91). 
In agreement with this, Mitchell et al. (2011) (92) reported an association between HIV RNA 
shedding and pro-inflammatory IL-8 and IL-1β concentrations in CVF. Moreover, BV-
associated bacteria were associated with increased HIV RNA shedding in CVF compared to 
L. jensenii abundance (93), which likely explains the increased risk of HIV transmission to 
uninfected partners that is associated with BV.  
In addition to directly inducing a pro-inflammatory response, G. vaginalis produces a toxin, 
vaginolysin, which is cytolytic to the host cells (94). In vitro stimulation of vaginal keratinocytes 
with vaginolysin causes the release of lactate dehydrogenase, which is indicative of cellular 
permeabilization (95). Sierra et al. (2018) (87) quantified soluble e-cadherin (a molecular 
marker of a disrupted cervical epithelial barrier) in CVF of G. vaginalis colonized mice and 
similarly found that e-cadherin was significantly increased in G. vaginalis colonized mice 
compared to controls. As previously mentioned, damaged tissue releases DAMPs which 
activate PRRs to induce a pro-inflammatory response. Thus, the ability of G. vaginalis to 
disrupt the epithelial barrier is likely to exacerbate inflammation due to tissue damage, as well 
as allow for entry of cell-free and cell-associated HIV particles (96). It has further been reported 
that vaginolysin treatment of HeLa cells in vitro activates the p38 MAP kinase pathway and 
increases IL-8 production (94). 
 
1.4 Anti-inflammatory effect of Lactobacillus species 
In contrast to BV-associated bacteria, vaginal Lactobacillus spp. have been associated with 
decreased inflammatory mediator concentrations in the FGT and a reduced inflammatory 
response to bacterial (27,29,86,97) and fungal pathogens (86) in vitro. Hearps et al. (2017) 
(28) found that lactic acid (a metabolite produced by lactobacilli) reduced pro-inflammatory 
cytokine IL-8, IL-6 and TNF-α production by ectocervical, endocervical and vaginal epithelial 
cells in response to TLR agonists. The authors thus proposed that lactic acid plays a role in 
the anti-inflammatory effect of Lactobacillus spp. A recent study by Santos et al. (2018) (86) 
isolated L. fermentum and L. plantarum from women with optimal vaginal microbiomes. The 
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study found that these Lactobacillus spp. suppressed pro-inflammatory cytokine (TNF-α, IL-
1β, IL-6, IL-8) secretion by HeLa cells stimulated with G. vaginalis and Candida albicans. 
Similarly, we have previously found that clinical vaginal Lactobacillus isolates, including L. 
crispatus, L. jensenii, L. mucosae and L. vaginalis, obtained from South African women, 
significantly supressed IL-6 and IL-8 production by ectocervical (CaSki) and vaginal epithelial 
(VK2) cells in response to G. vaginalis, although IL-1α and IL-1β were upregulated in the 
presence of the Lactobacillus spp. (29,98). Furthermore, the production of D-lactate produced 
in the cell culture system correlated with decreased cytokine production (98). At present, the 
molecular mechanisms by which Lactobacillus spp. may regulate inflammatory responses, 
and hence reduce risk of HIV acquisition, are largely unknown.  
 
1.4.1 Effect of FGT bacteria on the expression and activation of PRRs 
Microorganisms in the FGT activate TLRs to initiate an immune response via the TLR 
signalling cascade. It has been found that CVL from women with BV significantly increased 
TLR4 expression by peripheral blood mononuclear cells (PBMCs) compared to CVL from 
women without BV, however TLR2 remained unchanged (67). Finamore et al. (2014) (99) 
found that Lactobacillus spp. reduced TLR4 expression by intestinal Caco-2 cells stimulated 
with enteropathogenic Escherichia coli in vitro. More relevant to the FGT, a recent study by 
Tobita et al. (2017) (100) investigated the anti-inflammatory effect of vaginal Lactobacillus 
bacteria on human embryonic intestinal cells in the context of mother-to-child bacterial transfer 
and the establishment of the gut microbiome. The study reported that LPS stimulated cells 
had reduced TLR4 expression in the presence of L. gasseri and L. crispatus in vitro. Thus, 
inhibition of TLR activation and signalling by Lactobacillus spp. may be a plausible anti-
inflammatory mechanism in the FGT. Further research is necessary, as studies using 
appropriate cell lines from the FGT, BV-associated bacteria and vaginal Lactobacillus spp. 
have not been done before. Horton et al. (2009) (101) used a microarray approach to compare 
gene expression of cervical mononuclear cells (CMCs) to peripheral blood mononuclear cells 
(PBMCs). The study found that TLRs 1, 2, 4, 5, 6 and 8 were significantly overexpressed in 
CMCs compared to PBMCs. Using a similar transcriptomics approach, this study aimed to 
investigate potential changes in TLR expression and activation of TLR signalling pathways in 
vaginal epithelial cells stimulated with BV-associated bacteria in the presence and absence of 
Lactobacillus spp. The role of suppression of certain TLR signalling cascades in mediating the 




1.4.2 The effect of FGT bacteria on intracellular inflammatory pathways 
The modulation of FGT epithelial cell inflammatory responses by Lactobacillus spp. has not 
been extensively studied. However, previous studies have proposed that Lactobacillus spp. 
act on intracellular signalling pathways involved in inflammation (28). Zalenskaya et al. (2015) 
(102) found that P. bivia induced the expression of seven pro-inflammatory genes (3 to 75 
fold) by vaginal epithelial cells in vitro, while L. gasseri did not, thus, discriminating the 
transcriptome of an optimal FGT compared to a non-optimal one.  
In other cell lines, such as macrophages and monocytes, Lactobacillus spp.  have been found 
to interfere with the NF-κB pathway (80,103). Lee et al. (2008) (103) found that L. casei 
reduced IκBα degradation and cytosolic p65 in LPS-stimulated macrophages in vitro. Similarly, 
L. johnsonii was found to reduce the activation of NF-kB and inhibit the translocation of p65 
into the nucleus of LPS-stimulated macrophages in vitro (104). Furthermore, lactic acid, which 
is one of the main metabolites produced by Lactobacillus bacteria (105), was found to delay 
LPS induced IκBα degradation in human monocytes in vitro (106). It has also been proposed 
that Lactobacillus spp. modulate cytokine release by monocyte-macrophages by upregulating 
negative regulators of the NF-κB pathway in vitro (107). Studies using these cell lines suggest 
that Lactobacillus spp. may act on similar intracellular pathways involved in inflammation in 
vaginal epithelial cells.  However, the exact mechanisms by which Lactobacillus spp. may 
target this pathway are still unknown. Contrary to these findings, in non-immune cells, heat 
labile components of Lactobacillus spp. were found to enhance NF-κB activation and TNF 
production while reducing IL-6 and IL-8 production by urinary bladder cells stimulated with E. 
coli in vitro (108).  However, research using epithelial cells of the FGT, as well as Lactobacillus 
spp. commonly isolated from the FGT, is limited and necessary to fully understand how 
Lactobacillus spp. potentially act on inflammatory pathways of epithelial cells in the FGT.  
This study investigated the anti-inflammatory properties of Lactobacillus spp. isolated from the 
FGTs of South African women. G. vaginalis was used to stimulate vaginal epithelial cells in 
the presence or absence of vaginal Lactobacillus spp., inflammatory cytokine production was 
measured using Luminex and changes in gene expression evaluated using microarray. 
Microarray assay allows for the detection of upregulated and downregulated gene expression 
in a sample. mRNA is transcribed from DNA and is the intermediary molecule which transfers 
the genetic information obtained in the nucleus, to the cytoplasm where protein expression 
takes place. When a gene is expressed, many copies of mRNA, specific for the gene, are 
transcribed and translated to produce the corresponding protein. Therefore, by evaluating the 
mRNA, the relative gene expression can be assessed (109). Thus, this approach has identified 
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potential inflammatory signalling pathways targeted by Lactobacillus spp. to modulate pro-
inflammatory cytokine production induced by G. vaginalis.  
1.5 Aims and Objectives 
Objective: Evaluate the underlying mechanisms of the immunomodulatory effect of 
Lactobacillus species on vaginal immune cells stimulated by Gardnerella vaginalis. 
Specific aims:  
1. To use transcriptomics to investigate whether pro-inflammatory signalling pathways 
are overexpressed in CMCs versus matching PBMCs isolated from South African 
women. 
2. To investigate the effect of vaginal Lactobacillus isolates on pro-inflammatory cytokine 
production by vaginal epithelial cells stimulated with BV-associated G. vaginalis 
(ATCC® 14018™).  
3. To use transcriptomics to evaluate whether lactobacilli modulate vaginal epithelial cell 
pro-inflammatory cytokine responses to G. vaginalis by influencing the expression of 
components of inflammatory signalling pathways, including PRRs, negative feedback 














Chapter 2: Materials and Methods 
2.1 Comparison of gene expression in CMC and PBMC samples  
2.1.1 Groote Schuur study cohort and sample collection 
Matched cervical cytobrush and blood samples were collected from n=5 black, chronically 
HIV-infected women on antiretroviral therapy (ART), from the Gynaecology Outpatient Clinic, 
Groote Schuur Hospital, Cape Town, South Africa (Principal Investigator: Associate Professor 
Jo-Ann Passmore). The presence of clinical signs and symptoms of STIs and BV were 
recorded by the study nurse and plasma HIV viral load was measured for each participant 
using Nuclisens Easyq HIV-1 Version 1.2 (BioMerieux, Lyon, France) by the National Health 
Laboratory Service (NHLS).  
2.1.2 CMC and PBMC sample processing 
CMCs and PBMCs were isolated from the cytobrush and blood samples, respectively, by Ficoll 
density gradient centrifugation. Thereafter, the samples were stored in RNAlater reagent 
(Qiagen, Germany) at -80°C until RNA extraction. RNA was extracted from the samples using 
the RNeasy Plus Mini Kit (Qiagen, Germany), by Dr Lindi Masson (Division of Medical 
Virology, UCT, Cape Town, South Africa).  
2.1.3 Gene expression analysis of CMC and PBMC samples using microarray Illumina 
platform 
Prior to evaluation of CMC and PBMC gene expression profiles, RNA quality and quantity 
were assessed using a NanoDrop and Agilent RNA 6000 Pico Kits on an Agilent 2100 
Bioanalyzer (Agilent Technologies, CA, USA). RNA was amplified using Illumina® TotalPrepTM 
RNA Amplification Kits (Ambion, Inc., TX, USA). Gene expression in the matched CMC and 
PBMC samples was evaluated using the microarray Illumina HumanHT-12 v3 Gene 
Expression BeadChip (Ambion, Inc., TX, USA), at the Baylor Centre for Immunology Research 
(Dallas, TX, US) by Dr Lindi Masson. The assay was performed according to the 
manufacturer’s instructions and all samples were processed in a single batch and loaded on 
the same BeadChip (Ambion, Inc., TX, USA). Briefly, mRNA was reverse transcribed to 
synthesize first strand cDNA. The first strand-cDNA was then converted to a double-stranded 
DNA (dsDNA) template for transcription. The cDNA product was then purified to remove RNA 
and other contaminants using purification beads which would inhibit in vitro transcription. 
cDNA yield and size distribution of each sample was assessed using a NanoDrop 
spectrophotometer and an Aligent 2100 Bioanalyzer. In vitro transcription (IVT) was then 
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performed and multiple copies of biotinylated cRNA were amplified and labelled from the ds-
cDNA templates. The cRNA was then purified to remove unincorporated nucleotide 
triphosphates (NTPs), salts and other contaminants. The cRNA was then quantitated. 
Hybridization was then performed and cRNA was normalized and dispensed onto the 
BeadChip. The RNA-loaded BeadChips were placed in Hyb chambers and incubated in the 
Illumina hybridization oven overnight at 58°C. Thereafter, the BeadChip underwent a series 
of wash steps according to the manufacturer’s instructions. Cy3-Streptavidin was then added 
to the BeadChip to bind to the analytical probes hybridized to the BeadChip to allow for signal 
detection. Thereafter, the BeadChip was washed, dried and scanned with the iScan Reader. 
All downstream data analysis was then conducted as part of this dissertation. 
 
2.2 Effect of vaginal Lactobacillus isolates on inflammatory responses to G. 
vaginalis 
2.2.1 Women’s Initiative in Sexual health (WISH) study 
A total of 149 women aged 16-22 years old were enrolled in the WISH European & Developing 
Countries Clinical Trials Partnership (EDCTP)-funded study (Principal Investigator: Associate 
Professor Jo-Ann Passmore) in Masiphumelele, Cape Town (2013-2015). Several clinical 
samples were collected for each participant, along with demographic and behavioural data. 
Menstrual cups (Softcup®, Evofem Inc, San Diego, CA, USA) were used to collect 
cervicovaginal fluid (CVF). Lateral vaginal wall and vulvovaginal swabs were also collected. 
The lateral vaginal wall swabs were used to measure pH and test for the presence of STIs by 
PCR [by the National Institute of Communicable Diseases (NICD) STI Surveillance 
Laboratory, Sandringham, Johannesburg] (110). The STI tests included bacterial STIs, 
Chlamydia trachomatis, Neisseria gonorrhoeae and Treponema pallidum; protozoan, 
Trichomonas vaginalis; and viral, herpes simplex virus (HSV). Swabs were used for the 
diagnosis of BV (Gram-strain Nugent score of 7-10) and candidiasis (NICD Laboratory).  
2.2.2 Isolation of Lactobacillus bacteria 
Preceding this study, CVF samples were processed by Dr Smritee Dabee, Dr Shameem 
Jaumdally and Mrs Hoyam Gamieldien (Medical Virology, UCT). Phosphate buffered saline 
was used to dilute the CVF samples and stored in 20% glycerol at -80°C. For the isolation of 
Lactobacillus species, CVF samples were thawed and cultured in Man, Rogosa Sharpe (MRS; 
Sigma-Aldrich, USA) broth at 37°C, anaerobically for 48hrs. Thereafter, to obtain single 
colonies, the samples were streaked on MRS agar and incubated for an additional 48hrs at 
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37°C anaerobically. Colonies with varying morphology were then selected and cultured 
separately in MRS broth at 37°C, anaerobically for 72hrs. Lactobacilli were isolated by Mrs 
Hoyam Gamieldien and Dr Monalisa Manhanzva. A total of 115 lactobacilli were isolated from 
vaginal fluid samples and identified to species level by Matrix Assisted Laser Desorption 
Ionization-Time of Flight (MALDI-TOF) at the University of the Western Cape (UWC) and by 
Dr Remy Froissart (University of Montpellier, France).  
2.2.3 Bacterial isolate selection 
Inflammatory cytokine production by VK2 cells induced by G. vaginalis and these Lactobacillus 
isolates were previously evaluated (98). Chemokines MIP-3α, MIP-1α, MIP-1β, IP-10 and 
cytokines IL-8, IL-6, IL-1α and IL-1β were measured using Luminex. Overall, Lactobacillus 
isolates suppressed the inflammatory response of VK2 cells to G. vaginalis (98). A total of 
eight Lactobacillus isolates, including L. jensenii 3, L. vaginalis 3, L. crispatus 3, L. mucosae 
2, L. crispatus 1, L. jensenii 2, L. mucosae 4, L. vaginalis 4 were selected for the current study 
based on their abilities to suppress inflammatory responses to G. vaginalis (ATCC 14018), 
clade 1 (111). 
2.2.4 Bacterial culture and standardisation 
Bacterial culture media was prepared according to Appendix I. Lactobacillus spp. and G. 
vaginalis frozen stocks stored in 60% glycerol were used to inoculate MRS broth (Sigma-
Aldrich, USA) and Brain heart infusion broth (BHI; Sigma-Aldrich, USA), respectively.  
Prior to this study, baseline CFU/ml in cultures standardised to an optical density (OD) of 
0.1+0.01 for the Lactobacillus spp. and G. vaginalis were quantified by Ms Manhanzva 
(Medical Virology, UCT) to allow for standardisation of cultures using OD measurements. 
Lactobacillus spp. and G. vaginalis were inoculated from frozen stocks in 1.5ml MRS and BHI 
broth and incubated anaerobically for 48 hours, at 37°C. Thereafter, 1ml of each culture was 
sub-cultured in 14ml MRS (for lactobacilli) or BHI (for G. vaginalis) and incubated for 24 hours. 
An aliquot of 1.5ml of each culture was then centrifuged at 10 000rpm for 5 minutes, washed 
twice with 1ml PBS (Sigma-Aldrich, USA) and resuspended in 1ml of MRS or BHI. The OD at 
wavelength 600nm (OD600) was measured for each culture using a spectrophotometer 
(Thermo Fisher Scientific Inc., USA) and standardised to an OD600 of 0.1+0.01 with MRS or 
BHI broth. For all Lactobacillus spp. and the G. vaginalis culture, serial dilutions of 1:100 in 
MRS or BHI were performed and 50µl of each dilution was plated onto MRS or BHI agar plates 
and incubated anaerobically for 48 hours at 37°C. Thereafter, the CFU/ml per plate were 
counted and used to calculate the baseline CFU/ml for each sample at OD600 0.1+0.01, to be 
used for downstream standardization of samples.  
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Standardisation of the bacterial cultures to CFU/ml was performed by measuring the optical 
density at 600nm (OD600) using a spectrophotometer (Thermo Fisher Scientific Inc., USA), of 
1:10 dilutions of the cultures. These OD600 readings were then multiplied by 10 to obtain the 
OD600 of the neat cultures. Using these readings the number of bacteria in the neat cultures, 
baseline CFU/ml and the relative volumes needed to obtain the required CFU/ml, were 
calculated.  
 
2.2.5 Human primary vaginal epithelial cell (VK2) culture 
2.2.5.1 Thawing VK2 cells 
Human vaginal epithelial cells [VK2/E6E7 (ATCC® CRL­2616™)] were cultured in 
Keratinocyte-Serum Free Medium (KSFM; GIBCO-BRL 17005042, Thermo Fisher Scientific, 
USA), supplemented with 0.1ng/ml human recombinant epidermal growth factor (EGF), 
0.05mg/ml bovine pituitary extract (BPE), additional calcium chloride 44.1mg/L (final 
concentration 0.4mM) and 1% penicillin and streptomycin (pen/strep), recommended by 
ATCC. The frozen cell stocks were thawed by gentle agitation in a 37°C water bath, transferred 
to 9ml prewarmed (at 37°C) KSFM and centrifuged at 2000rpm for 7 minutes. The supernatant 
was then removed, and the cell pellet was resuspended in 1ml KSFM and transferred to a T25 
cell culture flask containing 7.5ml prewarmed (at 37°C) KSFM and incubated at 37°C with 5% 
CO2.  
2.2.5.2 VK2 cell subculture 
An inverted light microscope was used to monitor the confluency of the cells and the cells 
were subcultured at 60% confluency. To subculture, the old KSFM media was removed and 
the cells were washed twice with 5ml PBS (Sigma-Aldrich, USA) prewarmed at 37°C. 
Thereafter, the cells were lifted with prewarmed 3ml tryplE express reagent (ThermoFischer 
Scientific, USA) for a T25 flask or 5ml for a T75 flask and incubated at 37°C, 5% CO2 for 5-10 
minutes. Alternatively, 1ml trypsin/ethylenediaminetetraacetic acid (EDTA) (0.25%) for a T25 
flask and 3ml for a T75 flask was used to detach the cells. Once the cells were detached from 
the culture flask the dissociation reagent was neutralised with 5ml (for a T25 flask) or 8ml (for 
a T75 flask) of Dulbecco’s Modified Eagle’s Medium/HamsF12 (DMEM:HamsF12; Sigma-
Aldrich, USA) containing 10% bovine foetal calf serum (FCS) and centrifuged at 2000rpm for 
7 minutes. The supernatant was then removed, and the cell pellet was resuspended in 1ml 
KSFM. A manual cell count was done by trypan blue staining of 15µl of the cell suspension 
with 15µl of trypan blue dye (Gibco, ThermoFischer, USA). This suspension was then pipetted 
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onto a haemocytometer and viewed using a light microscope. The cells were counted in two 
quadrants of the haemocytometer and the total cell count was obtained using the following 
formula: (A + B) x 104 x 1ml. The volume of cell suspension for the required seeding density 
into culture flasks, transwells or 24 well plates, was then calculated based on the ratio of cells 
in the 1ml suspension, to the required cell seeding density.  
 
2.2.6 Optimization of methods for bacterial-VK2 cell coculture  
Pilot assays were performed in order to assess and optimize (i) VK2 cell growth and viability 
under experimental conditions, (ii) cell storage media to optimize RNA yield and quality and 
(iii) cytokine responses under different culture conditions.   
2.2.6.1 VK2 cell culture in transwells 
As previous experiments characterising the anti-inflammatory effects of Lactobacillus isolates 
had been conducted in 24-well culture plates (29), culture of VK2 cells in transwell systems 
was first optimised. Corning transwell polyester membrane 24mm (6 well) cell culture inserts 
(Sigma-Aldrich CLS3450, USA) were used to culture VK2 cells. The system contains an apical 
and basal compartment which contain KSFM media, with the cells cultured on the polyester 
membrane containing 0.4µm pores to allow for the diffusion of media and cellular metabolites 
(manufacturer’s protocol). Prior to seeding the cells, 2.6ml KSFM media was added to the 
apical and 1.4ml to the basal compartments of the transwell system and incubated at 37°C, 
5% CO2 for 1 hr for an initial equilibrium period which aids in cell attachment, as recommended 
by the manufacturer’s protocol. A seeding density of 0.3 x 106 cells/well was used and the cells 
were grown for 7 days at 37°C, 5% CO2, with media changed every 2-3 days.  
Following the 7-day incubation period, the cells were harvested for RNA extraction. The KSFM 
media was removed and the cells were washed thrice with PBS. Thereafter, 1ml and 1.5ml 
trypsin/EDTA was added to the apical and basal compartments, respectively and incubated at 
37°C, 5% CO2 for 5-10 minutes until the cells were detached from the membrane. An inverted 
light microscope was used to monitor the detachment of the cells. A total of 5ml 
DMEM:HamsF12 (10% FCS) was used to neutralise the trypsin/EDTA and the cell suspension 
was centrifuged at 2000rpm for 7 minutes. Thereafter, the supernatant was discarded, the cell 
pellet loosened by flicking and resuspended in 1ml KSFM. Cell counts were performed as 
described above. The cell suspension was then centrifuged again at 2000rpm for 7 minutes, 
the supernatant discarded, and the cell pellet resuspended in either 350µl RLT lysis buffer 
(Qiagen, USA) containing 1% 12M beta-mercaptoethanol (BME) or RNALater (Sigma-Aldrich, 
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USA) RNA stabilizing reagent. The samples which were resuspended in RLT buffer were 
vigorously vortexed for 60 seconds to ensure complete homogenization. All samples were 
stored at -80°C until RNA extraction.  
 
2.2.6.2 Bacterial stimulation of VK2 cells in transwell culture systems 
A total of 0.3 x 106 cells/well was seeded onto each transwell insert and cultured for 7 days as 
described above, after which bacterial stimulation of the cells was performed. The 
Lactobacillus isolates and G. vaginalis were cultured for 24 and 48 hours, respectively and 
standardised as previously described (29). Lactobacillus isolates and G. vaginalis cultures 
were standardised to 16.72 x 106 CFU/well in 1.5ml of media. This CFU/well was based on 
the culture volume of the 6-well transwell inserts proportional to the 24 well plate culture. A 
total of 750µl of each standardized Lactobacillus spp. and G. vaginalis was added to the wells 
and therefore 3x the number of CFUs used in previous 24 well experiments (29) was used for 
the transwell culture system. 
Whereas previously, we had incubated VK2 cells with Lactobacillus isolates for 5 hours, 
followed by a 20 hours incubation with G. vaginalis prior to measurement of protein 
concentrations (29), for assessment of mRNA, a shorter incubation period was needed to 
ensure the detection of mRNA before its degradation.  Lactobacillus isolates were thus co-
cultured with VK2 cells at 37°C, 5% CO2 for 3 hours. Thereafter, G. vaginalis was co-cultured 
with the lactobacilli pre-treated VK2 cells and incubated for an additional 3 hours at 37°C, 5% 
CO2. Unstimulated cells and cells stimulated with G. vaginalis in isolation were used as 
controls.  Thereafter, the cell supernatants were collected and centrifuged in 0.4µm Corning® 
Costar® SpinX tubes (ThermoFischer, USA) at 4000rpm for 10 minutes and stored at -80°C 
for cytokine measurement. For RNA extraction, the cells were harvested from the transwells, 
cell counts and viability assessed and the cells stored in RLT lysis buffer (1% BME) at -80°C 








2.2.6.3 Bacterial stimulation of VK2 cells in 24 well plates 
Previous data show that the VK2 cell viability is unchanged by the addition of these 
Lactobacillus isolates and G. vaginalis in the 24 well plates (98). Therefore, bacterial-VK2 co-
culture experiments were also conducted in 24 well plates. Three independent experiments 
were performed to obtain three biological replicates for each condition.  
The Lactobacillus isolates and G. vaginalis were cultured in triplicate independent cultures for 
24 hours and 48 hours respectively, as previously described. The cultures were centrifuged at 
4000rpm for 10 minutes, after which the supernatants were discarded, and the bacterial cell 
pellet was resuspended in KSFM without antibiotics. Thereafter, the Lactobacillus isolates 
were standardised to 4.18 x 106 CFU/500µl and G. vaginalis was standardised to 4.18 x 107 
CFU/500µl as previously described (29).  
The VK2 cells were cultured as previously described, from 3 frozen vial stocks for which 3 
independent assays were performed. A total of 0.5 x 106 VK2 cells/well were seeded into 24 
well plates and cultured to 80% confluency. VK2 cells were co-cultured with each Lactobacillus 
isolate (4.18x106CFU/well) in 500µl of media at 37°C, 5% CO2 for 6 hours, in triplicate. 
Thereafter, G. vaginalis (4.18x107CFU/well) in 500µl of media was co-cultured with lactobacilli 
pre-treated VK2 cells in a final volume of 1ml media/well, for an additional 6 hours at 37°C, 
5% CO2. Cells only and G. vaginalis-VK2 cell co-culture controls were included in duplicate for 
each independent biological triplicate.  
Following the 12-hour incubation, the cell supernatants were collected, centrifuged in 0.4µm 
SpinX tubes at 4000rpm for 10 minutes and stored at -80°C for cytokine and lactic acid 
detection assays. Thereafter, the cells were washed thrice with 500µl PBS. To detach the cells 
from the well surface, 300µl of prewarmed typlE express reagent (Gibco, ThermoFischer, 
USA) was added to each well and the cells were incubated at 37°C, 5% CO2 for 10 minutes. 
Cell scrapers (TPP, Germany) were used to detach the remaining cells on the well surface. 
The tryplE express reagent was neutralised with 700µl of DMEM:Ham’sF12. An aliquot of 15µl 
of the cell suspension was used for cell counting by trypan blue staining as described above. 
The cell suspension was centrifuged at 2000rpm for 7 minutes. Thereafter, the supernatant 
was removed, and the cell pellet was loosened by flicking, resuspended in 350µl of RLT lysis 
buffer (1% BME) and vortexed vigorously to homogenize the sample. The samples were then 





2.2.7 RNA extraction  
RNA extraction was performed using the RNeasy Plus Mini Kit (Qiagen, Germany) according 
to the manufacturer’s instructions. Reagents were reconstituted according to the kit protocol. 
The samples stored in RNALater were first centrifuged at 3000xg for 5 minutes, thereafter the 
supernatants were discarded, the cells were resuspended in 350µl RLT lysis buffer (1% BME) 
and homogenized by vortexing vigorously. A total of 350µl of 70% ethanol was added to each 
sample in a spin column placed in a collection tube and centrifuged for 15 seconds at 
10 000rpm. The flow through was then discarded and the spin column placed back into the 
collection tube. Thereafter, 700µl RW1 buffer was added to the spin column and centrifuged 
at 10 000rpm for 15 seconds, the flow through was then discarded and the spin column placed 
back into the collection tube. A total of 500µl of buffer RPE was used to wash the column 
membrane and centrifuged at 10 000rpm for 15 seconds. The flow through was then 
discarded. Thereafter, 500µl of RPE was added to the spin column and centrifuged for 2 
minutes. The spin column was then placed into a new 1.5ml collection tube. For the final RNA 
elution step, a total of 30µl of RNase free water prewarmed to 42°C was added to the spin 
column and centrifuged for 1 minute at 10 000rpm. Using another 30µl of prewarmed RNase 
free water, the elution step was repeated. The total RNA volume for each sample was thus 
60µl. RNA samples were stored at -80°C in 2 aliquots, a separate aliquot for RNA quality 
assessment.   
 
2.2.8 Cytokine detection by Luminex assay 
Cell culture supernatants were thawed at 4°C overnight prior to conducting the Luminex assay. 
In order to measure the concentrations of 10 cytokines in the cell culture supernatants of VK2 
cells stimulated by bacteria, a magnetic Luminex Screening Assay (Human Premixed Multi-
Analyte Kit; R&D Systems, Biotechne) was performed. The cytokines measured included: 
interleukin-8 (IL-8), macrophage inflammatory protein-1-alpha and beta (MIP-1α and MIP-1β), 
interleukin-6 (IL-6), interferon-gamma-induced protein (IP-10), interleukin 1-beta (IL-1β), 
macrophage inflammatory protein-3-alpha (MIP-3α), interleukin-1-alpha (IL-1α), interleukin-1 
receptor antagonist (IL1-RA) and monokine induced by interferon-gamma (MIG/CXCL9).  
These cytokines were selected based on previous studies that have demonstrated that 
Lactobacillus spp. and their metabolites reduced inflammatory responses by FGT epithelial 
cells in vitro (28,29,112). In addition, these Lactobacillus spp. isolated from the WISH cohort 




All the kit reagents were at room temperature and prepared according to the manufacturer’s 
protocol. Standard 1 (highest concentration) consisted of 100µl of each standard added to 
500µl of calibrator diluent RD6-52. Using standard 1, a 3-fold dilution series was performed to 
prepare standards 2-6 in calibrator diluent RD6-52. 
Standards and samples were then added to wells on a 96 well microplate (50µl of each) 
according to a plate layout. Diluent RD1-2 was used to dilute the microparticles, mixed well by 
vortex and 50µl was added to each well containing either standard or sample. A foil plate 
sealer was used to protect the plate from light and incubated at room temperature for 2 hours 
on a horizontal plate shaker, set to 800rpm.  
Thereafter, the microplate was placed on an automated magnetic plate washer (Bio-Plex 
ProTM Wash Station, Bio-Rad Laboratories, USA) which draws the microparticles to the bottom 
of the plate during the wash steps. The microplate was washed thrice with wash buffer.  
Diluent RD2-1 was used to dilute the biotin antibody cocktail and 50µl was added to each well 
on the 96 well microplate. The plate was then incubated at room temperature, protected from 
light for 1 hour on a horizontal plate shaker set at 800rpm. Thereafter, the wash steps were 
repeated as described above. Streptavidin-Phycoerythrin (PE) was diluted in wash buffer and 
50µl was added to each well. The plate was incubated at room temperature, protected from 
light for 30 minutes on a horizontal plate shaker set at 800rpm. The wash steps were then 
repeated, followed by resuspension of the microparticles with by adding 100µl wash buffer to 
each well. The plate was incubated at room temperature for 2 minutes on a horizontal plate 
shaker set at 800rpm. Thereafter, a Bio-PlexTM Suspension Array Reader (Bio-Rad 
Laboratories Inc®, USA) was used to read the microplate and cytokine concentrations were 
calculated using BIO-plex manager software (version 4; Bio-Rad Laboratories Inc®, USA) 
from standard curves using a 5-parameter logistic regression (Appendix II).  
 
2.2.9 Detection of lactic acid in stimulated VK2 cell culture supernatants and pH 
measurement 
Colorimetric assay kits (Sigma-Aldrich, USA) were used to measure the concentrations of D- 
and L- lactate in the VK2 cell culture supernatants following stimulation with bacterial isolates 
in 24 well plates. Frozen supernatants were thawed at 4°C overnight and assay kits were 
thawed at room temperature prior to usage. Reagents were reconstituted according to the kit 
protocol. Standards of 0, 2, 4, 6, 8 and 10nmole were prepared according to the kit protocol. 
D- and L-lactate standards were added in duplicate to the appropriate wells on 96 well plates 
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and brought to a final volume of 50μl with D- and L- lactate assay buffers, respectively. Sample 
were added to appropriate wells on each plate in duplicate (50µl of each sample).  
Reaction mixes were prepared according to the kit protocol; volumes were adjusted according 
to the number of wells used. The D-lactate reaction mix was made up of D-lactate assay buffer, 
D-lactate enzyme mix and D-lactate substrate. The L-lactate reaction mix was made up of L-
lactate assay buffer, L-lactate enzyme mix and L-lactate probe. D- or the L-lactate reaction 
mix was added to all wells on the 96 well plates (50µl/well). The plates were incubated for 30 
minutes at room temperature protected from light. An ELISA plate reader (VersaMaxTM, 
Molecular Devices LLC, USA) was used to measure the absorbance at 450nm for D-lactate 
and 570nm for L-lactate.  
Prior to generating the standard curves using GraphPad Prism V.8 (GraphPad Prism 
Software, USA; Appendix III), absorbance readings of the standard blanks were subtracted 
from all standards. The absorbance of the sample blank was subtracted from all sample 
absorbance readings as well. The standard curves were used to interpolate the D- and L- 
lactate amounts (nmole) using GraphPad Prism and the concentrations (ng/ml) were 
calculated using the equations in Appendix IV provided by the manufacturer’s protocol.  
The pH levels of the samples were measured using pH strips range 1-14 (Macherey-Nagel, 
Germany). Calculation of total lactic acid was done using the Henderson-Hasselbalch 
equation: 







2.2.10 Microarray Affymetrix assay 
The microarray Affymetrix assay was performed at the Centre for Proteomics and Genomic 
research (CPGR), Cape Town, South Africa. The samples were prepared for microarray using 
a GeneChipTM WT PLUS Reagent kit according to the manufacturer’s protocol. The detailed 
protocol is included in Appendix V. Briefly, double-stranded cDNA synthesis was followed by 
cRNA synthesis and purification. cRNA yield of each sample was assessed by using a 
NanoDrop spectrophotometer. cRNA size distribution was assessed using an Agilent 2100 
Bioanalyzer. The cRNA was then reverse transcribed using second-cycle primers, 
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synthesizing sense-strand cDNA. The cRNA template of the RNA-DNA hybrid was then 
hydrolysed using RNAse H, generating single stranded cDNA. The remaining sense-strand 
cDNA was then purified using purification beads, to remove enzymes, salts and 
unincorporated dNTPs. cDNA yield and size distribution of each sample was assessed using 
a NanoDrop spectrophotometer and an Aligent 2100 Bioanalyzer. Uracil-DNA glycosylase 
(UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) was used to fragment the sense-
strand cDNA. A DNA labelling reagent linked to biotin was used to label the fragmented cDNA 
by terminal deoxynucleotidyl transferase (TdT). The hybridization master mix was prepared 
and added to the fragmented and labelled ss-cDNA samples producing a hybridization cocktail 
and incubated according to the manufacturer’s protocol. The hybridization cocktail was added 
to the GeneChipTM Cartridge Array and incubated. Thereafter, the Array was washed and 
stained according to the manufacturer’s protocol. The GeneChip Cartridge Array was then 
scanned.  
 
2.2.11 Data analysis 
GraphPad Prism V.8 (GraphPad Software, USA), STATA v13.1, R Studio v1.2.5001 (RStudio, 
USA) and the Database for Annotation, Visualization and Integrated Discovery (DAVID 
Bioinformatics resources) v6.8, were used to analyse data. Prior to statistical analysis, data 
distribution was tested using the Shapiro-Wilk test. Parametric statistical tests were used for 
normally distributed data and non-parametric statistical tests were used for data which was 
not normally distributed.  
2.2.11.1. Illumina microarray data  
The Illumina microarray data analysis workflow by Du et al. (2010) (113), with modifications, 
was used to analyse the data. The data were normalized using Illumina BeadStudio by 
subtracting background and scaling the average signal intensity for each sample to the global 
average signal intensity for all 10 samples. The data were then log2-transformed and 
normalised by quantile normalisation, followed by quality control assessment to detect 
potential outlier data points, using the R Studio Bioconductor lumi package. The R Studio 
Bioconductor limma package was then used for differential gene expression analysis of CMCs 
compared to PBMCs. Differentially expressed genes were filtered according to adjusted p-
values and were considered significantly expressed if adj. p≤0.05. Furthermore, the significant 
differentially expressed genes were filtered based on log fold change (FC) and were 
considered upregulated or downregulated if logFC≥1.5 or logFC≤-1.5, respectively. Principal 
components analysis (PCA) and a heatmap displaying hierarchical clustering of differentially 
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expressed genes were generated using R studio mixOmics and complexHeatmap packages, 
respectively. All R scripts used are in Appendix VI. Genes were annotated using the Illumina 
humanHT-12 v3 annotation file (114) Gene Entrez IDs were inputted into the DAVID 
Bioinformatics resources v6.8 (115) and to obtain Kyoto Encyclopedia of Genes and Genomes 
(KEGG) biological pathways upregulated and downregulated in CMCs compared to PBMCs. 
DAVID Bioinformatics resources v6.8 gene enrichment pathway analysis is performed using 
an EASE Score, which is a Fisher Exact P-value. A P-value ≤ 0.05 is considered an enriched 
KEGG pathway (116,117). The Fisher’s Exact test statistically tests whether the proportion of 
DEGs mapped to the KEGG pathway are by random chance in comparison to the proportion 
of genes in the human genome involved in the KEGG pathway (116,117). CIBERSORT and 
xCell analyses of gene expression data were used to enumerate immune cell populations in 
CMCs and PBMCs (118,119).  
2.2.11.2. Luminex cytokine data 
An unpaired two-tailed non-parametric Mann-Whitney U test was used to evaluate differences 
in cytokine responses of VK2 cells induced by G. vaginalis (4.18x107CFU/well) alone and in 
combination with each Lactobacillus isolate (4.18x106CFU/well) in 1ml of media. PCA plots 
and heatmaps displaying unsupervised hierarchical clustering of cytokine responses were 
generated using R Studio mixOmics and heatmap packages (script in Appendix VII). PCA 
was also used to group all inflammatory cytokines and chemokines and generate estimates 
representative of the overall inflammatory responses. P-values were adjusted for multiple 
comparisons using a false discovery rate step-down procedure (120). Statistical correlations 
between lactic acid production and cytokine responses were evaluated using Spearman’s 
Rank correlation.  
2.2.11.3. Affymetrix microarray data 
The affymetrix microarray data analysis workflow by Klaus & Reisenauer (2018) (121), with 
modifications, was used to pre-process the data. The raw data CEL files were inputted into R 
studio, log2-transformed using the Bioconductor oligo and Biobase packages. Quality control 
assessments to detect potential outliers, were done using the R Studio oligo and 
arrayQualityMetrix packages. Affymetrix raw data were normalized by Robust Multichip 
Average (RMA) normalization using the oligo package in R studio. PCA and heatmaps 
showing hierarchical clustering of genes were generated using R Studio ggplot and ggplot2 
package. The R Studio Bioconductor limma package was used for differential gene expression 
analysis of VK2 cells stimulated with G. vaginalis (4.18x107CFU/well) alone and in 
combination with each Lactobacillus isolate (4.18x106CFU/well) in 1ml of media. Differentially 
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expressed genes were filtered according to adjusted p-value and were considered significantly 
expressed if adj.p≤0.05. Significantly differentially expressed genes were filtered according to 
logFC and genes were considered upregulated or downregulated if logFC>1.5 or logFC<-1.5, 
respectively. Genes were annotated using the Clariom S HumanHT annotation file (122) . 
Gene Entrez IDs were inputted into DAVID Bioinformatics resources v6.8 (115) and the WEB-
based Gene Set analysis Toolkit (WebGestalt) (123) to obtain KEGG biological pathways 
upregulated and downregulated in VK2 cells stimulated with G. vaginalis  alone and in 
combination with each Lactobacillus isolate. Fisher’s Exact statistical test was used for 
enrichment analysis of KEGG pathways as described above (116,117). All R scripts used are 




















Chapter 3: Results 
3.1 Groote Schuur study cohort 
Matched cervical cytobrush and blood samples were collected from five black, chronically HIV-
infected women who were enrolled at the Gynaecology Outpatient Clinic, Groote Schuur 
Hospital, Cape Town, South Africa (Principal Investigator: Associate Professor Jo-Ann 
Passmore). A total of 60% (n=3) of participants were viral load (VL) suppressed (plasma 
VL<50 copies/ml) and 40% (n= 2) of participants had detectable viral loads, while the average 
blood CD4+ T cell count of the participants was 605.4 cells/ul (Table 1). None of the women 
had clinical signs or symptoms of STIs or BV. However, one participant was diagnosed with a 
stenosed cervix (Table 1).  
Table 1 Demographic and clinical characteristics of Groote Schuur cohort  
Demographic characteristics n (%) 
South African 5 (100) 
Black race 5 (100) 
Clinical characteristics  
Chronic HIV-1+ 5 (100) 
ARV treatment 5 (100) 
Average CD4+ count (cells/µl) 605.4 
Detectable VL 2/5 (40) 
BV/STI signs or symptoms 0/5 (0) 
Cervical stenosis 1/5 (10) 









3.2 Gene transcription of matched CMCs and PBMCs 
Using a microarray Illumina HumanHT-12 v3 Gene Expression BeadChip platform, the 
potential differences in gene transcription of CMC compared to matched PBMC samples 
obtained from HIV-infected women, were evaluated.  
The RNA quality was assessed for all samples. The samples showed some RNA degradation, 
however the quality of all samples was suitable for microarray analysis. RNA integrity numbers 
(RIN) obtained were 5.3-8.4 and 8.6-9.8, for CMC and PBMC samples, respectively 
(Appendix IX). A total of three CMC samples, NY76_CMC, NY82_CMC and NY133C_CMC 
had partially degraded RNA, RINs 6.4, 7.4 and 5.3, respectively (Appendix IX). All PBMC 
sample RINs were above 8, which is considered good quality RNA with minimal degradation 
(Appendix IX). The RNA quantity of the samples was above the required input for microarray 
analysis (Appendix IX).  
A total of 48668 genes were detected. Prior to normalization, although median values for all 
samples tended to be similar, some variation was observed, particularly for sample 
NY76_CMC which had the highest median intensity value (Figure 2A). Following quantile 
normalization, no outliers were detected and all median values for the samples were the same 
(Figure 2B). Further analysis was done using the normalized data. Additional quality control 
assessment of the normalized microarray data were then performed to further detect potential 
outliers, of which there were none (Appendix X). CMC and PBMC samples clustered together, 







Figure 3 Relationships between samples based on 48668 genes expressed in CMC and PBMC samples. RNA was extracted 
from matched CMCs and PBMCs isolated from cervical cytobrush and blood samples obtained from chronically HIV-infected 
women. Gene expression analysis of RNA samples were evaluated using Illumina Human HT-12 V3 Gene Expression Beadchip. 
Quantile normalization was performed on raw data. Normalized data were preprocessed using the R Bioconductor lumi 
package. Relationships between samples based on 48668 genes was plotted using hierarchical clustering. The lengths of the 
vertical lines in the dendrogram indicate the degree of relatedness to the adjacent samples or clusters. Blue: CMC sample 













Figure 2 Quantile normalized Illumina microarray raw data of matched CMC and PBMC samples. A) Boxplots showing raw 
data. B) Boxplots showing quantile normalized raw data. Horizontal lines of boxes indicate the first quartile, median and 
third quartile, while the error bars indicate the minimum and maximum signal intensities, for each sample. RNA was 
extracted from matched CMCs and PBMCs isolated from cervical cytobrush and blood samples obtained from chronically 
HIV-infected women. Gene expression analysis of RNA samples were evaluated using Illumina Human HT-12 V3 Gene 
Expression Beadchip. Quantile normalization was performed on raw data using the lumi R package. CMC: cervicovaginal 
mononuclear cells, PBMC: Peripheral blood mononuclear cells.  
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3.3 Genes differentially expressed in CMCs compared to PBMCs and 
downstream signalling pathways detected 
The R Studio Bioconductor limma package was used to identify genes that were differentially 
expressed in CMCs compared to PBMCs. Although this study included a small sample size,  
2867 genes were significantly differentially expressed in CMCs compared to PBMCs, adjusted 
(adj.) p≤0.05 (Figure 4A), with 119 genes upregulated (logFC≥1.5) and 57 genes 
downregulated (logFC≤-1.5) in CMCs compared to PBMCs (Figure 4B, Appendix XI). 
Downstream pathway analysis, using DAVID Bioinformatics resources v6.8 revealed that five 
genes that were upregulated in CMCs compared to PBMCs mapped to the NF-κB signalling 
pathway (IL-1β, TNF-R1, IκBα, IL-8 and COX2; Figures 5A and 6), four mapped to the TLR 
signalling pathway (IκBα, OPN, IL-1β and IL-8; Figures 5A and 7) and five mapped to the 
TNF signalling pathway (TNF-R1, IκBα, IL-1β, NF-κB iα and Ptgs2; Figures 5A and 8). A total 
of 7 genes encoding large (S15e, L17e, S3, S29e, S15Ae, L19e, S14e) and 8 genes encoding 
short ribosomal subunits (L30e, L21e, S3Ae, S6e, S17e, S27e, S27Ae, S12e) were 
downregulated in CMCs compared to PBMCs (Figures 5B and 9). Downregulated genes in 
CMCs compared to PBMCs which mapped to the sphingolipid pathway, were Fyn, PI3K, S1P1 
and S1P5 (Figures 5B and 10), to the T cell receptor signalling pathway, were Fyn, CD3ζ, 
ITK and PI3K (Figures 5B and 11) and to the natural killer cell mediated cytotoxicity pathway, 
were CD48, Perforin, CD3ζ, Fyn and PI3K (Figures 5B and 12). Key genes significantly 
upregulated in proinflammatory pathways were IL-1β, TNF-R1 and IL-8 (adj. p=2.6112x10-5, 
adj. p=0.0036, adj. p=0.0003, respectively, Figure 13A-C). Key genes significantly 
downregulated in pathways were Fyn, CD3ζ and PI3K (adj. p=0.0002, adj. p=0.0002, adj. 
p=2.6112x10-5, respectively, Figure 13D-F). Key genes were defined as those which mapped 
to several pathways.  
Although the NF-κB, TNF, TLR and NOD-like receptor signalling pathways were 
overrepresented in CMCs compared to PBMCs (p=0.0018, p=0.0261, p=0.0261, p=0.0437, 
respectively, Figure 5A), significance was not upheld after adjusting for multiple comparisons 
due to the small sample size (adj. p=1, Figure 5A). Ribosome, sphingolipid, T cell receptor 
and natural killer cell mediated cytotoxicity signalling pathways were underrepresented in 
CMCs compared to PBMCs (p=1.8071x10-15, p=0.0243, p=0.0154, p=0.254, respectively, 
Figure 5B), with the ribosome pathway remaining significant after adjusting for multiple 
comparisons (adj. p=2.0095x10-12, Figure 5B).  
CIBERSORT and xCell analyses of the gene expression data were used to evaluate the 
predicted absolute abundance of cell populations in CMC and PBMC samples (Appendix XII). 
Overall, the CIBERSORT predicted abundance of the majority of immune cell types was 
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greater in CMCs compared to PBMCs (Appendix XII, Figure 52A). However, predicted 
absolute abundance of monocytes, CD8+ T cells, CD4+ naïve T cells, activated natural killer 
cells (p=0.0079) and resting mast cells (p=0.0159) were significantly underrepresented in 
CMCs compared to PBMCs (Appendix XII, Figure 52A). While neutrophils were significantly 
overrepresented in CMCs compared to PBMCs (p=0.0079). However, all significant p-values 
were not upheld after adjusting for multiple comparisons.  
Similarly, xCell predicted abundance of CD4+ T cells, CD4+ memory T cells, CD4+ naïve T 
cells, CD8+ T cells, CD8+ effector T cells (Tem), and CD8+ naïve T cells were significantly 
underrepresented in CMCs compared to PBMCs (adj. p=0.0364, adj. p=0.0492, adj. p=0.0342, 
adj. p= 0.0336, adj. p=0.0346, adj. p= 0.0336, respectively, Appendix XII, Figure 52B). xCell 
predicted mast cell and CD4+ central memory (Tcm) T cell abundance was also significantly 
underrepresented in CMCs compared to PBMCs (p=0.0141 and p=0.0271), however, not 
significantly after adjusting for multiple comparisons. In contrast, xCell predicted abundances 
of epithelial cells and keratinocytes were significantly overrepresented in CMCs compared to 
PBMCs (adj. p=0.0063 and adj. p=0.01575, respectively, Appendix XII, Figure 52B). In 
addition, xCell predicted abundance of platelets, lymphoid progenitor cells (CLP), conventional 
dendritic cells (cDC) and Th1 cells was significantly underrepresented in CMCs compared to 
PBMCs (p=0.0114, p=0.0114, p=0.0322, p=0.0343, respectively), while natural killer T (NKT) 
cells and activated dendritic (aDC) cells were overrepresented in CMCs compared to PBMCs 
(p=0.0184 and p=0.0215, respectively, Appendix XII, Figure 52B), however not significantly 
after adjusting for multiple comparisons.   
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Figure 4 Differential gene expression in CMCs compared to PBMCs. A) Principal component analysis (PCA) clustering of 
samples based on differential gene expression. B) Unsupervised hierarchical clustering of groups based on differential gene 
expression. RNA was extracted from 5 CMC and 5 matched PBMC samples isolated from cervical cytobrush and blood 
samples obtained from chronically HIV-infected women. Gene expression was evaluated using the microarray Illumina 
HumanHT-12 v3 Gene Expression BeadChip platform. Gene expression data were normalized by quantile normalization. 
Differential gene expression analysis was performed using R Bioconductor limma package. Genes were considered 
differentially expressed if adj. p≤0.05 and up- or downregulated if log fold change (FC) ≥ 1.5 or ≤ -1.5, respectively. The 
dendogram above the heatmap indicates the degree of relatedness between the genes expressed. The horizontal “branches” 
have arbitrary lengths and the length of the vertical “branches” indicate the degrees of similarity between the gene 
expression profiles. Purple, through white, to red indicates low to high gene expression. CMC: cervical mononuclear cells, 











Figure 5 Signaling pathways upregulated (A) and downregulated (B) in CMCs compared to PBMCs. The pie chart shows the 
proportion of differentially expressed genes in CMC compared to PBMC samples for each signaling pathway, key 
proinflammatory signaling pathways are boxed. RNA was extracted from 5 CMC and 5 matched PBMC samples isolated from 
cervical cytobrush and blood samples obtained from chronically HIV-1 infected women. Gene expression was evaluated using 
a microarray Illumina HumanHT-12 v3 Gene Expression BeadChip platform. Gene expression data were normalized by 
quantile normalization. Differential gene expression analysis was performed using the R Bioconductor limma package. Genes 
were considered differentially expressed if adj. p≤0.05, and up- or downregulated if log fold change (FC) ≥ 1.5 or ≤ -1.5, 
respectively. Differentially expressed probeset IDs were annotated using the Illumina humanHT-12 v3 annotation file. 
Upregulated gene Entrez identity numbers were inputted to DAVID Bioinformatics resources v6.8 to obtain biological KEGG 
pathways upregulated. CMC: cervical mononuclear cells, PBMC: peripheral blood mononuclear cells. TNF: tumor necrosis 






Figure 6 Upregulated genes in the NF-Kappa B signaling pathway in CMCs compared to PBMCs. KEGG pro-inflammatory 
signaling pathway, adapted from DAVID Bioinformatics resources v6.8 is shown. Red boxes indicate upregulated mediators 
in CMCs compared to PBMCs. RNA was extracted from 5 CMC and 5 matched PBMC samples, isolated from cervical cytobrush 
and blood samples obtained from chronically HIV-1 infected women. Gene expression was evaluated using a microarray 
Illumina HumanHT-12 v3 Gene Expression BeadChip platform. Gene expression data were normalized by quantile 
normalization. Differential gene expression analysis was performed using R Bioconductor limma package. Genes were 
considered differentially expressed if adj. p≤0.05 and up- or downregulated if log fold change (FC) ≥ 1.5 or ≤ -1.5, respectively. 
Differentially expressed probeset IDs were annotated using the Illumina humanHT-12 v3 annotation file. Upregulated gene 
Entrez identity numbers were inputted to DAVID Bioinformatics resources v6.8 to obtain biological KEGG pathways 
upregulated. CMC: cervical mononuclear cells, PBMC: peripheral blood mononuclear cells, IL-1β: Interleukin-1 Beta, TNF-R1: 
tumor necrosis factor receptor 1, IκBα: nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alpha, IL-




Figure 7 Upregulated genes in the Toll-like receptor signaling pathway in CMCs compared to PBMCs. The KEGG pro-
inflammatory signaling pathway, adapted from DAVID Bioinformatics resources v6.8 is shown. Red boxes indicate upregulated 
mediators in CMCs compared to PBMCs. RNA was extracted from 5 CMC and 5 matched PBMC samples, isolated from cervical 
cytobrush and blood samples obtained from chronically HIV-1 infected women. Gene expression was evaluated using a 
microarray Illumina HumanHT-12 v3 Gene Expression BeadChip platform. Gene expression data were normalized by quantile 
normalization. Differential gene expression analysis was performed using R Bioconductor limma package. Genes were 
considered differentially expressed if adj. p≤0.05 and up- or downregulated if log fold change (FC) ≥ 1.5 or ≤ -1.5, respectively. 
Differentially expressed probeset IDs were annotated using the Illumina humanHT-12 v3 annotation file. Upregulated gene 
Entrez identity numbers were inputted to DAVID Bioinformatics resources v6.8 to obtain biological KEGG pathways upregulated. 
CMC: cervical mononuclear cells, PBMC: peripheral blood mononuclear cells, IL-1β: Interleukin-1 Beta, IκBα: nuclear factor of 




Figure 8 Upregulated genes in the TNF signaling pathway in CMCs compared to PBMCs. The KEGG pro-inflammatory 
signaling pathway, adapted from DAVID Bioinformatics resources v6.8 is shown. Red boxes indicate upregulated mediators 
in CMCs compared to PBMCs. RNA was extracted from 5 CMC and 5 matched PBMC samples, isolated from cervical cytobrush 
and blood samples obtained from chronically HIV-1 infected women. Gene expression was evaluated using a microarray 
Illumina HumanHT-12 v3 Gene Expression BeadChip platform. Gene expression data were normalized by quantile 
normalization. Differential gene expression analysis was performed using R Bioconductor limma package. Genes were 
considered differentially expressed if, adj. p≤0.05 and up- or downregulated if log fold change (FC) ≥ 1.5 or ≤ -1.5, 
respectively. Differentially expressed probeset IDs were annotated using the Illumina humanHT-12 v3 annotation file. 
Upregulated gene Entrez identity numbers were inputted to DAVID Bioinformatics resoources v6.8 to obtain biological KEGG 
pathways upregulated. CMC: cervical mononuclear cells, PBMC: peripheral blood mononuclear cells, IL-1β: Interleukin-1 
Beta, IκBα: nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alpha, TNFR1: tumor necrosis factor 




Figure 9 Ribosomal subunits downregulated in CMCs compared to PBMCs. KEGG large and short ribosomal subunits, 
adapted from DAVID Bioinformatics resources v6.8, are shown. Blue boxes indicate downregulated mediators in CMCs 
compared to PBMCs. RNA was extracted from 5 CMC and 5 matched PBMC samples, isolated from cervical cytobrush and 
blood samples obtained from chronically HIV-1 infected women. Gene expression was evaluated using a microarray Illumina 
HumanHT-12 v3 Gene Expression BeadChip platform. Gene expression data were normalized by quantile normalization. 
Differential gene expression analysis was performed using R Bioconductor limma package. Genes were considered 
differentially expressed if adj. p≤0.05 and up- or downregulated if log fold change (FC) ≥ 1.5 or ≤ -1.5, respectively. 
Differentially expressed probeset IDs were annotated using the Illumina humanHT-12 v3 annotation file. Upregulated gene 
Entrez identity numbers were inputted to DAVID Bioinformatics resources v6.8 to obtain biological KEGG pathways 




Figure 10 Downregulated genes in the Sphingolipid signalling pathway in CMCs compared to PBMCs. The KEGG sphingolipid 
signaling pathway, adapted from DAVID Bioinformatics resources v6.8 is shown. Blue boxes indicate downregulated 
mediators in CMCs compared to PBMCs. RNA was extracted from 5 CMC and 5 matched PBMC samples, isolated from cervical 
cytobrush and blood samples obtained from chronically HIV-1 infected women. Gene expression was evaluated using a 
microarray Illumina HumanHT-12 v3 Gene Expression BeadChip platform. Gene expression data were normalized by quantile 
normalization. Differential gene expression analysis was performed using R Bioconductor limma package. Genes were 
considered differentially expressed if adj. p≤0.05 and up- or downregulated if log fold change (FC) ≥ 1.5 or ≤ -1.5, respectively. 
Differentially expressed probeset IDs were annotated using the Illumina humanHT-12 v3 annotation file. Upregulated gene 
Entrez identity numbers were inputted to DAVID Bioinformatics resources v6.8 to obtain biological KEGG pathways 
upregulated. CMC: cervical mononuclear cells, PBMC: peripheral blood mononuclear cells, Fyn: proto-oncogene tyrosine-
protein kinase Fyn, PI3K: phosphoinositide 3-kinase, S1P1: sphinogosine-1-phosphate 1 receptor, S1P5: sphingosine-1-




Figure 11 Downregulated genes in the T cell receptor signalling pathway in CMCs compared to PBMCs. The KEGG 
sphingolipid signaling pathway, adapted from DAVID Bioinformatics resources v6.8, is shown, blue boxes indicate 
downregulated mediators in CMCs compared to PBMCs. RNA was extracted from 5 CMC and 5 matched PBMC samples, 
isolated from cervical cytobrush and blood samples obtained from chronically HIV-1 infected women. Gene expression was 
evaluated using a microarray Illumina HumanHT-12 v3 Gene Expression BeadChip platform. Gene expression data were 
normalized by quantile normalization. Differential gene expression analysis was performed using R Bioconductor limma 
package. Genes were considered differentially expressed if adj. p≤0.05 and up- or downregulated if log fold change (FC) ≥ 1.5 
or ≤ -1.5, respectively. Differentially expressed probeset IDs were annotated using the Illumina humanHT-12 v3 annotation 
file. Upregulated gene Entrez identity numbers were inputted to DAVID Bioinformatics resources v6.8 to obtain biological 
KEGG pathways upregulated. CMC: cervical mononuclear cells, PBMC: peripheral blood mononuclear cells, Fyn: proto-




Figure 12 Downregulated genes in the Natural killer cell mediated cytotoxicity pathway in CMCs compared to PBMCs. The 
KEGG pro-inflammatory signaling pathway, adapted from DAVID Bioinformatics resources v6.8, is shown. Blue boxes indicate 
downregulated mediators in CMCs compared to PBMCs. RNA was extracted from 5 CMC and 5 matched PBMC samples, 
isolated from cervical cytobrush and blood samples obtained from chronically HIV-1 infected women. Gene expression was 
evaluated using a microarray Illumina HumanHT-12 v3 Gene Expression BeadChip platform. Gene expression data were 
normalized by quantile normalization. Differential gene expression analysis was performed using R Bioconductor limma 
package. Genes were considered differentially expressed if adj. p≤0.05 and up- or downregulated if log fold change (FC) ≥ 
1.5 or ≤ -1.5, respectively. Differentially expressed probeset IDs were annotated using the Illumina humanHT-12 v3 
annotation file. Upregulated gene Entrez identity numbers were inputted to DAVID Bioinformatics resources v6.8 to obtain 
biological KEGG pathways upregulated. CMC: cervical mononuclear cells, PBMC: peripheral blood mononuclear cells. Fyn: 
proto-oncogene tyrosine-protein kinase Fyn, PI3K: phosphoinositide 3-kinase, CD3ζ: CD3 zeta chain of CD4+ and CD8+ T cells, 






Figure 13 Key upregulated and downregulated genes common to inflammatory signalling pathways. Raw average signal 
intensity data for key genes involved in pro-inflammatory signalling pathways that were A-C) upregulated and D-F) 
downregulated in CMCs compared to PBMCs are shown. RNA was extracted from 5 CMC and 5 matched PBMC samples, 
isolated from cervical cytobrush and blood samples obtained from chronically HIV-1 infected women. Gene expression was 
evaluated using a microarray Illumina HumanHT-12 v3 Gene Expression BeadChip platform. Gene expression data were 
normalized by quantile normalization. Differential gene expression analysis was performed using R Bioconductor limma 
package. Genes were considered differentially expressed if adj. p≤0.05 and up- or downregulated if log fold change (FC) ≥ 
1.5 or ≤ -1.5, respectively. Differentially expressed probeset IDs were annotated using the Illumina humanHT-12 v3 
annotation file. Upregulated gene Entrez identity numbers were inputted to DAVID Bioinformatics resources to obtain 
biological KEGG pathways upregulated in CMCs compared to PBMCs. CMC: cervical mononuclear cells, PBMC: peripheral 
blood mononuclear cells, IL1β: Interleukin 1 Beta, TNF-R1: tumor necrosis factor receptor 1, IL8: Interleukin 8, Fyn: proto-











































































































3.4. WISH study cohort and Lactobacillus selection 
The WISH study enrolled 149 women in Masiphumelele, Cape Town, South Africa between 
2013 and 2015 (110). Lateral wall and vulvovaginal swabs were collected to test for STIs, 
Nugent scoring and candidiasis diagnosis, as mentioned above. Cervicovaginal fluid was also 
collected, from which 115 Lactobacillus species and strains were isolated. Eight Lactobacillus 
isolates of varying species were selected for the current study (Table 2) based on their 
previously determined in vitro inflammatory profiles, (Figure 14) (98).  
 













STI status Swab pH SC pH 
Lactobacillus jensenii 3 (LJ3)   18 10 Pos Neg 5.3 5.6 
Lactobacillus vaginalis 3 (LV3) 18 0 Neg NG 4.7 3.6 
Lactobacillus crispatus 3 (LC3) 17 0 Neg Neg 4.4 4.1 
Lactobacillus mucosae 2 (LM2) 22 8 Pos HSV-2 4.4 4.8 
Lactobacillus crispatus 1 (LC1)    19 2 Neg Neg 4.1 4.7 
Lactobacillus jensenii 2 (LJ2) 17 1 Neg CT,NG,TV 4.1 3.6 
Lactobacillus mucosae 4 (LM4) 21 8 Pos Neg 5.3 5 
Lactobacillus vaginalis 4 (LV4) 18 9 Pos CT 5 4.7 
BV: bacterial vaginosis, STI: sexually transmitted infection, SC: softcup, CT: Chlamydia trachomatis, NG: 























Figure 14 Previously quantified overall inflammatory responses of VK2 cells to G. vaginalis and Lactobacillus isolate co-
culture. VK2 cells were seeded into 24 well plates (1 x 105 cells/well) and cultured to confluence. Monolayers were pre-
treated with Lactobacillus isolates (4.18 x 106 CFU/well) in 500µl of media for 5 hrs at 37°C, 5% CO2, followed by a stimulation 
with G. vaginalis (1 x 107 CFU/well) in 500µl for a total culture volume of 1ml, for an additional 20hrs incubation. Cell 
supernatants were harvested and tested for chemokine and cytokine production by Luminex assay. Raw cytokine data were 
log-10 transformed and factor analysis was used to generate a factor score (including MIP-3α, MIP-1α, MIP-1β, IP-10, IL-8, IL-
6, IL-1α and IL-1β) for each isolate. Blue boxes indicate isolates selected for this study. LC: L. crispatus, LJ: L. jensenii, LV: L. 
vaginalis, LM: L. mucosae, GV: Gardnerella vaginalis.  
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3.5 Quality of RNA extracted from VK2 cells stored in RLT lysis buffer compared 
to RNALater 
To evaluate the optimal cell storage solution and the transwell cell culture system, VK2 cells 
were cultured in transwell inserts and harvested to assess RNA yield and quality after RNA 
extraction.  
An average of 7.46 x 105 live cells was harvested from the transwell inserts (Figure 15A). The 
RNA yield was varied among the samples (Figure 15B). The samples stored in RNALater 
prior to RNA extraction, yielded a significantly (p=0.0190) lower RNA concentration (ng/µl) 
than the samples stored in RLT lysis buffer (Figure 15B). 
An acceptable RIN value is between 7-10. A total of n=9 samples passed the RNA integrity 
assessment, RINs: 7.9-9.8, while n=1 sample did not, with a RIN of 5.5 (Figure 15C, 
Appendix XIII). All samples stored in RLT lysis buffer prior to RNA extraction passed the RNA 
integrity assessment and tended to have higher RINs (above 9) than the samples stored in 
RNALater (Figure 15C, Appendix XIII). A total of n=7 RNA samples were “pure” based on an 
A260/A280 ratio of 2, while n=3 samples had A260/A280 ratios of 1.7, 1.5 and 1.9, indicating 
the presence of phenols, proteins or other contaminants with absorbance at 280nm (Figure 
15D). Notably, all the samples stored in RLT lysis buffer prior to RNA extraction, yielded “pure” 
RNA. In contrast, only n=1 sample had an acceptable A260/A230 ratio of 1.7, while the ratios 
of n=9 samples varied between 0.05 and 1.2, indicating the presence of contaminants with 








































































































































































































Figure 15 Quality of RNA extracted from VK2 cells cultured in transwells. A) Cell count of live VK2 cells after culture in 
transwell inserts for 7 days; each bar represents a separate transwell culture. B) RNA yield. C-D) RNA quality assessed by RIN, 
A260/A280 and A260/A230 ratios. Acceptable RINs are between 7-10. Acceptable A260/A280 and A260/A230 ratios are 1.7-
2.0 and 1.5-3, respectively, red dotted lines indicate lower limits. VK2 cells were cultured in 24mm transwell inserts with 
0.4µm pores, at 37°C, 5% CO2 for 7 days, with media changed every 2-3 days. The cells were harvested and stored in either 
RNALater or RLT lysis buffer, at -80°C. RNA was extracted using the Qiagen RNeasy mini kit. RNA quality and quantity were 
assessed using an Agilent 2100 Bioanalyzer and NanoDrop 8000 spectrophotometer. Nonparametric Mann-Whitney U test 
was used to evaluate the difference between RNA yield of samples stored in RNALater versus RLT lysis buffer. p≤0.05 was 










3.6 Cytokine responses by VK2 cells stimulated with Lactobacillus species and 
G. vaginalis in transwells compared to stimulation in 24 well plates 
The aim of the Luminex assay was to assess inflammatory responses in order to group 
isolates into cytokine-suppressive versus non-cytokine-suppressive lactobacilli before the 
microarray assay. Both isolates that induced an increase in inflammatory cytokine production 
and those that did not materially change cytokine production were grouped as “non-
suppressive. Even though strong cytokine suppressive responses were not expected at these 
short incubation times (6 and 12 hours), a short incubation period was required for the 
detection of transcriptional changes before mRNA degradation.  
As previous studies evaluating the impact of lactobacilli on inflammatory cytokine responses 
to G. vaginalis had been carried out in 24 well plate culture systems (29,98), a pilot experiment 
was conducted to determine whether similar responses were observed in transwell systems. 
VK2 cells were co-cultured with G. vaginalis (16.72 x 106 CFU/well) in the presence or absence 
of each Lactobacillus isolate (16.72 x 106 CFU/well) in 1.5ml of media in transwell inserts. The 
VK2 cell viability for all the cultures remained above 80% following co-culture with bacterial 
spp. (Figure16A). The effect of Lactobacillus isolates on overall inflammatory responses 
varied according to species (Figure 16B). The VK2 cells stimulated by G. vaginalis only 
control did not induce inflammatory responses that were markedly greater than the VK2 cells 
only control when assayed in transwell inserts at the bacterial concentrations mentioned 
above, thus the effect of the Lactobacillus isolates on cytokine responses in this system was 
unclear (Figure 16B, Figure 17). It is thus likely that a greater number of G. vaginalis CFUs 
appropriate for the larger surface area and volume of media, and incubation for a longer period 
of time are needed to stimulate a significant response in this system.  
In tandem, triplicate independent assays were performed in 24 well plates using our already-
optimized protocol and a longer incubation period of 12 hours. Cells only and G. vaginalis-
VK2 cell only cultures were included as controls for each independent assay, in duplicate. In 
this system, similar to our previous studies, viability was generally comparable to the cells only 
control, except in the case of the LJ2/G. vaginalis coculture for which only 73% of the cells 
were viable (Figure 18A). PCA of the cytokine data to generate component estimates showed 
that G. vaginalis significantly induced an increased overall inflammatory response by VK2 cells 
compared to cells only (p=0.0022, Figure 18B). LJ3, LV3, LC3, LC1 and LJ2 had higher 
overall inflammatory responses compared to LM2, LM4 and LV4 (Figure 18B).  
PCA of the cytokine data showed that 63% of the variance in the cytokine data were explained 
by PC1 and 20% of the variance was explained by PC2 (Figure 19A). Unsupervised clustering 
showed LM2, LM4 and LV4 to be cytokine-suppressive, clustering below G. vaginalis-VK2 cell 
54 
 
responses, while LC1, LC3, LJ3, LV3 and LJ2 were not suppressive of cytokine responses, 
clustering close to or above G. vaginalis-VK2 cell responses (Figure 19B). Based on this 
analysis, isolates were grouped as cytokine-suppressive or non-cytokine-suppressive of 
inflammatory responses to G. vaginalis for downstream microarray analysis. 
LM2, LM4 and LV4 significantly reduced IL-6 production by VK2 cells (adj. p=0.0194, Figure 
20E). LJ2 and LM4 showed a significant reduction in IP-10 compared to G. vaginalis-VK2 cell 
cultures (adj. p=0.0194, Figure 20F). LC1 and LJ2 significantly increased IL-1α and IL-1β 
responses by VK2 cells (adj. p=0.0194 and adj. p=0.0133, respectively, Figure 20G and H). 
Only LM4 significantly reduced the MIP-3α response by VK2 cells (adj. p=0.0133, Figure 20I). 
The IL-1RA response by VK2 cells remained mostly unchanged by Lactobacillus spp., with 




























Figure 16 Overall cytokine response by VK2 cells cultured in transwells stimulated by Lactobacillus species and G. vaginalis.  
A) VK2 cell viability (%) after bacterial stimulation. B) Overall inflammatory response by VK2 cells stimulated with G. vaginalis 
in the absence or presence of Lactobacillus isolates. VK2 cells were seeded into transwell inserts (0.3x106 cells/well) and 
grown to confluence. Monolayers were stimulated with Lactobacillus isolates (16.72 x 106 CFU/well) and incubated for 3 hrs 
at 37°C, 5% CO2. G. vaginalis (16.72 x 106 CFU/well) was then added to the Lactobacillus-VK2 cell cultures and incubated for 
an additional 3 hrs at 37°C, 5% CO2. VK2 cells only and G. vaginalis only stimulated VK2 cells were included as controls. Cell 
viability was assessed by trypan blue staining. Cell culture supernatants were collected, and cytokine production assessed 
by Luminex assay. All cytokine and chemokine (IL-8, MIP-1α, MIP-1β, MIP-3α, IP-10, IL-6, IL-1α and IL-1β) responses were 
grouped onto one component (c1) to generate inflammatory estimate scores, using STATA v13.1. Bars indicate c1 scores for 
each isolate. GV: G. vaginalis, LJ3: L. jensenii 3, LV3: L. vaginalis 3, LC3: L. crispatus 3, LM2: L. mucosae 2, LC1: L. crispatus 1, 































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 17 Cytokine responses by VK2 cells cultured in transwells stimulated by Lactobacillus species and G. vaginalis.           
A) VK2 cell viability (%) after bacterial stimulation. B-J) Cytokine production by VK2 cells stimulated by G. vaginalis in the 
absence or presence of Lactobacillus spp. VK2 cells were seeded into transwell inserts (0.3x106 cells/well) and grown to 
confluence. Monolayers were stimulated with Lactobacillus isolates (16.72 x 106 CFU/well) and incubated for 3 hrs at 37°C, 
5% CO2. G. vaginalis (16.72 x 106 CFU/well) was then added to the Lactobacillus-VK2 cell cultures and incubated for an 
additional 3 hrs at 37°C, 5% CO2. VK2 cells only and G. vaginalis only stimulated VK2 cells were included as controls. Cell 
viability was assessed by trypan blue staining. Cell culture supernatants were collected, and cytokine production assessed 
by Luminex assay. GV: G. vaginalis, LJ3: L. jensenii 3, LV3: L. vaginalis 3, LC3: L. crispatus 3, LM2: L. mucosae 2, LC1: L. crispatus 
1, LJ2: L. jensenii 2, LM4: L. mucosae 4. LV4: L. vaginalis 4, IL-8: interleukin-8, MIP-1α: macrophage inflammatory protein 1 
alpha, MIP-1β: macrophage inflammatory protein 1 beta, IL-6: interleukin-6, IP-10: interferon gamma induced protein 10, 
IL-1α: interleukin 1 alpha, IL-1β: interleukin 1 beta, MIP-3α: macrophage inflammatory protein 3 alpha, IL-1RA: interleukin 




















Figure 18 Overall inflammatory responses by VK2 cells cultured in 24 well plates stimulated with Lactobacillus isolates and 
G. vaginalis.  A) VK2 cell viability (%) after bacterial stimulation. B) Overall inflammatory responses by VK2 cells stimulated 
with G. vaginalis in the absence or presence of Lactobacillus isolates. VK2 cells were seeded into 24 well plates (0.5x106 
cells/well) and grown to confluence. Monolayers were stimulated with Lactobacillus isolates (4.18x106 CFU/well) and 
incubated for 6 hrs at 37°C, 5% CO2. G. vaginalis (4.18x107 CFU/well) was then added to the Lactobacillus-VK2 cell cultures 
and incubated for an additional 6 hrs at 37°C, 5% CO2. Triplicate independent assays were performed. VK2 cells only and G. 
vaginalis only stimulated VK2 cells were included as controls, in duplicate for each independent assay. Cell viability was 
assessed by trypan blue staining. Cell culture supernatants were collected, and cytokine production assessed by Luminex 
assay. All cytokine and chemokine (IL-8, MIP-1α, MIP-1β, MIP-3α, IP-10, IL-6, IL-1α, IL-1β and IL-1RA) responses were grouped 
onto one component (c1) to generate inflammatory estimate scores, using STATA v13.1. Bars display the mean c1 values and 
error bars indicate standard deviation from the mean.  Nonparametric Mann Whitney U test was used to statistically test the 
difference in overall inflammatory response of VK2 cells induced by G. vaginalis compared to cells only, and overall 
inflammatory responses of VK2 cells co-cultured with G. vaginalis in the absence or presence of Lactobacillus isolates, p≤0.05 
was considered significant. GV: G. vaginalis, LJ3: L. jensenii 3, LV3: L. vaginalis 3, LC3: L. crispatus 3, LM2: L. mucosae 2, LC1: 



















































































































































































Figure 19 Principal component analysis (PCA) and heatmap showing cytokine responses of VK2 cells stimulated with G. 
vaginalis and Lactobacillus species. A) PCA was performed to evaluate clustering of the samples based on cytokine 
responses. B) Unsupervised hierarchical clustering was used to group the samples based on cytokine production. VK2 cells 
were seeded into 24 well plates (0.5x106 cells/well) and grown to confluence. Monolayers were stimulated with Lactobacillus 
isolates (4.18x106 CFU/well) and incubated for 6 hrs at 37°C, 5% CO2. G. vaginalis (4.18x107 CFU/well) was then added to the 
Lactobacillus-VK2 cell cultures and incubated for an additional 6 hrs at 37°C, 5% CO2. Triplicate independent assays were 
performed. VK2 cells only and G. vaginalis only stimulated VK2 cells were included as controls, in duplicate for each 
independent assay. The R Studio mixOmics package was used to conduct the PCA. R Studio was also used to perform the 
hierarchical clustering analysis and generate a heatmap. Data were log10-transformed and matrix scaled. The averages of the 
replicate values are displayed. The heatmap depicts cytokine production, with low-high concentrations indicated by blue 
through white to red, respectively. The dendogram above the heatmap indicates the degrees of relatedness between the 
various cytokines measured. The horizontal “branches” have arbitrary lengths and the lengths of the vertical “branches” 
indicate the degrees of similarity between the cytokines. The left-hand side dendogram demonstrates relationships between 
the cytokine expression profiles in cells that were unstimulated, G. vaginalis stimulated and stimulated with Lactobacillus 
isolates and G. vaginalis in combination. Shorter and longer horizontal branch lengths between the isolates for this 
dendogram, indicate higher or lower degrees of similarity between the cytokine profiles, respectively. GV: G. vaginalis, LJ3: 
L. jensenii 3, LV3: L. vaginalis 3, LC3: L. crispatus 3, LM2: L. mucosae 2, LC1: L. crispatus 1, LJ2: L. jensenii 2, LM4: L. mucosae 
4. LV4: L. vaginalis 4. PC1: principal component 1, PC2: principal component 2, Expl. var: explained variance, IL-8: interleukin-
8, MIP-1α: macrophage inflammatory protein 1 alpha, MIP-1β: macrophage inflammatory protein 1 beta, IL-6: interleukin-
6, IP-10: interferon gamma induced protein 10, IL-1α: interleukin 1 alpha, IL-1β: interleukin 1 beta, MIP-3α: macrophage 

















































































































































































































































































































































































































































































































































































































































































































Figure 20 Cytokine responses by VK2 cells cultured in 24 well plates stimulated by Lactobacillus isolates and G. vaginalis.           
A) VK2 cell viability (%) after bacterial stimulation. B-J) Cytokine production by VK2 cells stimulated by G. vaginalis in the 
absence or presence of Lactobacillus spp. VK2 cells were seeded into 24 well plates (0.5x106 cells/well) and grown to 
confluence. Monolayers were stimulated with Lactobacillus isolates (4.18x106 CFU/well) and incubated for 6 hrs at 37°C, 5% 
CO2. G. vaginalis (4.18x107 CFU/well) was then added to the Lactobacillus-VK2 cell cultures and incubated for an additional 
6 hrs at 37°C, 5% CO2. Triplicate independent assays were performed. VK2 cells only and G. vaginalis only stimulated VK2 
cells were included as controls, in duplicate for each independent assay. Cell viability was assessed by trypan blue staining. 
Cell culture supernatants were collected, and cytokine production assessed by Luminex assay. Nonparametric Mann Whitney 
U test was used to statistically test the difference in cytokine responses of VK2 cells stimulated with G. vaginalis only and in 
combination with each Lactobacillus isolate. GV: G. vaginalis, LJ3: L. jensenii 3, LV3: L. vaginalis 3, LC3: L. crispatus 3, LM2: L. 
mucosae 2, LC1: L. crispatus 1, LJ2: L. jensenii 2, LM4: L. mucosae 4. LV4: L. vaginalis 4, IL-8: interleukin-8, MIP-1α: 
macrophage inflammatory protein 1 alpha, MIP-1β: macrophage inflammatory protein 1 beta, IL-6: interleukin-6, IP-10: 
interferon gamma induced protein 10, IL-1α: interleukin 1 alpha, IL-1β: interleukin 1 beta, MIP-3α: macrophage 
inflammatory protein 3 alpha, IL-1RA: interleukin 1 receptor antagonist.  
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3.7 Lactic acid production by Lactobacillus isolates in the VK2 cell 24 well 
culture system  
After culture of Lactobacillus isolates (4.18x106CFU/well) with VK2 cells in combination with 
G. vaginalis (4.18x107CFU/well) in 1ml of media, all the Lactobacillus isolates produced D-
Lactate, while LJ3, LV3 and LJ2 produced high levels (Figure 21A). However, L-lactate 
production was low and not detected in some cultures (Figure 21B). LJ3 and LC1 did not 
produce L lactate, while LV3, LC3, LM2, LJ2 and LV4 produced low levels and LM4 produced 
the highest (Figure 21B). As expected, G. vaginalis produced very little D- and L-lactate 
(Figure 21A and B). The sample pH measurements were between 7-9 (Appendix XIV), 
hence using the Henderson-Hasselbalch equation, the total lactic acid concentration 
calculated was low (Figure 21C). Non-cytokine-suppressive lactobacilli produced significantly 
greater amounts of D-lactate than cytokine-suppressive lactobacilli (p=0.0476, Figure 21D), 
while the total lactic acid production did not differ between cytokine-suppressive and non-
cytokine-suppressive lactobacilli (Figure 21E).  
Associations between D- and L-lactate and cytokine responses were evaluated using 
Spearman’s rank correlation. D-lactate production was significantly positively associated with 
IL-8 and IL-6 responses by VK2 cells (r=0.7381, p=0.0458, Figure 22A and E), however, not 
significantly after adjusting for multiple comparisons (adj. p=0.4122, Figure 22A and E). L-
lactate production tended to be negatively associated with MIP-1α, MIP-1β and IL-1β 
responses by VK2 cells (r=-0.527 and r=-0.6587, respectively), however, not significantly 




















































































































































































































Figure 21 Lactate production by Lactobacillus isolates in VK2 cell cultures. A) D-Lactate and B) L-Lactate colorimetric 
detection and C) total lactic acid detection, in cell culture supernatants of VK2 cells stimulated with G. vaginalis alone and in 
combination with each Lactobacillus isolate. D) D- and L-lactate colorimetric detection in cell culture supernatants of VK2 
cells stimulated by G. vaginalis and in combination with non-suppressive (NS) lactobacilli and suppressive (S) lactobacilli. VK2 
cells were seeded into 24 well plates (0.5x106 cells/well) and grown to confluence. Monolayers were stimulated with each 
Lactobacillus isolate (4.18x106CFU/well) isolate and incubated for 6 hours at 37°C, 5% CO2. Thereafter, G. vaginalis (4.18x107 
CFU/well) was then added to the Lactobacillus-VK2 cell cultures and incubated for an additional 6 hrs at 37°C, 5% CO2. 
Triplicate independent assays were performed. VK2 cells only and G. vaginalis only stimulated VK2 cells were included as 
controls, in duplicate for each independent assay. Cell culture supernatants were used to evaluate D- and L-lactate 
production using colorimetric assays, with samples assayed in duplicate. Lactate concentrations were determined by 
standard curves. All samples were corrected for D-and L-lactate detected in VK2 cells only cultures. Culture pH readings were 
measured using pH strips. Using the Henderson-Hasselbalch equation, pH values and the sum of D- and L- lactate 
concentrations were used to calculate the total lactic acid. Mann Whitney U test was used to statistically test the difference 
in lactate production between cytokine-suppressive and non-suppressive lactobacilli, p≤0.05 considered significant. GV: G. 
vaginalis, LJ3: L. jensenii 3, LV3: L. vaginalis 3, LC3: L. crispatus 3, LM2: L. mucosae 2, LC1: L. crispatus 1, LJ2: L. jensenii 2, 
LM4: L. mucosae 4. LV4: L. vaginalis 4, NS: non-suppressive, S: suppressive.  
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Figure 22 Correlations between D-lactate production and cytokine responses in VK2 cell cultures co-cultured with 
Lactobacillus spp. and G. vaginalis. A-I) Correlations between D-lactate production and cytokine responses, with the means 
of replicates shown. VK2 cells were seeded into 24 well plates (0.5x106 cells/well) and grown to confluence. Monolayers were 
stimulated with each Lactobacillus isolate (4.18x106CFU/well) isolate and incubated for 6 hours at 37°C, 5% CO2. Thereafter, 
G. vaginalis (4.18x107 CFU/well) was then added to the Lactobacillus-VK2 cell cultures and incubated for an additional 6 hrs 
at 37°C, 5% CO2. Triplicate independent assays were performed. VK2 cells only and G. vaginalis only stimulated VK2 cells 
were included as controls, in duplicate for each independent assay. Cell culture supernatants were used to evaluate D-lactate 
production using a colorimetric assay, with samples assayed in duplicate. D-Lactate concentrations were determined by 
standard curves. All samples were corrected for D-lactate detected in VK2 cells only cultures. Spearman’s rank correlation 
was used to statistically test the correlations between D-lactate and cytokine responses, p≤0.05 considered significant. IL-8: 
interleukin-8, MIP-1α: macrophage inflammatory protein 1 alpha, MIP-1β: macrophage inflammatory protein 1 beta, MIP-
3α: macrophage inflammatory protein 3 alpha, IL-6: interleukin-6, IP-10: interferon gamma induced protein 10, IL-1α: 
interleukin 1 alpha, IL-1β: interleukin 1 beta, IL-1RA: interleukin 1 receptor antagonist.  
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Figure 23 Correlations between L-lactate production and cytokine responses in VK2 cell cultures co-cultured with 
Lactobacillus spp. and G. vaginalis. A-I) Correlations between L-lactate production and cytokine responses, with the means 
of replicates shown. VK2 cells were seeded into 24 well plates (0.5x106 cells/well) and grown to confluence. Monolayers were 
stimulated with each Lactobacillus isolate (4.18x106CFU/well) isolate and incubated for 6 hours at 37°C, 5% CO2. Thereafter, 
G. vaginalis (4.18x107 CFU/well) was then added to the Lactobacillus-VK2 cell cultures and incubated for an additional 6 hrs 
at 37°C, 5% CO2. Triplicate independent assays were performed. VK2 cells only and G. vaginalis only stimulated VK2 cells 
were included as controls, in duplicate for each independent assay. Cell culture supernatants were used to evaluate L-lactate 
production using a colorimetric assay, with samples assayed in duplicate. L-Lactate concentrations were determined by 
standard curves. All samples were corrected for L-lactate detected in VK2 cells only cultures. Spearman’s rank correlation 
was used to statistically test the correlations between L-lactate and cytokine responses, p≤0.05 considered significant. IL-8: 
interleukin-8, MIP-1α: macrophage inflammatory protein 1 alpha, MIP-1β: macrophage inflammatory protein 1 beta, MIP-
3α: macrophage inflammatory protein 3 alpha, IL-6: interleukin-6, IP-10: interferon gamma induced protein 10, IL-1α: 
interleukin 1 alpha, IL-1β: interleukin 1 beta, IL-1RA: interleukin 1 receptor antagonist.  
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3.8 Quality of RNA extracted from VK2 cells stimulated with Lactobacillus 
species and G. vaginalis in 24 well plates 
RNA was extracted from all 36 samples, including VK2 cells cultured alone, co-cultured with 
G. vaginalis (4.18 x 107CFU/well) and co-cultured with lactobacilli (4.18 x 106CFU/well) and 
G. vaginalis (4.18 x 107CFU/well) in combination, in 1ml of media. RNA integrity, quality and 
quantity were assessed using an Agilent 2100 Bioanalyzer and Nanodrop 8000 
spectrophotometer.  
A total of n=35 samples passed quality assessment with RINs 7.4 – 10, apart from LJ2+GV 
which did not (RIN: 5.2, Figure 24A, Appendix XV). A total of 2/3 LJ2+GV samples had 
acceptable RIN values (RIN: 7.4 and 8, Figure 24A, Appendix XV). Interestingly, LJ2+GV 
was the same co-culture that exhibited lower viability and induced substantially higher 
inflammatory responses relative to the other samples. In addition, LJ2 was isolated from a 
participant who tested positive for multiple STIs, including CT, NG and TV (Table 2).  
Therefore, this sample was included in the microarray analysis. A total of n=21 samples had 
fully intact RNA, with RINs of 10 (Figure 24A), while n=14 had partially degraded RNA, with 
RINs of 7.4-9.9. All samples had an acceptable A260/A280 ratios of 1.9 – 2.1, with n=33 
samples “pure” with ratios of 2 (Figure 24B). However, the A260/A230 ratios varied between 
0.1 – 2.0 which indicated the presence of contaminants with absorbance at 230nm and 
additional sample clean-up procedures were thus conducted (Figure 24B). The RNA quantity 
varied among the samples, however all of the samples yielded greater than 100ng of RNA 
required for microarray input (Figure 24C). Based on the RNA quality results, n=30 samples 




















Figure 24 Quality of RNA extracted from VK2 cells stimulated with bacterial isolates. A) Bar graph showing RNA integrity 
numbers (RIN) for each sample. B) Boxplot showing A260/A280 ratios of samples. C) Bar graph showing RNA quantity (ng/µl) 
extracted from each sample. VK2 cells were seeded into 24 well plates (0.5x106 cells/well) and grown to confluence. 
Monolayers were stimulated with each Lactobacillus isolate (4.18 X 106CFU/500µl) and incubated for 6 hours at 37°C, 5% 
CO2. Thereafter, G. vaginalis (4.18x107 CFU/500µl) was then added to the Lactobacillus-VK2 cell cultures and incubated for 
an additional 6 hrs at 37°C, 5% CO2. Triplicate independent assays were performed. VK2 cells only and G. vaginalis only 
stimulated VK2 cells were included as controls, in duplicate for each independent assay. VK2 cells were harvested following 
the stimulation assay and stored in RLT lysis buffer at -80°C. RNA was extracted, and quality assessment was performed using 
an Agilent 2100 Bioanalyzer and NanoDrop 8000 spectrometer. Acceptable RINs are between 7-10. Acceptable A260/A280 
and A260/A230 ratios are 1.7-2.0 and 1.5-3, respectively, dotted lines indicate lower limits. RIN: RNA integrity number, GV: 
G. vaginalis, LJ3: L. jensenii 3, LV3: L. vaginalis 3, LC3: L. crispatus 3, LM2: L. mucosae 2, LC1: L. crispatus 1, LJ2: L. jensenii 2, 










































































































































































































































































































































































































































































































While bacterial stimulation in both the transwell and the 24 well plate culture systems yielded 
viable VK2 cells and good quality RNA of sufficient quantity, only the stimulation assay 
performed in the 24 well plates yielded expected cytokine responses and these samples were 
thus assessed by microarray analysis (Figure 25). The transwell culture system thus requires 
further optimization and, in the future, G. vaginalis and Lactobacillus isolates will be titrated 








Figure 25 Comparison of transwell and 24 well VK2 cell culture systems. VK2 cells were seeded into transwells or 24 
well plates and grown to confluence. Monolayers were stimulated with each Lactobacillus isolate and G. vaginalis in 
combination. Cytokine concentrations in the cell supernatants were measured by Luminex assay. VK2 cells were 
harvested and RNA extracted using the RNeasy mini kit. RNA quality and yield were assessed by an Agilent 2100 
Bioanalyzer and NanoDrop 8000 spectrophotometer.  
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3.9 Overall gene transcription of VK2 cells stimulated by Lactobacillus isolates 
and G. vaginalis in combination 
The Affymetrix Microarray Platform was used to evaluate the potential effect of Lactobacillus 
isolates (4.18x106CFU/well) on VK2 cell gene expression, particularly those involved in 
inflammatory responses induced by G. vaginalis (4.18x107CFU/well), in 1ml of media.  
Although, 1/3 LJ2+GV samples had a RIN of 5.2, cRNA and sscDNA synthesis, and cDNA 
fragmentation of the microarray assay passed QC assessment using an Agilent 2100 
Bioanalyzer and Nanodrop 8000 spectrophotometer (not shown). Thus, this sample was 
included in the microarray data analysis, as more detailed characterization of this isolate in 
the future would be interesting.  
Following log-2 transformation and normalization by Robust MultiChip Average normalization 
(RMA) of gene expression raw data, no outliers were detected (Figure 26A and B). 
Furthermore, log2-transformed raw data revealed similar median values for all samples 
(Figure 26A), while all median values were the same after RMA normalization of raw data 
(Figure 26B). Further analysis was performed using the RMA normalized data.  
A total of 27189 genes were expressed. Based on PCA clustering analysis of samples, three 
clusters are observed: the cells only samples; GV, LJ3+GV, LV3+GV, LC3+GV, LM2+GV, 
LC1+GV, LM4+GV and LV4+GV samples; and LJ2+GV samples (Figure 27). PC1 explained 













Figure 27 PCA clustering of samples based on total gene expression. VK2 cells were seeded into 24 well plates (0.5x106 
cells/well) and grown to confluence. Monolayers were stimulated with each Lactobacillus isolate (4.18 X 106CFU/well) isolate 
and incubated for 6 hours at 37°C, 5% CO2. Thereafter, G. vaginalis (4.18x107 CFU/well) was then added to the Lactobacillus-
VK2 cell cultures and incubated for an additional 6 hrs at 37°C, 5% CO2. VK2 cells only and G. vaginalis only stimulated VK2 
cells were included as controls. Triplicate independent assays were performed. VK2 cells were harvested following the 
stimulation assay and stored in RLT lysis buffer at -80°C. RNA was extracted and gene expression analysis was then performed 
using microarray Affymetrix GeneChip whole transcript array platform. The R studio Bioconductor oligo package was used 
to normalize raw data using Robust MultiChip Average (RMA) normalization. Principal component analysis (PCA) was 
performed to evaluate clustering of the samples based on 27189 genes expressed. The PCA plot was generated using the R 
Studio ggplot2 package. GV: G. vaginalis, LJ3: L. jensenii 3, LV3: L. vaginalis 3, LC3: L. crispatus 3, LM2: L. mucosae 2, LC1: L. 
crispatus 1, LJ2: L. jensenii 2, LM4: L. mucosae 4. LV4: L. vaginalis 4, PCA: principal component analysis, PC: principal 
component. 
Figure 26 RMA normalization of Affymetrix raw data. A) Boxplots showing log2-transformed raw data. B) Boxplots showing 
RMA normalization of raw data. VK2 cells were seeded into 24 well plates (0.5x106 cells/well) and grown to confluence. 
Monolayers were stimulated with each Lactobacillus isolate (4.18 X 106CFU/well) and incubated for 6 hours at 37°C, 5% CO2. 
Thereafter, G. vaginalis (4.18x107 CFU/well) was then added to the Lactobacillus-VK2 cell cultures and incubated for an 
additional 6 hrs at 37°C, 5% CO2. VK2 cells only and G. vaginalis only stimulated VK2 cells were included as controls. Triplicate 
independent assays were performed. VK2 cells were harvested following the stimulation assay and stored in RLT lysis buffer 
at -80°C. RNA was extracted using the Qiagen RNeasy mini kit and gene expression analysis was then performed using 
microarray Affymetrix GeneChip whole transcript array platform. The R Studio Bioconductor oligo package was used to 
normalize raw data using Robust MultiChip Average (RMA) normalization. GV: G. vaginalis, LJ3: L. jensenii 3, LV3: L. vaginalis 




3.10 Differential gene expression and signalling pathways in G. vaginalis 
stimulated VK2 cells compared to unstimulated VK2 cells 
G. vaginalis (4.28x107CFU/well) was cultured with VK2 cells in 1ml of media and gene 
expression was assessed using the Affymetrix Microarray Platform. The R Studio 
Bioconductor limma package was used to determine differentially expressed genes between 
G. vaginalis stimulated VK2 cells compared to unstimulated VK2 cells. DAVID Bioinformatics 
Resources v6.8 was used to assess upregulated signaling pathways.  
A total of 4421 genes were significantly differentially expressed by G. vaginalis stimulated VK2 
cells compared to unstimulated cells (adj. p≤0.05), with 142 logFC≥1.5 upregulated 
(Appendix XVI) and 26 genes logFC≤-1.5 downregulated (Table 3, Figure 28). Upregulated 
genes mapped to 28 KEGG signaling pathways (Figure 29). The cytokine-cytokine interaction 
signaling pathway was the most significantly upregulated (adj. p=3.60x10-6, Figure 30), with 
mediators including chemokines (CCL5, CXCL1, CXCL8, CXCL3, CXCL10, CXCL11), 
proinflammatory cytokines (IL-6, IL23A, IL1A, ILB), adaptive immune cytokines and receptors 
(IL2RG, TSLP), VEGI (dendritic cell maturation factor), TNF receptors (GITRL, 41BB) and 
INHBB (member of TGF-beta family) mapping to this pathway (Figure 30). The TNF signaling 
pathway was also significantly upregulated (adj. p=0.0018, Figure 29) and included the 
mediators cIAP1/2 (member of the inhibitor of apotosis proteins), chemokines (CCL2, CCL5, 
CCL20, CXCL12, IL1B, IL6), Tnfaip3 (TNF induced protein), Icam1 (cell surface glycoprotein) 
and Ptgs2 (prostaglandin synthase, Figure 31). The NF-κB  signaling pathway was 
significantly upregulated (adj. p=0.0037, Figure 29), with mediators including proinflammatory 
cytokines and chemokines (IL1B, IL8), receptor associated adaptor protein (EDARADD), 
members of the inhibitor of apotosis family proteins (cIAP1/2, BIRC2), RELB (NF-κB  subunit), 
apotosis regulating proteins (Bcl.2, BCL2A), Tnfaip3 (also known as A20) and SLC 
(membrane transport protein) mapping to this pathway (Figure 32). The NOD-like receptor 
signaling pathway was significantly upregulated (adj. p=0.0284, Figure 29), the mediators 
cIAP, Tnfaip3, proinflammatory cytokines and chemokines (proIL1β, IL-1β, IL18, IL10, IL8, 
CXCL) and defensins (host defense peptide) mapped to this pathway (Figure 33). TLR 
signaling and MAPK signaling pathways were significantly upregulated (p=1.19x10-4 and 
p=0.0172, respectively), however these were not upheld after adjusting or multiple 
comparisons (adj. p=0.1370 and adj. p=1, Figure 29). The mediators TLR2 (pattern 
recognition receptor), IRF7 (transcription factor), proinfammatory cytokines (IL1B, IL6, IL8, 
RANTES, IP10) and chemokine (ITAC) mapped to the TLR signaling pathway (Figure 34), 
while the mediators GF (transcription factor), RTK (cell surface receptor), RasGRP (Ras 
activator), protein kinases (LZK, MKP), proinflammatory mediators (IL1, NF-κB ) mapped to 
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the MAPK signaling pathway (Figure 35). Key genes common to these pathways were CCL5, 
cIAP, IL-6, A20, CXCL10, CXCL18 and IL1B, which were significantly upregulated in G. 
vaginalis stimulated VK2 cells compared to unstimulated VK2 cells (adj. p=3.2123x10-7, adj. 
p=7.2093x10-8, adj. p=0.0008, adj. p=1.0007x10-6, adj. p= 1.1514x10-7, adj. p= 1.0139x10-7, 
adj. p= 1.1452x10-6, Figure 36).  
A total of 27 genes were downregulated in G. vaginalis-stimulated VK2 cells compared to 
unstimulated VK2 cells (logFC≤-1.5, Table 3, Figure 37). PKA, Sestrins and PGC-1α 
















Figure 28 Heatmap showing upregulated and downregulated genes in VK2 cells stimulated with G. vaginalis compared to 
unstimulated cells. Unsupervised hierarchical clustering of groups based on differentially upregulated and downregulated 
genes in G. vaginalis stimulated VK2 cells compared to unstimulated VK2 cells. VK2 cells were seeded into 24 well plates 
(0.5x106 cells/well) and grown to confluence. G. vaginalis (4.18x107CFU/well) was added to the VK2 cell cultures and 
incubated for 6 hrs at 37°C, 5% CO2, in triplicate independent assays. VK2 cells only controls were included in triplicate 
independent assays. VK2 cells were then harvested and RNA was extracted. Gene expression analysis was then performed 
using the microarray Affymetrix GeneChip whole transcript array platform. Affymetrix data were normalized using Robust 
Multichip Average (RMA) normalization. Differential gene expression analysis was performed using the R Bioconductor 
limma package. Genes were considered differentially expressed if adj. p≤0.05 and upregulated or downregulated if log fold 
change (FC) ≥ 1.5 or ≤ -1.5, respectively. The dendogram above the heatmap indicates the degree of relatedness between 
the genes expressed. The horizontal “branches” have arbitrary lengths and the lengths of the vertical “branches” indicate 
the degrees of similarity between the gene expression profiles. The left-hand side dendogram demonstrates relationships 
between the gene expression profiles of G. vaginalis stimulated and unstimulated VK2 cells. Shorter or longer horizontal 
branch lengths between the isolates for this dendogram, indicate higher or lower degrees of similarity between the gene 
expression profiles of samples, respectively. DE: differentially expressed genes. Blue, through white, to red indicates low to 
high gene expression. 
Figure 29 Upregulated genes mapped to pro-inflammatory signalling pathways in G. vaginalis stimulated VK2 cells 
compared to unstimulated VK2 cells. The pie chart shows the proportion of differentially expressed genes upregulated in G. 
vaginalis stimulated VK2 cells compared to unstimulated VK2 cells for each signaling pathway, key proinflammatory signaling 
pathways are boxed. VK2 cells were seeded into 24 well plates (0.5x106 cells/well) and grown to confluence. G. vaginalis 
(4.18x107CFU/well) was added to the VK2 cell cultures and incubated for 6 hrs at 37°C, 5% CO2, in triplicate independent 
assays. VK2 cells only controls were included in triplicate independent assays. VK2 cells were then harvested and RNA was 
extracted. Gene expression analysis was then performed using microarray Affymetrix GeneChip whole transcript array 
platform. Affymetrix data were normalized using Robust Multichip Average (RMA) normalization. Differential gene 
expression analysis was performed using R Bioconductor limma package. Genes were considered differentially expressed if 
adj. p≤0.05 and upregulated or downregulated if log fold change (FC) ≥ 1.5 or ≤ -1.5, respectively. Genes were annotated 
using the Clariom S Human annotation file. Upregulated gene Entrez identity numbers were used in DAVID Bioinformatics 
Resources v6.8 to obtain biological pathways upregulated. TNF: Tumor Necrosis Factor, NF-Kappa-B: Nuclear factor kappa-
light-chain-enhancer of activated B cells, NOD-like: Nucleotide-binding oligomerization domain-like, MAPK: Mitogen-





Figure 30 Upregulated genes in the cytokine-cytokine receptor signaling pathway in G. vaginalis stimulated VK2 cells 
compared to unstimulated VK2 cells. KEGG cytokine-cytokine signaling pathway adapted from DAVID Bioinformatics 
resources, upregulated in VK2 cells cultured with G. vaginalis (4.18x107CFU/well) compared to VK2 cell culture only, red 
boxes indicate mediators upregulated in G. vaginalis stimulated VK2 cells compared to VK2 cell culture only. VK2 cells were 
seeded into 24 well plates (0.5x106 cells/well) and grown to confluence. G. vaginalis (4.18x107CFU/well) was added to the 
VK2 cell cultures and incubated for 6 hrs at 37°C, 5% CO2, in triplicate independent assays. VK2 cells only controls were 
included in triplicate independent assays. VK2 cells were then harvested and RNA was extracted. Gene expression analysis 
was then performed using microarray Affymetrix GeneChip whole transcript array platform. Affymetrix data were 
normalized using Robust Multichip Average (RMA) normalization. Differential gene expression analysis was performed using 
R Bioconductor limma package. Genes were considered differentially expressed if adj. p≤0.05 and upregulated or 
downregulated if log fold change (FC) ≥ 1.5 or ≤ -1.5, respectively. Genes were annotated using the Clariom S Human 
annotation file. Upregulated gene Entrez identity numbers were used in DAVID Bioinformatics resources v6.8 to obtain 
biological pathways upregulated. CCL5: chemokine c-c motif ligand 5, CXCL2,-3,-8,-10,-11: chemokine c-x-c motif ligand 2,-
3,-8,-10,-11, IL2RG: Interleukin 2 receptor gamma, IL7R: IL-7 receptor, TSLP: thymic stromal lymphopoietin, TSLPR: thymic 
stromal lymphopoietin receptor, IL-6: Interleukin 6, IL-1A: Interleukin 1 alpha, IL-23A: Interleukin 23 alpha, IL-1B: interleukin 
1 beta, VEGI: vascular epithelial growth inhibitor, 4IBB: 4-IBB/CD137/tumor necrosis factor superfamily receptor 9, GITRL: 




Figure 31 Upregulated genes in the tumor necrosis factor (TNF) signaling pathway in G. vaginalis stimulated VK2 cells 
compared to unstimulated VK2 cells. KEGG TNF signaling pathway adapted from DAVID Bioinformatics resources, 
upregulated in VK2 cells cultured with G. vaginalis (4.18x107CFU/well) compared to VK2 cell culture only, red boxes indicate 
mediators upregulated in G. vaginalis stimulated VK2 cells compared to VK2 cell culture only. VK2 cells were seeded into 24 
well plates (0.5x106 cells/well) and grown to confluence. G. vaginalis (4.18x107CFU/well) was then added to the VK2 cell 
cultures and incubated for 6 hrs at 37°C, 5% CO2, in triplicate independent assays. VK2 cells only were included in triplicate 
independent assays. VK2 cells were then harvested and RNA was extracted. Gene expression analysis was then performed 
using microarray Affymetrix GeneChip whole transcript array platform. Affymetrix data were normalized using Robust 
Multichip Average (RMA) normalization. Differential gene expression analysis was performed using R Bioconductor limma 
package. Genes were considered differentially expressed if, adj. p≤0.05 and upregulated or downregulated if log fold change 
(FC) ≥ 1.5 or ≤ -1.5, respectively. Genes were annotated using the Clariom S Human annotation file. Upregulated gene Entrez 
identity numbers were used in DAVID Bioinformatics resources v6.8 to obtain biological pathways upregulated. TNF: tumor 
necrosis factor, CCL5: chemokine c-c motif ligand 5, CXCL10,-12,-13: chemokine c-x-c motif ligand 10,-12,-13, IL-6: Interleukin 
6, IL-1B: interleukin 1 beta, Cc12,-15,-120: chemokine c-c motif ligand 12,-15,-120, Tnfaip3: TNF alpha induced protein 3, 




Figure 32 Upregulated genes in the NFκB signaling signaling pathway in G. vaginalis stimulated VK2 cells compared to 
unstimulated VK2 cells. KEGG NFκB signaling pathway adapted from DAVID Bioinformatics resources, upregulated in VK2 
cells cultured with G. vaginalis (4.18x107CFU/well) compared to VK2 cell culture only, red boxes indicate mediators 
upregulated in G. vaginalis stimulated VK2 cells compared to VK2 cell culture only. VK2 cells were seeded into 24 well plates 
(0.5x106 cells/well) and grown to confluence. G. vaginalis (4.18x107CFU/well) was added to the VK2 cell cultures and 
incubated for 6 hrs at 37°C, 5% CO2, in triplicate independent assays. VK2 cells only controls were included in triplicate 
independent assays. VK2 cells were then harvested and RNA was extracted. Gene expression analysis was then performed 
using microarray Affymetrix GeneChip whole transcript array platform. Affymetrix data were normalized using Robust 
Multichip Average (RMA) normalization. Differential gene expression analysis was performed using R Bioconductor limma 
package. Genes were considered differentially expressed if, adj. p≤0.05 and upregulated or downregulated if log fold change 
(FC) ≥ 1.5 or ≤ -1.5, respectively. Genes were annotated using the Clariom S Human annotation file. Upregulated gene Entrez 
identity numbers were used in DAVID Bioinformatics resources v6.8 to obtain biological pathways upregulated. IL-1β: 
Interleukin 1 beta, cIAP1/2: cellular inhibitor apoptosis protein 1 or 2, EDARADD: Ectodysplasin-A receptor-associated 
adapter protein, BIRC2: baculoviral IAP repeat-containing protein 2, RELB: transcription factor RelB, NFκB subunit, Bcl.2: B 
cell lymphoma 2, CXCL8: chemokine c-x-c motif ligand 8, IL-8: interleukin 8, A20: tumor necrosis factor, alpha-induced protein 







Figure 33 Upregulated genes in the nuclear oligomerization domain (NOD)-like receptor signalling pathway in G. vaginalis 
stimulated VK2 cells compared to unstimulated VK2 cells. KEGG NOD-like receptor signaling pathway adapted from DAVID 
Bioinformatics resources, upregulated in VK2 cells cultured with G. vaginalis compared to VK2 cell culture only, red boxes 
indicate mediators upregulated in G. vaginalis stimulated VK2 cells compared to VK2 cell culture only. VK2 cells were seeded 
into 24 well plates (0.5x106 cells/well) and grown to confluence. G. vaginalis (4.18x107CFU/well) was added to the VK2 cell 
cultures and incubated for 6 hrs at 37°C, 5% CO2, in triplicate independent assays. VK2 cells only controls were included in 
triplicate independent assays. VK2 cells were then harvested and RNA was extracted. Gene expression analysis was then 
performed using microarray Affymetrix GeneChip whole transcript array platform. Affymetrix data were normalized using 
Robust Multichip Average (RMA) normalization. Differential gene expression analysis was performed using R Bioconductor 
limma package. Genes were considered differentially expressed if, adj. p≤0.05 and upregulated or downregulated if log fold 
change (FC) ≥ 1.5 or ≤ -1.5, respectively. Genes were annotated using the Clariom S Human annotation file. Upregulated gene 
Entrez identity numbers were used in DAVID Bioinformatics resources v6.8 to obtain biological pathways upregulated. cIAP: 
cellular inhibitor of apoptosis protein, A20: tumor necrosis factor, alpha-induced protein 3, proIL1.β: pro-interleukin 1 beta, 




Figure 34 Upregulated genes in the toll-like receptor signalling pathway in G. vaginalis stimulated VK2 cells compared to 
unstimulated VK2 cells. KEGG toll-like receptor signaling pathway adapted from DAVID Bioinformatics resources, 
upregulated in VK2 cells cultured with G. vaginalis compared to VK2 cell culture only, red boxes indicate mediators 
upregulated in G. vaginalis stimulated VK2 cells compared to VK2 cell culture only. VK2 cells were seeded into 24 well plates 
(0.5x106 cells/well) and grown to confluence. G. vaginalis (4.18x107CFU/well) was added to the VK2 cell cultures and 
incubated for 6 hrs at 37°C, 5% CO2, in triplicate independent assays. VK2 cells only controls were included in triplicate 
independent assays. VK2 cells were then harvested and RNA was extracted. Gene expression analysis was then performed 
using microarray Affymetrix GeneChip whole transcript array platform. Affymetrix data were normalized using Robust 
Multichip Average (RMA) normalization. Differential gene expression analysis was performed using R Bioconductor limma 
package. Genes were considered differentially expressed if, adj. p≤0.05 and upregulated or downregulated if log fold change 
(FC) ≥ 1.5 or ≤ -1.5, respectively. Genes were annotated using the Clariom S Human annotation file. Upregulated gene Entrez 
identity numbers were used in DAVID Bioinformatics resources v6.8 to obtain biological pathways upregulated. TLR2: toll-
like receptor 2, IL-6: Interleukin 6, IL-1B: interleukin 1 beta, IRF7: interferon regulatory factor 7, IL-8: interleukin 8, RANTES: 
regulated on activation, normal T cell expressed and secreted/chemokine c-c motif ligand 5 (CCL5) , IP-10: interferon gamma 




Figure 35 Upregulated genes in the mitogen activated protein kinase (MAPK) signalling pathway in G. vaginalis stimulated 
VK2 cells compared to unstimulated VK2 cells. KEGG MAPK signaling pathway adapted from DAVID Bioinformatics 
resources, upregulated in VK2 cells cultured with G. vaginalis compared to VK2 cell culture only, red boxes indicate mediators 
upregulated in G. vaginalis stimulated VK2 cells compared to VK2 cell culture only. VK2 cells were seeded into 24 well plates 
(0.5x106 cells/well) and grown to confluence. G. vaginalis (4.18x107CFU/well) was added to the VK2 cell cultures and 
incubated for 6 hrs at 37°C, 5% CO2, in triplicate independent assays. VK2 cells only controls were included in triplicate 
independent assays. VK2 cells were then harvested and RNA was extracted. Gene expression analysis was then performed 
using microarray Affymetrix GeneChip whole transcript array platform. Affymetrix data were normalized using Robust 
Multichip Average (RMA) normalization. Differential gene expression analysis was performed using R Bioconductor limma 
package. Genes were considered differentially expressed if, adj. p≤0.05 and upregulated or downregulated if log fold change 
(FC) ≥ 1.5 or ≤ -1.5, respectively. Genes were annotated using the Clariom S Human annotation file. Upregulated gene Entrez 
identity numbers were used in DAVID Bioinformatics resources v6.8 to obtain biological pathways upregulated. GF: growth 
factor, RTK: receptor tyrosine kinase, IL-1: interleukin 1, RasGRP: RAS guanyl-releasing protein, LZK: leucine zipper-bearing 
kinase/mitogen activated protein kinase kinase kinase 13, MKP: mitogen activated protein kinase, NFκB: Nuclear factor 




































Figure 36 Key upregulated genes common to pro-inflammatory signaling pathways in G. vaginalis stimulated VK2 cells. 
Normalized signal intensity data for genes upregulated in G. vaginalis stimulated cells compared to unstimulated VK2 cells. 
Bars show mean signal intensities of genes and error bars indicate standard deviation of the mean. VK2 cells were seeded 
into 24 well plates (0.5x106 cells/well) and grown to confluence. G. vaginalis (4.18x107CFU/well) was added to the VK2 cell 
cultures and incubated for 6 hrs at 37°C, 5% CO2, in triplicate independent assays. VK2 cells only were included as controls 
in triplicate independent assays. VK2 cells were then harvested and RNA was extracted. Gene expression analysis was then 
performed using microarray Affymetrix GeneChip whole transcript array platform. Affymetrix data were normalized using 
Robust Multichip Average (RMA) normalization. Differential gene expression analysis was performed using the R 
Bioconductor limma package. Genes were considered differentially expressed if adj. p≤0.05 and upregulated or 
downregulated if log fold change (FC) ≥ 1.5 or ≤ -1.5, respectively. Genes were annotated using the Clariom S Human 
annotation file. CCL5: chemokine c-c motif ligand 5, cIAP: cellular inhibitor of apoptosis protein, IL-6: interleukin 6, A20: 
tumor necrosis factor, alpha-induced protein 3, A20: tumor necrosis factor, alpha-induced protein 3, CXCL10: chemokine c-












































































Figure 37 Downregulated genes in G. vaginalis stimulated VK2 cells compared to unstimulated VK2 cells. Normalized signal 
intensity data for genes downregulated in G. vaginalis stimulated cells compared to unstimulated VK2 cells. Bars show mean 
signal intensities of genes and error bars indicate standard deviation of the mean. VK2 cells were seeded into 24 well plates 
(0.5x106 cells/well) and grown to confluence. G. vaginalis (4.18x107CFU/well) was added to the VK2 cell cultures and 
incubated for 6 hrs at 37°C, 5% CO2, in triplicate independent assays. VK2 cells only were included as controls in triplicate 
independent assays. VK2 cells were then harvested and RNA was extracted. Gene expression analysis was then performed 
using microarray Affymetrix GeneChip whole transcript array platform. Affymetrix data were normalized using Robust 
Multichip Average (RMA) normalization. Differential gene expression analysis was performed using the R Bioconductor limma 
package. Genes were considered differentially expressed if adj. p≤0.05 and upregulated or downregulated if log fold change 




Figure 38 Genes downregulated in the longevity regulating signaling pathway in G. vaginalis stimulated VK2 cells 
compared to unstimulated VK2 cells. KEGG longevity signaling pathway adapted from WebGestalt, downregulated in VK2 
cells cultured with G. vaginalis compared to VK2 cell culture only, blue boxes indicate mediators upregulated in G. vaginalis 
stimulated VK2 cells compared to VK2 cell culture only. VK2 cells were seeded into 24 well plates (0.5x106 cells/well) and 
grown to confluence. G. vaginalis (4.18x107CFU/well) was added to the VK2 cell cultures and incubated for 6 hrs at 37°C, 5% 
CO2, in triplicate independent assays. VK2 cells only were included as controls in triplicate independent assays. VK2 cells were 
then harvested and RNA was extracted. Gene expression analysis was then performed using microarray Affymetrix GeneChip 
whole transcript array platform. Affymetrix data were normalized by Robust Multichip Average (RMA) normalization. 
Differential gene expression analysis was performed using R Bioconductor limma package. Genes were considered 
differentially expressed if, adj. p≤0.05 and upregulated or downregulated if log fold change (FC) ≥ 1.5 or ≤ -1.5, respectively. 
Upregulated gene Entrez identity numbers were used in WebGestalt to obtain biological pathways upregulated. PKA: protein 
kinase A, PGC-1α: peroxisome proliferator-activated receptor gamma coactivator 1-alpha.  
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3.11 Effect of Lactobacillus species on gene transcription and signalling 
pathways of VK2 cells stimulated by G. vaginalis  
Affymetrix microarray was used to assess gene expression by VK2 cells cultured with 
Lactobacillus (4.18x106CFU/well) and G. vaginalis (4.18x107CFU/well) in combination in 1ml 
of media, in triplicate independent assays. The R studio Bioconductor limma package was 
used to assess differential gene expression in VK2 cells pre-incubated with Lactobacillus 
isolates and then G. vaginalis compared to VK2 cells stimulated only with G. vaginalis.  
Heatmaps show the mean normalized signal intensities for genes upregulated and 
downregulated in VK2 cells cultured with lactobacilli and G. vaginalis in combination (Figure 
39). For the Lactobacillus isolates that did not suppress inflammatory cytokine responses to 
G. vaginalis, the majority of the differentially expressed genes were upregulated compared to 
G. vaginalis only cultures. A total of 12/21 (57%), 7/12 (58%), 12/20 (60%), 17/26 (65%), and 
92/146 (65%) were upregulated for LJ3, LV3, LC3, LC1 and LJ2, respectively (Figures 39A-
D and 40). In contrast, the majority of differentially expressed genes were downregulated for 
isolates that did suppress inflammatory cytokine responses to G. vaginalis, with 13/13 (100%), 
35/64 (56%) and 10/13 (77%) genes downregulated for LM2, LM4 and LV4, respectively 
(Figure 39E-F and 41).   
Several unique genes were detected as upregulated or downregulated in VK2 cells co-cultured 
with certain Lactobacillus species (LM2, LM4, LJ3, LC1 and LJ2) and G. vaginalis in 
combination, compared to co-culture with G. vaginalis only. In contrast, no exclusively 
differentially expressed genes were detected in VK2 cells co-cultured with LV3, LC3 and LV4. 
Figures 42 and 43 show genes that were differentially expressed only in cells pre-incubated 
with one specific Lactobacillus species, but not in cells pre-incubated with any of the other 
Lactobacillus species compared to co-culture with G. vaginalis only. A total of 2/2 (100%), 9/24 
(37.5%), 2/11 (18%), 0/4 (0%) and 36/110 (32%) of the genes that were exclusively 
differentially expressed, were downregulated for LM2, LM4, LC1, LJ3 and LJ2 respectively 
(Figures 42 and 43). 
A separate limma analysis was performed which compared gene expression in VK2 cells co-
cultured with G. vaginalis compared to co-culture with lactobacilli (normalized microarray data 
grouped for all 8 Lactobacillus isolates) and G. vaginalis in combination. Several genes, 
including DDX58, CXCL11, IFIT3, IFIT2, IL7R, APOL2, TNFSF18, were downregulated in VK2 
cells co-cultured with lactobacilli and G. vaginalis in combination compared to co-culture with 
G. vaginalis only (Figure 44). In contrast, CYP1A1 was upregulated in VK2 cells co-cultured 
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with lactobacilli and G. vaginalis in combination compared to co-culture with G. vaginalis only 
(Figure 44).  
With the exception of TNFSF18, the expression of these genes were largely unchanged 
between Lactobacillus isolates that reduced (LM2, LM4 and LV4) or did not reduce (LJ3, LV3, 
LC3, LC1 and LJ2) inflammatory cytokine production in response to G. vaginalis (Figure 45). 
TNFS18 tended to be reduced in VK2 cells co-cultured with non-cytokine-suppressive 
lactobacilli compared to cytokine-suppressive lactobacilli, in combination with G. vaginalis, 
however not significantly (p=0.0643, Figure 45).  
Of the downregulated genes in VK2 cells co-cultured with lactobacilli and G. vaginalis in 
combination compared to co-culture with G. vaginalis only, CXCL11, IL7R and TNFSF18 (also 
known as GITRL as shown in the cytokine-cytokine interaction pathway) mapped to the 
cytokine-cytokine receptor signaling pathway (Figure 46).  
An additional limma analysis was performed to detect differentially expressed genes in VK2 
cells co-cultured with non-cytokine-suppressive lactobacilli and cytokine-suppressive 
lactobacilli (average normalized microarray data grouped for non-cytokine-suppressive and 
cytokine-suppressive isolates grouped separately) prior to incubation with G. vaginalis, 
compared to co-culture with G. vaginalis only. Downregulated genes in VK2 cells co-cultured 
with non-cytokine-suppressive lactobacilli or cytokine-suppressive lactobacilli and G. vaginalis 
in combination were similar (Figure 47A and B), however, downregulation of SAMD9L, 
DDX58 and IFIT1 were detected only for cytokine-suppressive lactobacilli (Figure 47B). While 
no upregulated genes were detected in VK2 cells co-cultured with cytokine-suppressive 
lactobacilli and G. vaginalis in combination, upregulation of CRCT1, CYP1A1, CYP1B1, 
TM4SF19, TMEM2 and RNASE7 was detected for non-cytokine-suppressive lactobacilli 
























Figure 39 Heatmaps of downregulated and upregulated genes in VK2 cells co-cultured with Lactobacillus isolates and G. 
vaginalis in combination compared to co-culture with G. vaginalis only. Heatmaps show normalized signal intensities of 
biological replicates (n=3). Downregulated and upregulated genes are displayed above and beneath the black dotted line, 
respectively. VK2 cells were seeded into 24 well plates (0.5x106 cells/well) and grown to confluence. Monolayers were 
stimulated with Lactobacillus isolates (4.18x106CFU/well) and incubated for 6 hrs at 37°C, 5% CO2, in triplicate independent 
assays. G. vaginalis (4.18x107CFU/well) was then added to the Lactobacillus-VK2 cell cultures and incubated for an additional 
6 hrs at 37°C, 5% CO2, in triplicate independent assays. VK2 cells were then harvested and RNA was extracted. Gene expression 
analysis was then performed using microarray Affymetrix GeneChip whole transcript array platform. Affymetrix data were 
normalized using Robust Multichip Average (RMA) normalization. Differential gene expression analysis was performed using 
R Bioconductor limma package. Genes were considered differentially expressed if adj. p≤0.05 and upregulated or 
downregulated if log fold change (FC) ≥ 1.5 or ≤ -1.5, respectively. Genes were annotated using the Clariom S Human 
annotation file. Heatmaps were generated using Graphpad Prism v8.0. Blue, through white to red indicates low to high gene 
expression, respectively. Gene symbols are displayed on the right-hand side. GV: G. vaginalis, LJ3: L. jensenii 3, LV3: L. vaginalis 




















































































































































































































































































































Figure 40 Heatmap of downregulated and upregulated genes in VK2 cells co-cultured with L. jensenii 2 and G. vaginalis in 
combination compared to co-culture with G. vaginalis only. Heatmaps show normalized signal intensities of biological 
replicates (n=3). Downregulated and upregulated genes are displayed above and beneath the black dotted line, respectively. 
VK2 cells were seeded into 24 well plates (0.5x106 cells/well) and grown to confluence. Monolayers were stimulated with L. 
jensenii 2 (4.18x106CFU/well) and incubated for 6 hrs at 37°C, 5% CO2, in triplicate independent assays. G. vaginalis 
(4.18x107CFU/well) was then added to the Lactobacillus-VK2 cell cultures and incubated for an additional 6 hrs at 37°C, 5% 
CO2, in triplicate independent assays. VK2 cells were then harvested and RNA was extracted. Gene expression analysis was 
then performed using microarray Affymetrix GeneChip whole transcript array platform. Affymetrix data were normalized 
using Robust Multichip Average (RMA) normalization. Differential gene expression analysis was performed using R 
Bioconductor limma package. Genes were considered differentially expressed if adj. p≤0.05 and upregulated or 
downregulated if log fold change (FC) ≥ 1.5 or ≤ -1.5, respectively. Genes were annotated using the Clariom S Human 
annotation file. Heatmap was generated using Graphpad Prism v8.0. Blue, through white to red indicates low to high gene 






































































































































































































Figure 41 Heatmap of downregulated and upregulated genes in VK2 cells co-cultured with L. mucosae 4 and G. vaginalis in 
combination compared to co-culture with G. vaginalis only. Heatmaps show mean normalized signal intensities of biological 
replicates (n=3). Downregulated and upregulated genes are displayed above and beneath the black dotted line, respectively. 
VK2 cells were seeded into 24 well plates (0.5x106 cells/well) and grown to confluence. Monolayers were stimulated with L. 
mucosae 4 (4.18x106CFU/well) and incubated for 6 hrs at 37°C, 5% CO2, in triplicate independent assays. G. vaginalis 
(4.18x107CFU/well) was then added to the Lactobacillus-VK2 cell cultures and incubated for an additional 6 hrs at 37°C, 5% 
CO2, in triplicate independent assays. VK2 cells were then harvested and RNA was extracted. Gene expression analysis was 
then performed using microarray Affymetrix GeneChip whole transcript array platform. Affymetrix data were normalized 
using Robust Multichip Average (RMA) normalization. Differential gene expression analysis was performed using R 
Bioconductor limma package. Genes were considered differentially expressed if adj. p≤0.05 and upregulated or 
downregulated if log fold change (FC) ≥ 1.5 or ≤ -1.5, respectively. Genes were annotated using the Clariom S Human 
annotation file. Heatmap was generated using Graphpad Prism v8.0. Blue, through white to red indicates low to high gene 






















































































































































































































































































Figure 42 Genes exclusively downregulated and upregulated in VK2 cells co-cultured with certain Lactobacillus species and 
G. vaginalis in combination compared to G. vaginalis-only cultures. Heatmaps show normalized signal intensities for genes 
(A) downregulated and (B) upregulated in VK2 cells co-cultured with L. mucosae 2 and L. mucosae 4, C-D) downregulated 
and upregulated in VK2 cells co-cultured with L. jensenii 3 and L. crispatus 1, in combination with G. vaginalis. Heatmaps 
show the normalized signal intensities of biological replicates. Downregulated and upregulated genes are displayed above 
and beneath the black dotted lines in B) and D). VK2 cells were seeded into 24 well plates (0.5x106 cells/well) and grown to 
confluence. Monolayers were stimulated with Lactobacillus isolates (4.18x106CFU/well) and incubated for 6 hrs at 37°C, 5% 
CO2, in triplicate independent assays. G. vaginalis (4.18x107CFU/well) was then added to the Lactobacillus-VK2 cell cultures 
and incubated for an additional 6 hrs at 37°C, 5% CO2, in triplicate independent assays. VK2 cells were then harvested and 
RNA was extracted. Gene expression analysis was then performed using microarray Affymetrix GeneChip whole transcript 
array platform. Affymetrix data were normalized by Robust Multichip Average (RMA) normalization. Differential gene 
expression analysis was performed using R Bioconductor limma package. Genes were considered differentially expressed if 
adj. p≤0.05 and upregulated or downregulated if log fold change (FC) ≥ 1.5 or ≤ -1.5, respectively. Genes were annotated 
using the Clariom S HumanHT annotation file. Heatmaps were generated using Graphpad Prism v8.0. Blue, through white to 
red indicates low to high gene expression, respectively. Gene symbols are displayed on the right-hand side. GV: G. vaginalis, 


















Figure 43 Genes exclusively downregulated and upregulated in VK2 cells co-cultured with L. jensenii 2 and G. vaginalis in 
combination compared to G. vaginalis-only cultures. Heatmap shows normalized signal intensities for genes downregulated 
and upregulated in VK2 cells co-cultured with L. jensenii 2 and in combination with G. vaginalis. Heatmap shows the 
normalized signal intensities of biological replicates (n=3). Downregulated and upregulated genes are displayed above and 
beneath the black dotted line.  VK2 cells were seeded into 24 well plates (0.5x106 cells/well) and grown to confluence. 
Monolayers were stimulated with L. jensenii 2 (4.18x106CFU/well) and incubated for 6 hrs at 37°C, 5% CO2, in triplicate 
independent assays. G. vaginalis (4.18x107CFU/well) was then added to the Lactobacillus-VK2 cell cultures and incubated for 
an additional 6 hrs at 37°C, 5% CO2, in triplicate independent assays. VK2 cells were then harvested and RNA was extracted. 
Gene expression analysis was then performed using microarray Affymetrix GeneChip whole transcript array platform. 
Affymetrix data were normalized by Robust Multichip Average (RMA) normalization. Differential gene expression analysis 
was performed using R Bioconductor limma package. Genes were considered differentially expressed if adj. p≤0.05 and 
upregulated or downregulated if log fold change (FC) ≥ 1.5 or ≤ -1.5, respectively. Genes were annotated using the Clariom 
S HumanHT annotation file. Heatmap was generated using Graphpad Prism v8.0. Blue, through white to red indicates low to 


































































































































































Figure 44 Genes commonly upregulated and downregulated in VK2 cells co-cultured with Lactobacillus isolates and G. 
vaginalis in combination (n=8) compared to G. vaginalis only cultures (n=3).  Heatmap shows genes downregulated and 
upregulated in VK2 cells co-cultured with lactobacilli and G. vaginalis in combination compared to co-culture with G. vaginalis 
only. Downregulated and upregulated genes are displayed above and beneath the black dotted line. VK2 cells were seeded 
into 24 well plates (0.5x106 cells/well) and grown to confluence. Monolayers were stimulated with Lactobacillus isolates 
(4.18x106CFU/well) and incubated for 6 hrs at 37°C, 5% CO2, in triplicate independent assays. G. vaginalis (4.18x107CFU/well) 
was then added to the Lactobacillus-VK2 cell cultures and incubated for an additional 6 hrs at 37°C, 5% CO2, in triplicate 
independent assays. VK2 cells were then harvested and RNA was extracted. Gene expression analysis was then performed 
using microarray Affymetrix GeneChip whole transcript array platform. Affymetrix data were normalized using Robust 
Multichip Average (RMA) normalization. Differential gene expression analysis was performed using R Bioconductor limma 
package. Genes were considered differentially expressed if adj. p≤0.05 and upregulated or downregulated if log fold change 
(FC) ≥ 1.5 or ≤ -1.5, respectively. Genes were annotated using the Clariom S Human annotation file. Heatmap was generated 
using Graphpad Prism v8.0. Blue, through white to red indicates low to high gene expression, respectively. Gene symbols are 























Figure 45 Genes commonly differentially expressed in VK2 cells co-cultured with Lactobacillus isolates and G. vaginalis in 
combination, stratified according to whether the lactobacilli suppressed (n=3) or did not suppress (n=5) inflammatory 
cytokine production in response to G. vaginalis.  Bar graph shows gene upregulated and downregulated in non-suppressive 
and suppressive lactobacilli. Error bars indicate the standard deviation of the mean. VK2 cells were seeded into 24 well plates 
(0.5x106 cells/well) and grown to confluence. Monolayers were stimulated with Lactobacillus isolates (4.18x106CFU/well) 
and incubated for 6 hrs at 37°C, 5% CO2, in triplicate independent assays. G. vaginalis (4.18x107CFU/well) was then added to 
the Lactobacillus-VK2 cell cultures and incubated for an additional 6 hrs at 37°C, 5% CO2, in triplicate independent assays. 
VK2 cells were then harvested and RNA was extracted. Gene expression analysis was then performed using microarray 
Affymetrix GeneChip whole transcript array platform. Affymetrix data RMA normalized. Differential gene expression analysis 
was performed using R Bioconductor limma package. Genes were considered differentially expressed if p≤0.05 and 
upregulated or downregulated if log fold change (FC) ≥ 1.5 or ≤ -1.5, respectively. Genes were annotated using the Clariom 
S Human annotation file. Student’s t test was used to statistically test the differences of gene expression between VK2 cells 
cultured with non-suppressive compared to Lactobacillus species and G. vaginalis in combination, p≤0.05 was considered 
significant. CYP1A1: cytochrome P450, family 1, subfamily A, polypeptide 1, DDX58: DExD/H-Box Helicase 58, CXCL11: 
chemokine c-x-c motif ligand 11, IFIT: interferon-induced protein with tetratricopeptide repeats, IL7R: interleukin 7 receptor, 
APOL2: apolipoprotein L2, TNFSF18: tumor necrosis factor ligand superfamily member 18.  






















Figure 46 Downregulated genes in the cytokine-cytokine signalling pathway in VK2 cells co-cultured with Lactobacillus 
species and G. vaginalis in combination compared to co-culture with G. vaginalis only. KEGG cytokine-cytokine receptor 
interaction signalling pathway adapted from DAVID Bioinformatics is shown.  Blue boxes indicate mediators downregulated 
in VK2 cells co-cultured with Lactobacillus isolates and G. vaginalis in combination, compared to G. vaginalis stimulated VK2 
cells. VK2 cells were seeded into 24 well plates (1x105 cells/well) and grown to confluence. Monolayers were stimulated with 
Lactobacillus isolates (4.18x106CFU/well) and incubated for 6 hrs at 37°C, 5% CO2, in triplicate independent assays. G. 
vaginalis (4.18x107CFU/well) was then added to the Lactobacillus-VK2 cell cultures and incubated for an additional 6 hrs at 
37°C, 5% CO2, in triplicate independent assays. VK2 cells were then harvested and RNA was extracted. Gene expression 
analysis was performed using the microarray Affymetrix GeneChIP whole transcript array platform. Affymetrix data were 
normalized using Robust Multichip (RMA) normalization. Differential gene expression analysis was performed using R 
Bioconductor limma package. Genes were considered differentially expressed if adj. p≤0.05 and upregulated or 
downregulated if log fold change (FC) ≥ 1.5 or ≤ -1.5, respectively. Genes were annotated using the Clariom S Human 
annotation file. Upregulated gene Entrez identity numbers were inputted to DAVID NIH to obtain biological pathways 





























































Figure 47 Genes downregulated and upregulated in VK2 cells co-cultured with suppressive and non-suppressive 
Lactobacillus isolates and G. vaginalis in combination compared to G. vaginalis-only cultures. Heatmaps show normalized 
signal intensities for genes (A-B) downregulated in VK2 cells co-cultured with cytokine non-suppressive (NS) and suppressive 
(S) lactobacilli and G. vaginalis in combination compared to co-culture with G. vaginalis only, C) upregulated in Vk2 cells co-
cultured with cytokine non-suppressive (NS) lactobacilli and G. vaginalis in combination compared to co-culture with G. 
vaginalis only. Heatmaps show the mean normalized signal intensities, blue boxes indicate downregulated genes specific to 
VK2 cells co-cultured with suppressive lactobacilli and G. vaginalis in combination. VK2 cells were seeded into 24 well plates 
(0.5x106 cells/well) and grown to confluence. Monolayers were stimulated with Lactobacillus isolates (4.18x106CFU/well) 
and incubated for 6 hrs at 37°C, 5% CO2, in triplicate independent assays. G. vaginalis (4.18x107CFU/well) was then added to 
the Lactobacillus-VK2 cell cultures and incubated for an additional 6 hrs at 37°C, 5% CO2, in triplicate independent assays. 
VK2 cells were then harvested and RNA was extracted. Gene expression analysis was then performed using microarray 
Affymetrix GeneChip whole transcript array platform. Affymetrix data were normalized using Robust Multichip Average 
(RMA) normalization. Differential gene expression analysis was performed using R Bioconductor limma package. Genes were 
considered differentially expressed if adj. p≤0.05 and upregulated or downregulated if log fold change (FC) ≥ 1.5 or ≤ -1.5, 
respectively. Genes were annotated using the Clariom S HumanHT annotation file. Heatmaps were generated using 
Graphpad Prism v8.0. Blue, through white to red indicates low to high gene expression, respectively. Gene symbols are 
displayed on the right-hand side. 
GV: G. vaginalis, NS: non-suppressive, S: suppressive. 
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Chapter 4: Discussion 
The maintenance of a microbial and immune homeostatic environment in the FGT is of utmost 
importance for favourable reproductive outcomes and reduced HIV and STI susceptibility. 
Defence against pathogenic microbes is crucial, while tolerance to commensal bacteria and 
allogenic sperm is maintained (47). Furthermore, the vaginal microbiome state plays an 
imperative role in the immunological environment of the FGT (81). A non-optimal vaginal 
microbiome and the inflammation caused by BV-associated bacteria is associated with an 
increased HIV acquisition (82) and HIV viral replication in vitro, which suggests possible 
increased HIV transmission in vivo (124) . Studies have shown that the optimal vaginal 
microbiome state, dominated by Lactobacillus species is associated with reduced 
inflammation and subsequent HIV susceptibility risk (21,29,81,85,125), however the 
mechanisms underlying the immunomodulatory capacity of these commensal bacteria is 
unknown. In this study, the gene expression patterns of cervicovaginal mononuclear cells 
(CMCs) and matched peripheral blood mononuclear cells (PBMCs) obtained from HIV 
chronically infected South African women, were evaluated to compare the expression of genes 
involved in microbial pattern recognition and inflammatory pathways between the two 
compartments. Furthermore, eight vaginal Lactobacillus species were chosen based on their 
immunomodulatory capabilities previously assessed in vitro (98), to evaluate their potential 
effect on the expression of VK2 cell inflammatory genes in response to a key BV-associated 
bacteria, G. vaginalis. It was found that 136 genes were differentially over-expressed, and 69 
genes under-expressed in CMCs compared to PBMCs. These significantly upregulated genes 
were mapped to proinflammatory signaling pathways, NF-κB, TNF, TLR and NOD-like 
receptor signalling. Key genes in these pathways were IL1β, TNF-R1 and IL8. Significantly 
downregulated genes in CMCs compared to PBMCs were mapped to ribosome, sphingolipid, 
T cell receptor and natural killer cell mediated cytotoxicity signaling. Key genes in these 
pathways were Fyn, CD3ζ and PI3K. It was found that G. vaginalis induced a potent 
proinflammatory cytokine response by VK2 cells. In contrast, 3/8 Lactobacillus isolates (LM2, 
LM4 and LV4) reduced the level of inflammatory cytokine production by VK2 cells in response 
to G. vaginalis. A total of 142 genes were upregulated and 27 genes downregulated in G. 
vaginalis-stimulated VK2 cells compared to unstimulated VK2 cells. Similar to the upregulated 
pathways observed in CMCs compared to PBMCs, genes that were upregulated in VK2 cells 
in response to G. vaginalis mapped to inflammatory signaling, cytokine-cytokine interaction, 
TNF, NF-κB , NOD-like, TLR and MAPK signaling pathways. Key genes in these pathways 
were CCL5, cIAP, A20, CXCL10 (IP-10 gene), CXCL8 (IL-8 gene) and IL1B. In contrast, 
among the 27 genes that were downregulated in G. vaginalis-stimulated VK2 cells, were those 
encoding several zinc finger proteins. Moreover, several of these downregulated genes were 
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mapped to the KEGG longevity pathway. Pretreatment with lactobacilli resulted in a significant 
downregulation of several proinflammatory genes compared to cells cultured with G. vaginalis 
only. On the other hand, CYP1A gene expression was upregulated in cells pretreated with 
lactobacilli and compared to cells stimulated with G. vaginalis only. When gene expression in 
response to pretreatment with lactobacilli that suppressed cytokine production in response to 
G. vaginalis (LM2, LM4 and LV4; termed “cytokine-suppressive”) was compared to lactobacilli 
that did not suppress cytokine production (LJ3, LV3, LC3, LC1 and LJ2; termed “non-cytokine-
suppressive”), it was found that the expression of several genes (SAMD9L, DDX58, IFIT1) 
was downregulated in VK2 cells co-cultured with cytokine-suppressive lactobacilli,  while 
RNASE7 and TMEM2 were upregulated in VK2 cells co-cultured with non-cytokine-
suppressive lactobacilli. Furthermore, several genes involved in epithelial barrier function 
(DKK1, ELF3) and preterm birth (AKR1C1-C3) were upregulated by incubation with specific 
Lactobacillus spp. prior to G. vaginalis stimulation compared to stimulation with G. vaginalis 
only.  
 
4.1 Gene expression patterns of the FGT compared to peripheral blood of HIV 
infected women 
Although gene expression patterns in cervical cytobrush samples from HIV negative Canadian 
women has previously been studied (101), no previous studies have evaluated gene 
expression in these samples from HIV infected or South African women. This is likely because 
the extraction of intact mRNA of sufficient quantity and quality for microarray analysis is 
extremely challenging – for the present study, 28 cytobrush samples from both HIV infected 
and uninfected women were processed to optimize methodology for mRNA extraction, with 
only five having mRNA of sufficient quality to proceed with microarray analysis, even though 
all PBMC samples had high quality mRNA (not shown). Gene expression patterns of CMCs 
and matched PBMCs of HIV negative women were previously shown to be highly unique 
(101). Similarly, this study found that CMCs and PBMCs of HIV infected women had distinct 
gene expression patterns. Pathway analysis of over-expressed genes in CMCs compared to 
PBMCs revealed the over-expression of genes mapped to several proinflammatory (NF-κB, 
TNF) and microbial pattern recognition (TLR, NOD) signaling pathways. Similarly, Horton et 
al. (2009) (101) found that TLR and cytokine-cytokine receptor interaction signaling pathways 
were over-expressed in CMCs compared to matched PBMCs of HIV-negative women. The 
FGT mucosal surface is exposed to many microbes and thus it is to be expected that 
proinflammatory signaling pathways may be over-expressed at this site compared to 
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peripheral blood. In addition, vaginal microbiome state and STI status increases inflammation 
in the FGT (83,126). A limitation of the present study is that BV/STI diagnosis was solely based 
on the presence of clinical signs or symptoms, and thus asymptomatic BV/STI cases in this 
study population may have gone undetected, and potentially contributed to the over-
expression of inflammatory pathways at this site compared to PBMCs. However, PCA analysis 
based on gene expression revealed that CMC samples were more heterogenous than PBMC 
samples. This heterogeneity may be explained by factors not evaluated, including, 
asymptomatic BV/STIs, vaginal microbiome composition, recent sexual activity, and vaginal 
hygiene practices, which may affect the microenvironment of the FGT (83,127,128). Although 
all participants were on ART, 2/5 had detectable plasma viral load. However, due to the small 
sample size, the study was not sufficiently powered to compare gene expression changes 
between women who were and were not virally suppressed. Vaginal HIV viral load was not 
assessed in this study, and therefore a direct link between inflammation and HIV viral shedding 
could not be evaluated. However, previous studies have found that inflammation in the FGT 
is associated with increased vaginal HIV shedding (129). In this study, IL-8 and NF-κB  
inhibitor alpha (NFKBIA), which is activated by NF-κB (130), expression was increased in 
CMCs compared to PBMCs. NF-κB  increases activation of the HIV LTR, subsequently 
increasing viral replication (91) and IL-8 increases HIV replication in macrophages and T 
lymphocytes in vitro (131). Thus, increased expression of genes involved in pro-inflammatory 
signaling in the FGT, as found in this study, may increase HIV shedding and subsequent 
transmission. 
Furthermore, this study found that genes mapped to the T cell receptor signaling and natural 
killer cell-mediated cytotoxicity pathways were under-expressed in CMCs compared to 
PBMCs of HIV-infected women. In contrast, Horton et al. (2009) (101) found these pathways 
to be over-expressed in CMCs compared to matched PBMCs of HIV negative women, 
although direction comparison of the results of these studies is not ideal, as they were based 
on very different populations of women. Nonetheless, under expression of genes mapping to 
these pathways in HIV-infected women may reflect CD4 T cell depletion at the genital mucosal 
site. Rapid CD4 T cell depletion occurs early in HIV infection at the gastrointestinal (GI) 
mucosal site (132). Similarly, CD4 T cells have been found to be depleted in the FGT during 
HIV infection, with an accumulation of terminally differentiated cells (133,134). Furthermore, 
IFN-γ and IL-2 T cell responses to HIV were lower in the cervix compared to blood of HIV-
infected women (134,135). Studies have shown that, although peripheral blood CD4 T cell 
populations were recovered following ART initiation, CD4 T cells in both the GI tract and FGT 
remain depleted (132,133). Furthermore, mucosal CD4 T cell depletion in the GI tract was 
found to occur at all stages of HIV infection (136). Therefore, despite chronic infection and 
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ART initiation of all the participants of this present study, depletion of CD4 T cells and T cell 
dysfunction at the genital mucosal site during HIV infection is plausible for this cohort. In 
contrast, an increase of circulating natural killer cells was found in acute HIV infection, which 
returned to pre-infection levels in chronic infection, however, chronic HIV infection causes a 
defect in natural killer group 2 D (NKG2D)-mediated NK killing (137). Therefore, under-
expression of T cell receptor signaling and natural killer cell-mediated cytotoxicity pathways in 
CMCs may be an HIV infection specific phenomenon. This study found that the mediators 
FYN, CD3ζ, PI3K and ITK were under-expressed in CMCs compared to matched PBMCs. Fyn 
and CD3ζ are required for T cell antigen receptor signal transduction, as the CD3 zeta chain 
is the signaling component of the TCR (138) and Fyn phosphorylates immunoreceptor tyrosine 
activation motifs in the CD3 zeta chains (139). Similarly, PI3K (phosphoinositide-3 kinase) is 
involved in innate immunity via TLR signaling and subsequent cytokine production, which 
influences adaptive immune responses (140). ITK (tyrosine-protein kinase) plays a role in T 
cell proliferation and differentiation via intracellular signaling (141). Thus, lower expression of 
these mediators in CMCs compared to PBMCs, as found in this study, potentially reflects 
reduced T cell activation and receptor signaling. Interestingly, a previous study by Trimble et 
al. (2000) (142) identified circulating HIV specific CD8 T cells by tetramer staining and found 
that these cells were CD3ζ-negative. These mediators are also components of the natural 
killer cell-mediated cytotoxicity pathway (115). A reduction in Fyn, CD3ζ and CD48 results in 
a reduction of lymphocyte activation (143–146). In addition, perforin was under-expressed in 
CMCs compared to PBMCs. Perforin is a cytolytic enzyme released by natural killer cells and 
cytotoxic T lymphocytes (CTLs) also known as CD8 T cells, which cause the formation of 
pores on target cells (147). Lower levels of perforin expression in CMCs may be explained by 
reduced frequency and/or compromised function of natural killer cells and CTLs at the cervix 
compared to PBMCs, as suggested by the under expression of Fyn, CD3ζ and CD48.  
The role of natural killer cells in the FGT is imperative for defence against intracellular 
pathogens and CD8+ T cells (CTLs) predominate over CD4+ T cells in the FGT (148). The 
reduction of these cells in HIV infected women may increase their risk for co-infection with 
other STIs, while a simultaneous increase in the expression of non-specific proinflammatory 
pathways may reduce epithelial barrier integrity, further increasing susceptibility to 
opportunistic infections. However, in this study, it is not clear whether genital mucosal CTL 
populations were reduced during chronic HIV infection or whether their functionality was 
altered, as mentioned above. However, the unique gene expression patterns in CMCs 
compared to PBMCs found in this study are likely to be at least partly due to differences in the 
cell populations between these two anatomical compartments. These differences have 
previously been reported by Horton et al. (2009) using flow cytometry analysis, which found 
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an increase in the majority of immune cell types in CMCs compared to PBMCs obtained from 
HIV-1 negative Canadian women(101). Similarly, in this present study, CIBERSORT analysis 
of the microarray data revealed that CMCs tended to include increased predicted innate 
immune cell populations compared to PBMCs, except for monocytes and resting mast cells 
which were increased in PBMCs. Furthermore, the CIBERSORT analysis also predicted a 
reduced abundance of naïve CD4+ T cells, CD8+ T cells and activated NK cells in CMCs, 
which suggests that the under-expression of mediators mapping to the T cell signaling and 
natural killer cell-mediated cytotoxicity pathways are likely due to a reduction in these cell 
populations in CMCs compared to PBMCs. While similar results were obtained by xCell 
analysis of the microarray data, a greater diversity of cell types were detected. Particularly, 
the predicted abundances of epithelial cells and keratinocytes were higher in CMCs compared 
to PBMCs. Epithelial cells and keratinocytes are important sentinels of immunity in the FGT 
(149,150), thus, the distinct gene expression patterns observed in CMCs may be attributed to 
the greater abundances of these cells at this site. 
Interestingly, this study found that genes mapped to the sphingolipid pathway were under-
expressed in CMCs compared to PBMCs. The sphingolipid pathway plays an important role 
in immune cell activation, trafficking and retention in inflamed tissues (151). Specifically, 
sphingosine-1-phosphate (S1P) activation of sphingosine-1-phosphate receptors (S1PR) 1-5 
expressed on immune cells, promotes the migration of lymphocytes from secondary lymphoid 
tissues to blood and lymphatic circulation (151). This migration of immune cells is largely 
dependent on the S1P concentration gradient and S1PR expression (151). Denton et al. 
(2014) found that in mice, activated T cell retention in lymph nodes was due to downregulation 
of S1PR expression by these cells (152). Similar findings were observed in peripheral tissue 
in mice, Mackay et al. (2015) found that the downregulation of S1PR coincides with the 
retention of CD8+ T cells in skin (153). Hence, in this present study, the under-expression of 
receptors S1P1 and S1P5 found in CMCs compared to PBMCs may provide insight to the 
mechanism of retention of the immune cells detected at this mucosal site. Notably, as 
discussed above, CD4+ and CD8+ T cells and NK cells were reduced in CMCs compared to 
PBMCs, thus it is unclear whether decreases in cytotoxicity genes such as perforin are due to 
reduced abundance of cytotoxic cells or impaired functionality.  An upregulation of S1P 
gradient and S1PRs promotes the trafficking of immune cells from the circulation to sites of 
injury (151). Therefore, the overrepresentation of S1PRs in PBMCs compared to CMCs would 
suggest that immune cells would effectively migrate to the cervix. Thus, the reduction in certain 
immune cell populations found in CMCs may indicate HIV-1 specific immune dysregulation, 
however, further research is needed to elucidate this phenomenon.   
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Furthermore, in this study, several long and short ribosomal subunits were under-expressed 
in CMCs compared to PBMCs. Similarly, Kleinman et al. (2014) (154) found a downregulation 
of genes involved in ribosome biogenesis in HIV-infected Jurkat cells in vitro and suggested 
that this regulation of host gene expression was mediated by the virus, linking HIV replication 
and the nucleolus.  
Therefore, the over- and under-expression of genes mapped to the respective signaling 
pathways mentioned above in CMCs relative to PBMCs from HIV infected women may play a 
role in increased HIV viral replication and transmission. 
 
 
4.2 Suppression of cytokine responses of VK2 cells to G. vaginalis by 
Lactobacillus species  
Previous studies have associated BV with increased proinflammatory mediators in the FGT 
(33,83,84). This study found that G. vaginalis (ATCC 14018) induced a proinflammatory 
response in VK2 cells, shown by significant increases in the production of proinflammatory 
cytokines and chemokines IL-8, IL-6 and IL-1α, chemokines IP-10, MIP-1α, MIP-1β and MIP-
3α, as well as anti-inflammatory IL-1RA. These findings are consistent with Chetwin et al. 
(2019) (29) and Manhanzvaet al. (2020) (98) that found that the same G. vaginalis reference 
strain elicited proinflammatory cytokine responses from ectocervical (CaSki) and VK2 cells in 
vitro. Similarly, recent studies have found that G. vaginalis induces TNF-α, IL-1β, IL-6 and IL-
8 production by HeLa cells in vitro (86) and IL-6 production in vivo in cervicovaginal fluid of 
mice (87). Consonantly, in vivo, Lennard et al. (2018) found that BV was associated with 
increased genital inflammation in a cohort of adolescent South African women (126). 
Furthermore, the study found that BV-associated bacterial taxa abundance, including G. 
vaginalis was increased in women with high genital inflammation (126). Interestingly, while BV 
is associated with upregulation of pro-inflammatory cytokines, several studies have shown 
that downregulation of chemokines may occur (13,83).Upregulation of chemokines by this G. 
vaginalis strain suggests that other species or strains may be involved in chemokine 
downregulation associated with BV, or alternatively that other human cells (such as immune 
cells) are involved. Gibbs et al. (2017) found that innate-like mucosal-associated invariant T 
(MAIT) cells were present in the upper and lower FGT and expressed IL-17/IL-22 following 
stimulation by E.coli in vitro (155). The authors concluded that this distinct cytokine profile of 
MAIT cells is important for immune homeostasis of the FGT in response to microbial induced 
inflammation (155). Similarly, studies have found that T regulatory (Treg) cells are important 
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immune response regulators, which protect the mucosal tissue against excessive 
inflammation in the FGT (156). Thus, immune cells in the FGT likely play a crucial role in 
modulating inflammatory responses induced by microbes at this site. Future studies including 
immune cells in this culture system would be useful.  
Modulation of chemokine production induced by G. vaginalis is of great significance in the 
FGT and HIV susceptibility. The MIP chemokine protein family are chemoattractants for 
immune cells and are secreted by several cell types, including epithelial cells (157). An 
increase in these chemokines in the FGT may increase HIV acquisition risk as many of the 
recruited immune cells are HIV target cells, especially CD4+ T cells (81). A study by 
Liebenberg et al. (2017) (125) found that genital IP-10 and MIP-1β concentrations were 
significantly associated with HIV acquisition in a cohort of South African women. Therefore, 
inflammation in the FGT induced by BV-associated bacteria is of utmost importance in the HIV 
prevention field.  
Imperative to HIV prevention strategies is the maintenance of an optimal vaginal microbiome, 
dominated by Lactobacillus species, and an improved understanding of the 
immunomodulatory capabilities of these commensal bacteria is needed. In this study, the co-
culture of Lactobacillus isolates and G. vaginalis elicited differing inflammatory responses by 
VK2 cells, as indicated by varying inflammatory principal component scores. The cytokine-
suppressive lactobacilli LM2, LM4 and LV4 reduced the proinflammatory response of VK2 
cells elicited by G. vaginalis and displayed significantly lower inflammatory estimate scores 
compared to non-cytokine-suppressive lactobacilli LJ3, LV3, LC3, LC1 and LJ2. Notably, VK2 
co-culture with certain Lactobacillus species and G. vaginalis in combination, induced a 
greater cytokine response than co-culture with G. vaginalis only. This suggests that VK2 co-
culture with certain lactobacilli only are inflammatory, as previously reported by Manhanzva et 
al. (2020) (98). While the underlying mechanism remains to be determined, differences in 
inflammatory profiles may be influenced by the peptidoglycan cell wall and membrane 
structures of particular strains, as well as proteins present in the cell wall. Previous studies 
have found that the immunomodulatory properties of Lactobacillus peptidoglycan, a toll like 
receptor (TLR) and nucleotide binding and oligomerization domain protein (NOD) agonist, are 
highly strain dependent (158,159). The IL-6 response of VK2 cells elicited by G. vaginalis was 
significantly reduced by each of the cytokine-suppressive lactobacilli and the IL-8 response 
tended to be reduced. IL-6 is a strong proinflammatory cytokine which recruits immune cells 
to injury sites and has shown to affect the longevity of T cells via an anti-apoptotic effect, 
promoting chronic inflammation (160). IL-8 functions similarly and both of these cytokines 
recruit and activate immune cells, including neutrophils and HIV target cells (161,162). 
Although neutrophil extracellular traps have been found to inhibit HIV infection in vitro (163), 
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their release of reactive oxygen species and proteases also contribute to tissue damage (164), 
which decreases FGT epithelial barrier integrity and may increase HIV acquisition risk (96). In 
addition, these cytokines recruit dendritic cells which have shown to increase HIV acquisition 
by trans-infection to CD4+ T cells (165). Moreover, dendritic cells also produce chemokines 
which recruit CD4 T cells (166). Hence, the immunosuppressive ability of lactobacilli to 
dampen the IL-6 and IL-8 responses induced by BV-associated bacteria in the FGT may 
reduce HIV acquisition risk in women. The mechanisms underlying the immunomodulatory 
effect of lactobacilli are not fully understood. Hearps et al. (2017) (28) found that both D- and 
L-lactic acid supress proinflammatory cytokine responses of cells from the FGT in vitro, 
suggesting that these metabolites that are produced by lactobacilli may be involved in their 
anti-inflammatory effects. Consistent with Hearps et al. (2017) (28), the present study found 
that increased L-lactate production by lactobacilli in the VK2 cell culture system was 
associated with reduced MIP-1α, MIP-1β and IL-8 responses by VK2 cells.  
It was found that greater suppression of inflammatory cytokine production was observed 
following a 24 hour incubation period (98) compared to the 12 hour incubation time of this 
study. This finding may indicate that the ability of Lactobacillus isolates to dampen 
inflammatory responses of VK2 cells in vitro may be influenced by incubation time. The effect 
of incubation time on the cytokine suppressive capability of lactobacilli in vitro may suggest 
that their growth and subsequent metabolite (e.g. lactic acid) production in the VK2 cell culture 
system influences their anti-inflammatory capabilities. Additionally, the anti-inflammatory 
effect of lactic acid was found to be due to the protonated lactic acid, rather than lactate (28). 
Protonation occurs at low pH (28) and therefore, at earlier incubation times, the pH may still 
be too high for protonation to occur. In support, culture pH recorded in the present study was 
higher than observed following 24 hours of incubation (98). Future time series experiments 
assessing the growth of lactobacilli, metabolite production and cytokine responses in the VK2 
cell culture system may be useful to elucidate this research question.  
 
 
4.3 Gene expression of VK2 cells altered by G. vaginalis 
The increase in inflammatory cytokine and chemokine production by VK2 cells in response to 
G. vaginalis that was observed is consistent with the microarray analysis of these cells which 
found that the majority of differentially expressed genes were upregulated. Gene expression 
analysis of G. vaginalis stimulated VK2 cells revealed an upregulation of 142 genes, which 
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mapped to key proinflammatory signaling pathways, including cytokine-cytokine receptor 
interaction, TNF, NF-κB, TLR, NOD-like receptor and MAPK signaling pathways.  
Expression of several C-C and C-X-C motif chemokine ligands, proinflammatory cytokines, 
including IL-1α, IL-1β and IL-6, and mediators of the cytokine-cytokine receptor and TNF 
signaling pathways were upregulated in G. vaginalis-stimulated VK2 cells. Similarly, TLR and 
NF-κB signaling upregulation in G. vaginalis-stimulated VK2 cells indicates the induction of an 
inflammatory state. TLR2 expression was upregulated in G. vaginalis stimulated VK2 cells 
compared to unstimulated VK2 cells. TLR2 detects bacterial lipoproteins and the bacterial cell 
wall component peptidoglycan of Gram-positive bacteria (167). Hence, upregulation of TLR2 
in response to G. vaginalis is appropriate, due to its Gram-positive cell wall structure which 
contains peptidoglycan (PGN) (168,169). Although, G. vaginalis displays Gram-variable 
staining, LPS (produced by Gram negative bacteria) has not been detected in its cell wall 
structure in vitro (168,170). Moreover, an in vivo study by Aroutcheva et al. (2008) (171) found 
only trace amounts of LPS in vaginal washes obtained from women with BV predominantly 
colonized by G. vaginalis. Consistent with a previous study by Fazeli et al. (2005) (65) showing 
that TLR4 is not expressed on vaginal epithelial cells in vivo, TLR4 expression was not 
upregulated in G. vaginalis stimulated-VK2 cells, while low level TLR4 expression was 
detected in all cultures.Thus it is unclear if these cells express surface TLR4, furthermore, G. 
vaginalis does not produce its LPS ligand which would induce a TLR4 response. Nonetheless, 
research on G. vaginalis-TLR interactions is limited and further studies using TLR reporter cell 
lines may be useful for the identification of other TLRs that are activated by G. vaginalis. TLR 
activation triggers a cascade of intracellular signaling which activates NF-κB  and 
subsequently induces the transcription of inflammatory cytokines, IL-1β, IL-6, IL-8 and 
RANTES (172). Consistent with this known inflammatory signaling pathway, this study found 
an increase in the expression of NF-κB, as well as the cytokines mentioned above, thus 
providing an improved understanding of G. vaginalis-induced inflammation in cells of the FGT.  
Interestingly, this study found that G. vaginalis downregulated the expression of certain host 
factors. A downregulation of expression of several zinc finger proteins (ZNF), ZNF30, ZNF302, 
ZNF483 and ZSCAN31, was found in G. vaginalis-stimulated VK2 cells compared to 
unstimulated VK2 cells. ZNF proteins have various molecular functions, among these are 
transcriptional regulation and signal transduction, as they interact with DNA, RNA and various 
proteins (173). Relevant to this present study, Hong et al. (2015) (174) found that ZNFA20 
attenuated LPS-induced production of prostaglandin E2, cyclooxygenase (COX)-2 and 
proinflammatory cytokines in human periodontal ligament cells in vitro. Others have found that 
ZNFA20 also inhibits NF-κB activation and apoptosis (175). In addition, ZNF658 was found to 
regulate the transcription of genes involved in zinc homeostasis (176). Zinc itself has anti-
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inflammatory and anti-oxidant properties, functioning intracellularly to regulate signaling 
pathways of the immune system (177). Zinc has been found to negatively regulate 
inflammation by modulating TLR and NF-κB  signaling (178). Thus, zinc homeostasis plays 
an important role in inflammatory responses, and a heightened inflammatory response is a 
clinical manifestation of zinc deficiency in humans (177). Furthermore, zinc deficiency is 
associated with increased inflammatory cytokines in vitro and in vivo (178). Studies have found 
an increase in IL-1β production by PBMCs obtained from zinc-deficient adults compared to 
zinc-sufficient PBMCs, after LPS stimulation of these cells (179). Thus, reduced expression of 
several zinc finger proteins in G. vaginalis stimulated VK2 cells, may have exacerbated the 
inflammatory response. In addition to the regulation of zinc homeostasis by some ZNF 
proteins, zinc deficiency may impact the expression and functions of ZNP proteins and zinc 
supplementation has been found to increase the expression of ZNFA20 (180). Hence, it is 
likely that ZNF proteins themselves have anti-inflammatory effects and the reduction of these 
ZNFs in G. vaginalis-stimulated cells may have exacerbated the proinflammatory response. 
Interestingly, ZNF protein mutations are implicated in skin diseases. Studies have found that 
downregulation of ZNF750 causes a reduced expression of genes involved in skin barrier 
formation (173). Therefore, a G. vaginalis-induced reduction of ZNF proteins in the FGT may 
be implicated in reduced barrier function at the FGT, and increased susceptibility to STI 
acquisition. In addition, genes mapped to the KEGG longevity regulating pathway were 
downregulated in G. vaginalis-stimulated VK2 cells compared to unstimulated VK2 cells. The 
longevity regulating pathway functions in cellular fitness and the attenuation of 
proinflammatory mediators to increase cellular survival (181–183). Hence, reduction in 
mediators mapping to this pathway may contribute to an excessive pro-inflammatory state, as 
well as reduced VK2 cellular fitness and survival. Although, VK2 cell viability in this study 
remained unchanged with G. vaginalis stimulation for a relatively short time (6 hours), this 
finding is potentially significant in vivo where exposure of vaginal epithelial cells to G. vaginalis 
is greater than the incubation time used in this in vitro model.  
 
4.4 Effect of Lactobacillus species on VK2 cell gene expression induced by G. 
vaginalis  
4.4.1 Downregulated genes in VK2 cells co-cultured with lactobacilli and G. vaginalis 
in combination 
The mechanisms underlying the immunomodulatory effect of vaginal lactobacilli are unknown. 
This study found that the expression of several genes, CXCL11, IFIT3, IFIT2, IL7R, APOL2, 
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DDX58 and TNFSF18, were downregulated in VK2 cells co-cultured with Lactobacillus spp. 
and G. vaginalis in combination, compared to cells stimulated only with G. vaginalis.  
The chemokine CXCL11 (otherwise known as interferon-inducible T-cell alpha 
chemoattractant or interferon-gamma-inducible protein 9) is a chemoattractant for T 
lymphocytes and macrophages (184,185). CXCL11 expression in the vaginal tract is not well 
studied, however, a previous in vivo study of chronic obstructive pulmonary disease found that 
suppression of CXCL11 gene expression caused a reduction in T lymphocyte recruitment to 
the lungs of rats (185). Thus, the ability of lactobacilli to supress CXCL11 expression in VK2 
cells induced by G. vaginalis, as found in this present study, provides insight into the protective 
capacity of lactobacilli against excessive recruitment of T lymphocytes (HIV target cells) to the 
FGT, potentially reducing HIV acquisition risk.  
IFIT2 and 3 (interferon-induced protein with tetratricopeptide repeats) are well known for their 
antiviral activity (186), and are involved in interferon gamma signaling in the immune system  
(187). In contrast their role in bacterial infection is less clear (188). In the context of chronic 
mastitis, IFIT3 was found to be induced in vitro in mammary epithelial cells stimulated by LPS 
and lipoteichoic acid (LTA), which forms part of the cell walls of Gram-negative and Gram-
positive bacteria, respectively (189). Thus, downregulation of IFIT3 in lactobacilli pre-treated 
VK2 cells is potentially an indication of an overall reduced inflammatory state. In contrast, in 
vitro overexpression of IFIT2 in transfected raw264.7 macrophages was found to supress 
LPS-induced TNF-α, IL-6  and MIP-2 protein expression (188). Thus, the potential 
immunomodulatory effect of reduced IFIT2 in lactobacilli pre-treated VK2 cells found in this 
study is unclear.  
In this study, expression of the IL-7 receptor (IL-7R) gene was downregulated in VK2 cells 
cultured with lactobacilli and G. vaginalis in combination, compared to G. vaginalis only 
stimulated VK2 cells. The IL-7/IL-7R pathway is important for lymphocyte development and T 
cell homeostasis (190). An increase in IL-7 and its receptor is linked to several inflammatory 
diseases such as allograft rejection, rheumatoid arthritis, psoriasis, multiple sclerosis and 
inflammatory bowel disease (191,192). Using an in vivo mouse model, Schreiber et al. (2019) 
(193) found that hyperexpression of IL-7 in transplanted islets caused a decrease in graft 
survival and increased CD4+ and CD8+ T cell infiltration. Furthermore, studies have shown 
that IL-7 overexpression and T cells highly expressing IL-7R results in colitis (191,194). 
Interestingly, the IL-7/IL-7R is implicated in HIV/SIV infection, as IL-7 expression is markedly 
increased in HIV infection, perhaps as the body’s physiological attempt to restore T cell loss 
(195), alternatively as a result of increased aberrant inflammation in HIV infection (196) . 
Moniuszko et al. (2006) (195) found a direct correlation between the absolute CD4 T cell 
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populations and IL-7R expressing T cells in blood, secondary lymphoid organs and various 
other tissues, including the vagina of SIV-infected macaques. The finding of this present study 
that lactobacilli reduced IL-7R expression on VK2 cells, suggests that these commensal 
bacteria could exert a similar effect on lymphocytes in the FGT, reducing HIV CD4 T cell 
targets at this site. However, further research is needed to elucidate the effect of lactobacilli 
on other cell populations in the FGT, in addition to epithelial cells. IL-7R is commonly 
expressed by lymphocytes (197). However, the IL-7R consists of an alpha chain and a 
common gamma chain, of which the IL-7Rα is lymphoid-specific, while the γ chain  may be 
expressed by cells of various haematopoietic lineages (197). Yamada et al. (1997) found that 
bacterial invasion of colonic epithelial cells induced IL-7R expression in vitro (198). 
Furthermore, its expression has been found in decidua specimens obtained from a cohort of 
pregnant women in China (199). Thus, future research to confirm IL-7R expression by vaginal 
epithelial cells would be useful to support the findings of this present study and elucidate the 
role of IL-7/IL-7R in immune modulation by lactobacilli in this this model system. The IL-7/IL-
7R has further been implicated in recurrent pregnancy loss. Wu et al. (2016) (199) found that 
IL-7R antagonist treatment in an abortion prone mouse model, significantly reduced fetal 
resorption rates via the downregulation of Th17 and upregulation of regulatory T cell (Treg)-
related factors. The study also found that IL-7 treatment of non-abortion prone mice, 
significantly increased fetal resorption rates by upregulation of Th17 and downregulation of 
Treg-related factors. A study by Willis et al. (2012) (191) found that IL-7R blockade suppressed 
innate and adaptive responses in colitis. The study found that in mice, colitis was reduced by 
an anti-IL7R antibody blockage of the IL-7R which resulted in reduced T cell proliferation and 
function. Furthermore, the innate immune response was also downregulated, with a reduction 
in the abundance of macrophages and dendritic cells and their activity. Hence, IL-7 and IL-7R 
play an important role in inflammation and are potential therapeutic targets to reduce 
inflammation.  Furthermore, thymic stromal lymphopoietin (TSLP) and its receptor (TSLPR) 
were upregulated in G. vaginalis-stimulated VK2 cells compared to unstimulated VK2 cells. 
TSLP pays an important role in immune responses, and signals through a heterodimeric 
receptor complex composed of an IL-7R alpha chain and a TSLPR (200). Thus, the reduction 
in IL-7R expression by lactobacilli pre-treated VK2 cells may be an important mechanism 
utilized by lactobacilli to reduce inflammatory responses induced by G. vaginalis. Taken 
together with previous research discussed above, modulation of IL-7/IL-7R signaling by an 
optimal vaginal microbiome dominant in Lactobacillus spp. in the FGT may reduce HIV 
susceptibility and improve pregnancy outcomes.  
Apolipoprotein L2 (APOL2) is a lipid-binding protein found intracellularly in the cytoplasm 
where it is involved in the movement of lipids and lipid binding to organelles and plays a role 
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in the pathways of cholesterol and sphingolipid transport to the plasma membrane (201,202). 
Inflammatory stimuli such as TNF-α and IFN-γ induce APOL2 expression in human dermal 
microvascular endothelial cells in vitro (203). G. vaginalis produces a cholesterol-dependant 
pore-forming toxin called vaginolysin, which utilizes cholesterol of the host cell plasma 
membrane (94). Reduction of cholesterol by statin was found to reduce the colonization and 
pathogenesis of G. vaginalis in the FGT of mice (95). This present study found that APOL2 
expression was downregulated in VK2 cells co-cultured with lactobacilli and G. vaginalis in 
combination compared to co-culture with G. vaginalis only. This finding may suggest a 
potential protective mechanism by lactobacilli against the pathogenesis of G. vaginalis, as a 
reduction in APOL2 may cause reduced transport of cholesterol to the plasma membrane of 
the VK2 cells, thus reducing the pathogenic effects of vaginolysin. 
TNFSF18 gene expression was downregulated in VK2 cells co-cultured with lactobacilli and 
G. vaginalis in combination compared to co-culture with G. vaginalis only. The TNFSF18 gene 
encodes the protein TNF ligand superfamily member 18, also known as glucocorticoid-
induced TNF receptor ligand (GITRL), a cytokine shown to modulate T lymphocyte survival 
(204). Its receptor is TNFRSF18/GITR (204). The cytokine is involved in proinflammatory 
responses and supresses Treg functions (205). Mahesh et al. (2006) (206) found that 
expression of TNFSF18 stimulates the secretion of proinflammatory cytokines and 
chemokines by T cells in vitro. Similarly, Bae et al. (2008) (207) found that the stimulation with 
TNFSF18 induced proinflammatory cytokine expression in a macrophage cell line and primary 
macrophages in vitro. Furthermore, the study found nuclear translocation of the NF-κB  p50 
subunit in response to TNFSF18 and the authors concluded that in macrophages, TNFSF18-
mediated inflammatory activation likely plays a role in the pathogenesis of inflammatory 
diseases (207). Therefore, a reduction in TNFSF18/GITRL is likely to suppress 
proinflammatory cytokine secretion by potentially reducing NF-κB translocation into the 
nucleus. Thus, downregulation of this gene may be an anti-inflammatory mechanism in 
lactobacilli pre-treated cells. 
4.4.2 Upregulated genes in VK2 cells co-cultured with lactobacilli and G. vaginalis in 
combination 
In contrast to the downregulated genes discussed above, CYP1A1 gene expression was 
upregulated in VK2 cells co-cultured with lactobacilli and G. vaginalis in combination compared 
to co-culture with G. vaginalis only. 
CYP1A1 is a member of the cytochrome p450 (CYP) family 1 and are involved in detoxification 
of xenobiotics, cellular metabolism and homeostasis (208). Studies have shown that these 
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enzymes are commonly downregulated during inflammation and host response to infection 
(209). This is consistent with the findings of this study, whereby higher expression of CYP 
enzymes was accompanied by a lower expression of proinflammatory cytokines by VK2 cells 
co-cultured with lactobacilli and G. vaginalis in combination compared to co-culture with G. 
vaginalis only. This suggests that higher proinflammatory cytokine expression in G. vaginalis 
only cultures resulted in a relative downregulation of CYP enzymes compared to lactobacilli 
and G. vaginalis co-cultures. In contrast, a previous study found that the proinflammatory 
cytokine TNF-α increased CYP1B1 expression in epithelial cells in vitro (210), thus the effect 
of cytokine production on these enzymes is heterogenous. Notably, TNF-α production was not 
measured in this study because it was not detected by Manhanzva et al. (2020) in the same 
culture system (98). However, of interest to this study is the potential anti-inflammatory effects 
of CYP enzymes. Arachidonic acid is metabolized into pro- and anti-inflammatory eicosanoids 
(211), via 3 major pathways COX, lipoxygenase (LOX) and CYP (212). CYP metabolizes 
arachidonic acid into epoxyeicosatrienoic acids (EETs) which display anti-inflammatory effects 
(213) both in vitro and in vivo (214). Thus, a potential increase in CYP expression in host cells 
induced by lactobacilli and subsequently increased production of EETs, may drive an anti-
inflammatory response in the presence of BV-associated bacteria. However, additional 
research is needed to determine the potential production of EETs in this culture system. 
Furthermore, an in vitro study by Zhang et al. (2018) (215), which used inflammatory epithelial 
cells obtained from bovine mammary glands with mastitis, found that CYP1A1 reduced in vitro 
LPS-induced TNF-α and IL-6 responses and NF-κB  activation. Moreover, the ability of non-
cytokine-suppressive lactobacilli to induce CYP expression in VK2 cells may explain the ability 
of these isolates to suppress IL-6 responses of VK2 cells, albeit to a lesser extent than 
cytokine-suppressive lactobacilli.  
4.4.3 Genes downregulated in VK2 cells co-cultured with cytokine-suppressive 
lactobacilli and G. vaginalis in combination 
Grouped limma analyses to detect genes downregulated in VK2 cells pre-treated with 
cytokine-suppressive lactobacilli (LM2, LM4, LV4) and non-cytokine-suppressive lactobacilli 
(LJ3, LV3, LC3, LC1, LV4) compared to stimulation with G. vaginalis only revealed similar 
differential gene expression between these groups. However, three genes (SAMDL, DDX58 
and IFIT1) were downregulated in VK2 cells co-cultured with cytokine-suppressive lactobacilli 
and G. vaginalis in combination compared to co-culture with G. vaginalis only.  
The sterile alpha motif domain-containing 9-like (SAMD9L) gene encodes a protein that is 
typically involved in cell growth, division and maturation (216). SAMD9L expression has been 
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shown to be induced by cytokines, particularly IFNs, in CD34+ hematopoietic stem and 
progenitor cells in vitro (217). Although, the relationship between SAMD9L and cytokine 
expression is unclear, it is possible that the lower expression of this gene in VK2 cells pre-
treated with cytokine-suppressive lactobacilli compared to stimulation with G. vaginalis only 
was due to reduced proinflammatory cytokine production. Alternatively, the inverse may be 
true and downregulation of SAMD9L may have contributed to the dampened pro-inflammatory 
responses observed in these cultures. Wang et al. (2014) (218) found that SAMD9L 
knockdown in hepatocellular (SK hep-1) cells was accompanied by a significant elevation in 
the Wnt/β-catenin signaling pathway, which has been shown to inhibit NF-κB in vitro (219,220).  
DDX58 is also known as RIG-I, a member of the RIG-I like receptor family a cytoplasmic PRR 
that is well known for the detection of viral dsRNA (221). A microarray study by MacPherson 
et al. (2014) (222) found that a multistrain probiotic including Lactobacillus helveticus, 
attenuated gene expression involved in the proinflammatory Th1 and innate immune system 
antiviral responses induced by dsRNA in intestinal epithelial cells in vitro. Of interest to this 
study, RIG-I receptors also recognize DAMPs, particularly immunocomplexes of small nuclear 
ribonuclearproteins (snRNPs) (223). As discussed in Chapter 1, DAMPs are released by 
damaged host cells and are detected by PRRs and induce inflammation (61). G. vaginalis has 
been shown to cause epithelial damage in vivo (87), which potentially results in the release of 
DAMPs by damaged cells. Hence, the downregulation of DDX58 in VK2 cells pre-treated with 
cytokine-suppressive lactobacilli could potentially reduce DAMP-induced inflammatory 
responses. However, additional research is needed to investigate potential DAMPs induced 
by G. vaginalis in this culture system. Alternatively, Schmolke et al. (2014) (224) found that 
RIG-I receptors detected the mRNA of intracellular Salmonella enterica in fibroblasts in vitro. 
As uptake of G. vaginalis by vaginal epithelial cells in vitro has previously been reported (225), 
G. vaginalis uptake by VK2 cells may have occurred and subsequent detection by RIG-I 
receptors may have been reduced due to RIG-I downregulation by VK2 cell pre-treatment with 
cytokine-suppressive lactobacilli. However, VK2 uptake of G. vaginalis and detection of its 
mRNA by RIG-I in this culture system needs further research for this conclusion. 
Similarly, interferon induced protein with tetratricopeptide repeats 1 (IFIT1) is well known for 
anti-viral function (187). IFIT1 has been shown to be induced by LPS via TIR-domain-
containing adaptor protein inducing interferon (TRIF)-dependent interferon regulatory factor 
(IRF) 3 activation in macrophages in vitro (226). The adaptor molecule TRIF is crucial for 
signal transduction from intracellular TLR3 and TLR4, however, TLR2 has been found to utilize 
TRIF as well (226). Interestingly, using a TRIF-deficient mouse model, Petnicki-Ocwieja et al. 
(2013) (226) found that synthetic lipopeptide Pam3CSK4 stimulation of bone marrow derived 
macrophages (BMDMs) obtained from these mice, produced significantly less IL-6 than 
108 
 
BMDMs isolated from wildtype mice. Furthermore, the study also found Pam3CSK4 stimulation 
of BMDMs isolated from TRIF-deficient mice displayed significantly less IFIT1 expression 
compared to wildtype mouse BMDMs (226). As discussed above, G. vaginalis may induce an 
immune response via the TLR2, as TLR2 expression was upregulated in G. vaginalis 
stimulated VK2 cells compared to unstimulated cells. Therefore, a downregulation of IFIT1 in 
VK2 cells pre-treated with cytokine-suppressive lactobacilli suggests an immunomodulatory 
mechanism downstream of the TLR2 signaling pathway.  
4.4.4 Genes upregulated in VK2 cells co-cultured with non-cytokine suppressive 
lactobacilli and G. vaginalis in combination 
In contrast, the grouped limma analysis detected several genes upregulated in VK2 cells co-
cultured with non-cytokine-suppressive lactobacilli (LJ3, LV3, LC3, LC1, LV4) and G. vaginalis 
in combination compared to co-culture with G. vaginalis only. Among these genes were 
RNase7 and TMEM2.  
Ribonuclease A family member 7 (RNase7) is a protein with antimicrobial and ribonuclease 
activity, its expression occurs in several epithelial tissues, and it is highly expressed in the 
skin, tonsils, pharynx and genitourinary tract (227). The antimicrobial and immunomodulatory 
properties of RNase7 have largely been studied in keratinocytes and in the human skin (228). 
RNase 7 is induced by pro-inflammatory cytokines and it has been suggested that a local 
inflammatory environment, such as in the case of psoriasis and atopic dermatitis, increases 
the expression of RNase7 on the skin (227–229). Therefore, the upregulation of RNase7 in 
VK2 cells co-cultured with non-cytokine suppressive lactobacilli may be a result of the 
increased inflammatory environment of these cultures. In addition, RNase7 expression by 
keratinocytes in vitro is induced in the presence of microorganisms and skin commensals have 
been shown to induce its expression as well, thereby strengthening cutaneous defence 
(227,228). Hence, the significantly increased induction of RNase7 expression in VK2 cells co-
cultured with lactobacilli and G. vaginalis in combination compared to co-culture with G. 
vaginalis only may be an antimicrobial protective mechanism by these commensal bacteria 
against G. vaginalis. RNase7 expression is rapidly increased on the skin surface following 
experimental barrier disruption (229), although it is not yet known whether RNase7 is 
expressed as part of the inflammatory response to barrier disruption or plays an active role in 
wound healing and further research is needed to elucidate its role in epithelial barrier function 
in the FGT. RNase7 has also shown to have immunomodulatory effects. Interestingly, RNase7 
is able to convert usually non-immunogenic self-DNA into a danger signal which elicits an 
immune response (228). A study by Kopfnagel et al. (2018) (230) found that RNase7 in 
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conjunction with human self-DNA induced a powerful IFN-α response by plasmacytoid 
dendritic cells in vitro. Furthermore, the IFN-α response was protective against herpes simplex 
virus 1 (HSV-1) in keratinocytes in vitro (230). As noted by Rademacher et al. (2019) (228), 
RNase7 may function as an alarmin, detecting skin barrier disruption by converting released 
self-DNA into a danger signal. This is an intriguing phenomenon in this present study, as 
higher RNase7 in lactobacilli-G. vaginalis-VK2 co-cultures may have potentially induced a 
proinflammatory response by converting DNA released from damaged VK2 cells, into danger 
signals. This may explain the increased inflammatory responses observed in the VK2 cells co-
cultured with non-suppressive lactobacilli and G. vaginalis in combination compared to co-
culture with G. vaginalis only, as RNase7 expression was significantly higher in the former 
cultures compared to the latter. However, as mentioned above, RNase7 expression is also 
induced by a proinflammatory environment, thus it is unclear whether the increased RNase7 
expression promoted the proinflammatory state or whether RNase7 expression was induced 
by the proinflammatory environment. Nonetheless, although RNase7 may play a role in 
antimicrobial and barrier function, it’s immunomodulatory effects in the context of the FGT 
based on the findings of this study are unclear and further research is needed to investigate 
this protein as a potential immunomodulator utilized by Lactobacillus species.  
Type II Transmembrane protein (TMEM2) is a member of the interferon-induced 
transmembrane (IFITM) protein superfamily, which functions as a hyaluronidase at the cell 
surface, which degrades hyaluronic acid (231). Studies investigating the immunomodulatory 
effect of hyaluronidases have mostly been on the skin surface and in the colon. Interestingly, 
Dokoshi et al. (2018) (232) found that the skin of mice treated with hyaluronidase had 
significantly reduced IL-6 expression after infection with Staphylococcus aureus and a 
reduced inflammatory infiltrate in the colon following dextran dulfate sodium-induced colitis, 
compared to control mice. Furthermore, RNA sequencing revealed that hyaluronidase altered 
genes involved in inflammatory, cytokine and immune-response related signaling pathways 
(232). In contrast, Fronza et al. (2014) (233) found that hyaluronidase treated rats had 
increased IL-1α, TNF-α, IL-4 and IL-10 compared to untreated rats in wound healing 
experiments. Notably, non-cytokine-suppressive lactobacilli dampened the IL-6 response of 
VK2 cells to G. vaginalis, albeit to a less extent than cytokine-suppressive lactobacilli. Hence, 
the upregulation of TMEM2 in VK2 cells pre-treated with these lactobacilli may suggest a 
hyaluronidase-mediated mechanism utilized to reduce the IL-6 response. Furthermore, the 
upregulation of TMEM2 may also explain why certain cytokines, e.g. IL-1α and IL-1β, were 
not dampened by lactobacilli. In addition, there may be a link between TMEM2 expression and 
endoplasmic reticulum (ER) stress. In the ER, the unfolded protein response (UPR) pathway 
is induced in attempt to maintain ER homeostasis during cellular stress, however in severe 
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stress, UPR promotes proinflammatory cytokine production (234). Several studies have 
implicated UPR in host cell cytotoxicity and inflammatory responses to bacterial infection 
(234). TMEM2 was found to modulate ER stress in vitro via the MAPK signaling pathway, 
promoting cell survival independent of the UPR pathway (235). However, one key mediator of 
the UPR pathway, transcription activator 4 (ATF4) was significantly increased in VK2 cells co-
cultured with non-cytokine-suppressive lactobacilli and G. vaginalis in combination compared 
to co-culture with G. vaginalis only. Interestingly, Zhang et al. (2013) (236) found that in vitro 
ATF4-knockdown in stimulated human monocytes reduced the IL-8 and IL-6 responses. 
Higher ATF4 expression in cells stimulated with non-cytokine-suppressive lactobacilli prior to 
G. vaginalis may explain why IL-6 responses were higher compared to cells pre-treated with 
cytokine-suppressive lactobacilli. Furthermore, the upregulation of TMEM2 in VK2 cells pre-
treated with non-cytokine-suppressive lactobacilli, could suggest that the increased 
proinflammatory response observed in these cells may be linked to increased ER stress. 
However, additional research is needed to fully understand the role of TMEM2 in inflammatory 
responses and ER stress in VK2 cells.  
4.4.5 Differential expression of genes involved in epithelial barrier function in VK2 cells 
co-cultured with Lactobacillus spp. and G. vaginalis in combination 
Dickkopf Wnt signaling pathway inhibitor 1 (DKK1) was downregulated in VK2 cells co-
cultured with cytokine-suppressive LM4 and G. vaginalis in combination, compared to co-
culture with G. vaginalis only. DKK1 is a Wnt antagonist, inhibiting the Wnt signaling pathway 
(237). Wnt signaling is important to maintain epithelial homeostasis and the inhibition of this 
pathway has resulted in crypt loss and tissue degradation in the context of colitis (238). The 
Wnt signaling pathway may be “a driver of injury repair” as it is integrated with proinflammatory 
signaling pathways, such as the NF-κB  pathway and was found to inhibit NF-κB  in colonic 
epithelial cells (219,220). Therefore, LM4-induced downregulation of DKK1 in VK2 cells and 
potential subsequent uninhibited Wnt signaling may be beneficial for the maintenance of 
epithelial homeostasis and reduced tissue degradation in the FGT. In addition, inhibited Wnt 
signaling may also lead to greater NF-κB inhibition in this culture system, as discussed above. 
Taken together with the downregulation of SAMD9L (which may also inhibit the Wnt signalling 
pathway discussed above), in VK2 cells pre-treated with cytokine-suppressive lactobacilli 
discussed above, the potential upregulation of the Wnt signaling pathway may be a crucial 
immunomodulatory and epithelial barrier protection mechanism utilized by these vaginal 





E74 like ETS transcription factor 3 (ELF3) and solute carrier family 26, member 9 (SLC26A9) 
were upregulated in VK2 cells co-cultured with cytokine-suppressive LM4 and G. vaginalis in 
combination compared to co-culture with G. vaginalis only. Interestingly, slight increases in 
these genes were also observed following co-culture with cytokine-suppressive LM2 and LV4, 
however not significantly. ELF3 is mostly involved in cell differentiation, proliferation and cell 
transformation (239). ELF3 has been shown to activate claudin-7, an essential component of 
epithelial tight junctions (240). Claudin-7 is a “pore-sealing” protein that increases the tightness 
of the epithelial monolayer marked by increased transepithelial electrical resistance (240). 
Thus, increased expression of ELF3 may result in increased claudin-7 activation and a 
strengthened epithelial barrier. Thus, upregulation of ELF3 in VK2 cells co-cultured with the 
cytokine-suppressive lactobacilli LM4 and G. vaginalis in combination and to a lesser extent 
LM2 and LV4, potentially increases epithelial barrier integrity in the presence of G. vaginalis, 
which would otherwise disrupt the epithelial barrier.  
 
Similarly, SLC26A9 potentially plays a role in the epithelial barrier function of the FGT through 
its importance in mucus function. SLC26A9 is a coupled Cl‾-HCO3‾ anion exchanger that is 
expressed on epithelial cells and is vital for epithelial function (241). Anion channels play 
important roles in mucus function. Mucus composition is 79% water and 3% solids, which is 
mainly comprised of mucins which are secreted in a dehydrated form. Thus, anion channel 
activity is needed to provide chloride and bicarbonate ions which ensure the mucus gel layer 
undergoes correct salination, hydration and proper pH regulation (242). Vaginal mucus 
viscosity, composition and pH are important for defence against pathogens, as well as fertility 
(64,243). Hence, the LM4 Lactobacillus sp. may potentially promote a favourable mucus 
environment in the FGT, promoting optimal microbial defence and fertility. Future studies to 
assess the influence of SLC26A9 expression on vaginal mucus consistency and function in 
vivo would be useful.  
4.4. 6 Genes involved in preterm birth upregulated in VK2 cells co-cultured with non-
cytokine suppressive LJ3 and G. vaginalis in combination  
Members of the aldo-keto reductase family 1 (AKR1, AKR1C1-AKR1C3) were upregulated in 
VK2 cells co-cultured with the non-cytokine-suppressive lactobacilli LJ3 and G. vaginalis 
compared to co-culture with G. vaginalis only. AKR1 enzymes play an important role in steroid 
hormone, prostaglandin and xenobiotic metabolism (244). Wang et al. (2007) (244) found that 
AKR1 expression in vitro was closely related to chronic inflammatory conditions and that IL-6 
induced AKR1C1 and AKR1C2 expression. Thus, it is likely that the pro-inflammatory 
conditions observed in VK2 co-culture with LJ3 and G. vaginalis in combination, induced AKR1 
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gene expression. However, whether these enzymes contribute to the lack of cytokine 
suppressive ability of LJ3 is unknown. Interestingly, AKR1 enzymes metabolize progesterone, 
thus causing a decrease in progesterone levels (245,246). Progesterone is vital for the 
maintenance of pregnancy and a reduced level in the FGT is linked to preterm birth (246,247). 
However, increased progesterone in the luteal phase of the menstrual cycle is associated with 
leukocyte recruitment to the endometrium and an increase in cervical CCR5+ CD4+ T cell 
populations (248,249). Hence, colonization by Lactobacillus sp. that cause increased AKR1 
expression in the FGT may result in decreased progesterone levels in the FGT that may 
increase the risk of preterm birth. However, this may be accompanied by reduced HIV target 
cell recruitment and hence reduced risk of HIV acquisition. Furthermore, AKR1 displays 
prostaglandin-F synthase activity (244). During labour, prostaglandins induce uterine 
contractions and cervical ripening, and prostaglandin synthase inhibitors prolong pregnancy 
by reducing uterine activity (250,251). Moreover, prostaglandins are important mediators in 
inflammation and nonsteroidal anti-inflammatories reduce inflammation by blocking 
prostaglandin synthesis (252). Hence, taken together with the knowledge that inflammation in 
the FGT is associated with preterm birth (17), the upregulation of AKR1 by certain lactobacilli 
may increase prostaglandin-induced uterine activity and preterm birth. Increased 
prostaglandin synthesis and inflammation may result in increased risk of HIV acquisition, 
although the combined impact of reduced progesterone (and hence HIV targets cells) together 
with increased inflammatory responses is unclear. Nonetheless, it appears that the non-
cytokine suppressive LJ3 may not beneficial for favourable reproductive outcomes in the FGT.   
 
 
4.5 Limitations  
Although the findings of this study have provided an improved understanding of gene 
expression patterns in the FGT compared to peripheral blood of HIV infected women, the 
sample size for the CMC compared to PBMC analysis was small. In addition, the study did not 
include samples obtained from HIV negative women. Future studies which include a larger 
sample size and HIV negative women will be useful to improve the power of the study and to 
improve the current understanding of the effect of HIV infection on gene expression patterns 
in the FGT.  
Although this study has provided novel insight into the immunomodulatory mechanisms of 
vaginal Lactobacillus spp. obtained from South African women, the in vitro model system used 
transformed vaginal epithelial cells and future research including primary cells would increase 
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the biological relevance of the findings. In addition, the in vitro model used is very simplified, 
as immune cells, which also contribute to inflammatory responses in vivo, were not included 
and the effects of single bacterial strains, as opposed to complex microbial communities, were 
evaluated. Moreover, inflammatory responses are highly strain specific, thus future research 
which includes additional G. vaginalis strains would be useful. The main purpose of this study 
was to understand how lactobacilli modulate inflammatory responses, rather than assess the 
efficacy of the Lactobacillus isolates as probiotic candidates, hence the in vitro model was 
more indicative of the change from an optimal to a non-optimal vaginal microbiome state. 
However, future studies including a modified in vitro method to add G. vaginalis to cell cultures 
prior to lactobacilli would be useful to elucidate these Lactobacillus spp. as candidates for BV 
adjunctive treatment. Notably, this study was cross-sectional, thus future research should 
include a time-course experiment to fully elucidate the bacterial growth, metabolite production 
and inflammatory responses in the cell culture system at varying time points. This study 
identified host key genes downregulated and upregulated by lactobacilli which should be 
validated using quantitative polymerase chain reaction assays.  
To focus on a greater effect size in gene expression changes, a logFC less than or equal to -
1.5 or greater than or equal to 1.5 was used to detect differentially downregulated or 
upregulated genes, respectively. However, logFC cutoffs of -1.2 or 1.2 would also be 
appropriate to detect differentially downregulated or upregulated genes. Future work will 




The findings of this study have improved our understanding of gene expression patterns in the 
FGT and the immunomodulatory mechanisms of South African vaginal Lactobacillus species. 
Immune cells isolated from the FGTs of HIV-infected women were found to be highly 
inflammatory compared to PBMCs, with a signature of reduced potential for adaptive 
immunity. It was found that the immunomodulatory properties of different Lactobacillus strains 
were highly divergent, with different strains inducing varying inflammatory mediators. This 
suggests that detailed characterisation of individual isolates is critical for selection of optimal 
biotherapeutics aimed at reducing HIV infection risk and improving reproductive health. It was 
however found that there were several genes that were commonly downregulated, as well as 
upregulated, in response to cytokine-suppressive and non-cytokine suppressive isolates. 
These are perhaps key genes that could be specifically targeted to reduce aberrant 
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inflammation. In the future it would be interesting to compare the expression of these genes 
in CMCs from women with Lactobacillus-dominant microbiota to those with BV. In addition to 
improving our understanding of the immunomodulatory properties of lactobacilli, this study 
further provides insight into the inflammatory mechanisms of G. vaginalis, which are largely 
unknown at present. These results could potentially be harnessed to improve prevention 
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Appendix I: Bacterial culture media preparation  
Mann Rogosa, Sharp (MRS) broth (1L):  
Added 51g of MRS powder, 50mg Cystein and 1ml Tween 80 to 500ml of pre-warmed reverse 
osmosis (RO)-water and mixed well. Once all reagents were dissolved, volume was made up 
to 1L with 500ml of RO-water. The broth was then autoclaved at 121°C for 30 minutes. Broth 
was stored at 4°C.  
Brain, Heart Infusion (BHI) broth (1L): 
Added 37g of BHI powder, 10g yeast extract, 1g soluble starch to 500ml of pre-warmed RO-
water and mixed well. Once all reagents were dissolved, volume was made up to 1L with 
500ml of RO-water. The broth was then autoclaved at 121°C for 30 minutes. Broth was stored 
















Appendix II: Luminex standard curves 


















Figure 48 Luminex standard curves for IL-8, MIP-1α, MIP-1β, IL-6, IP-10, IL-1α, IL-1β, IL-1RA. VK2 cells were seeded into 24 
well plates (0.5x106 cells/well) and grown to confluence. Monolayers were stimulated with Lactobacillus isolates (4.18x106 
CFU/well) and incubated for 6 hrs at 37°C, 5% CO2. G. vaginalis (4.18x107 CFU/well) was then added to the Lactobacillus-VK2 
cell cultures and incubated for an additional 6 hrs at 37°C, 5% CO2. Triplicate independent assays were performed. VK2 cells 
only and G. vaginalis only stimulated VK2 cells were included as controls, in duplicate for each independent assay. Cell culture 
supernatants were collected, and cytokine production assessed by Luminex assay. IL-8: interleukin-8, MIP-1α: macrophage 
inflammatory protein 1 alpha, MIP-1β: macrophage inflammatory protein 1 beta, IL-6: interleukin-6, IP-10: interferon gamma 
induced protein 10, IL-1α: interleukin 1 alpha, IL-1β: interleukin 1 beta, MIP-3α: macrophage inflammatory protein 3 alpha, 








































































































































































































































































Appendix IV: Equations to calculate D- and L- lactate sample concentrations  
D-lactate 
Sa = Amount of D-Lactate in unknown sample (nmole) from standard curve  
Sv = Sample volume (µl) added into the wells  
C = Concentration of D-Lactate in sample  
D-Lactate molecular weight (MW): 90.08 g/mole  
Sample Calculation  
Concentration of D-Lactate in sample: 
Sa/Sv = C nmole/µl  
C nmole/µl x D-lactate MW= C ng/µl 
 
L-lactate  
Sa = Amount of lactate acid in unknown sample (nmole) from standard curve  
Sv = Sample volume (µl) added into the wells.  
C = Concentration of lactate acid in sample   





































Figure 49: D- and L- lactate standard curves. D- and L- standards were prepared as per the kit protocol, generating 0, 




Lactate molecular weight (MW): 89.07 g/mole  
 
Sample Calculation  
Amount of Lactate (Sa) = 5.07 nmole  
Sample volume (Sv) = 50 µl 
Concentration of lactate in sample: 
Sa/Sv = C nmole/µl 
C nmole/ µl x L-lactate MW= C ng/ µl 
 
Appendix V: Affymetrix GeneChip Whole Transcript (WT) Expression array 
assay protocol 
Control RNA preparation  
Control RNA (1mg/ml total RNA from HeLa cells) was used for the positive control reaction to 
verify that all reagents worked as expected. A total of 2µl of the control RNA was added to 
78µl of nuclease-free water to obtain 80µl of 25ng/µl control RNA.  
 
Poly-A RNA control preparation 
Poly-A RNA controls were used to provide exogenous positive controls in order to monitor the 
entire target preparations. Serial dilutions of 1:20, 1:50, 1:10 of the poly-A RNA control was 
performed. A total of 2µl of the 4th dilution was added to total RNA.  
 
First-Strand cDNA synthesis 
Total RNA samples were first normalized to 100ng, which was used as input into the first-
strand cDNA synthesis reaction. The first-strand master mix was prepared for all the RNA 
samples, which contained 1µl of the first-strand enzyme added to 4µl of the first-strand buffer 
required for each sample. The master mix was vortexed and centrifuged briefly to mix and 
then collect the mixture at the bottom of the tube. On ice, 5µl of each RNA sample and 5µl 
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first-strand master mix was added to wells on a 96 well plate, for a final reaction volume of 
10µl/well and vortexed gently. The plate was incubated for 1hr at 25°C, then for 1hr at 42°C, 
then for 2min at 4°C in a thermal cycler. Thereafter, the plate was centrifuged briefly to collect 
the first-strand cDNA at the bottom of the wells and placed on ice for 2 min to cool the plate.  
Second-Strand cDNA synthesis  
The second-strand master mix was prepared for all first-strand cDNA samples, which 
contained 2µl of second-strand enzyme added to 18µl of second-strand buffer required for 
each sample. The master mix was vortexed and centrifuged briefly to mix and collect the 
mixture at the bottom of the tube. On ice, 20µl of the second-strand master mix and 10µl of 
the first-strand cDNA sample was added to wells on a 96 well plate for a final volume of 
30µl/well for each sample and vortexed gently. The plate was incubated for 1hr at 16°C, then 
for 10min at 65°C, then for 2min at 4°C in a thermal cycler. Thereafter, the plate was briefly 
centrifuged to collect the second-strand cDNA at the bottom of the wells and placed on ice.  
 
cRNA synthesis by in vitro Transcription (IVT) 
The IVT master mix was prepared for all second-strand cDNA samples, which contained 6µl 
of IVT enzyme added to 24µl IVT buffer required for each sample. The master mix was 
vortexed and centrifuged briefly to mix and collect the mixture at the bottom of the tube. At 
room temperature, 30µl of the IVT master mix and 30µl of second-strand cDNA was added to 
wells on a 96 well plate for a final volume of 60µl/well for each sample. The plate was incubated 
for 16hrs at 40°C, then at 4°C in a thermal cycler. Thereafter, the plate was centrifuged briefly 
to collect cRNA at the bottom of the well and placed on ice.  
 
cRNA Purification  
A total of 100µl of purification beads were added to 60µl of cRNA sample and transferred to a 
U-bottom 96 well plate and mixed thoroughly by pipetting up and down 10 times. The plate 
was incubated for 10 min at room temperature to allow the cRNA in the sample to bind to the 
purification beads. Thereafter, the plate was placed on a magnetic stand for 5min to capture 
the purification beads. The plate was kept on the magnetic stand and the supernatants were 
aspirated and discarded. Thereafter, the purification beads were washed 3 times with 200µl 
of 80% ethanol wash solution and left to dry for 5 min. The plate was then removed from the 
magnetic stand and 27µl of preheated (65°C) nuclease-free water was added to each sample, 
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incubated for 1 min to elute the cRNA. Eluted cRNA was mixed well by pipetting up and down 
10 times. Thereafter, the plate was placed on a magnetic stand for 5 min to capture the 
purification beads and the supernatant containing the eluted cRNA was transferred to a 96 
well plate and placed on ice.  
 
Assessment of cRNA yield and size distribution  
The cRNA concentration for each sample was determined by UV absorbance at 260nm 
using a NanoDrop Spectrophotometer. An agilent 2100 Bioanalyzer was used to assess the 
cRNA size distribution.  
 
2nd-cycle single-stranded cDNA synthesis 
All cRNA samples were normalized to 625ng/µl. On ice, 24µl of normalized cRNA sample and 
4µl of 2nd-cycle primers were added to wells on a 96 well plate and vortexed. The plate was 
incubated for 5 min at 70°C, then for 5 min at 25°C, then for 2 min at 4°C in a thermal cycler. 
Thereafter, the plate was briefly centrifuged to collect the cRNA/primers mix at the bottom of 
the well and placed on ice. The 2nd-cycle ss-cDNA master mix was prepared for all 
cRNA/primers samples, which contained 4µl of 2nd-cylce ss-cDNA enzyme added to 8µl 2nd-
cylce ss-cDNA buffer required for each sample. On ice, 12µl of 2nd-cycle ss-cDNA master mix 
and 28µl cRNA/primers sample was added to wells on a 96 well plate for a final volume of 
40µl. The plate was incubated for 10 min at 25°C, then for 90 min at 42°C, then for 10 min at 
70°C and for 2 min at 4°C in a thermal cycler. Thereafter, the plate was briefly centrifuged to 
collect the 2nd-cycle ss-cDNA at the bottom of the wells and placed on ice.  
 
RNA hydrolysis using RNase H 
On ice, 4µl of RNase H was added to each 2nd-cycle ss-cDNA sample and incubated for 45 
min at 37°C, then for 5 min at 95°C, then for 2 min at 4°C in a thermal cycler. Thereafter, the 
plate was briefly centrifuged to collect the hydrolysed 2nd-cycle ss-cDNA sample at the bottom 
of the wells. On ice, 11µl of nuclease-free water was added to hydrolysed 2nd-cycle ss-cDNA 





Purification of 2nd-cycle ss-cDNA  
The 2nd-cycle ss-cDNA samples were purified using purification beads as described above for 
cRNA.  
Assessment of cDNA yield and size distribution 
2nd-cycle ss-cDNA yield and size distribution was assessed as described above for cRNA.  
 
Fragmentation and labelling of ss-cDNA  
The ss-cDNA samples were first normalised to 176ng/µl. On ice, the fragmentation master mix 
was then prepared for all the samples, containing 1µl apurinic/apryrimidinic endonuclease 
1(APE1), 1µl uracil-DNA glycosylase (UDG) and 4.8µl cDNA fragmentation buffer and 10µl 
nuclease-free water, required for each sample. On ice, 16.8µl of the fragmentation master mix 
was added to 31.2µl of each ss-cDNA sample and incubated for 1hr at 37°C, then for 2 min at 
93°C and then for 2 min at 4°C in a thermal cycler. The plate was briefly centrifuged to collect 
the fragmented ss-cDNA at the bottom of the wells and placed on ice. The labelling master 
mix was then prepared for all fragmented ss-cDNA samples, containing 2µl terminal 
deoxynucleotidyl transferase (TdT), 1µl DNA labelling reagent and 12µl TdT buffer required 
for each sample. On ice, 15µl of the labelling master mix and 45µl of the fragmented sscDNA 
sample was added to wells on a 96 well plate. The plate was incubated for 1hr at 37°C, then 
for 10 min at 70°C and then for 2 min at 4°C in a thermal cycler. The plate was then placed on 
ice before proceeding to array hybridization.  
 
Whole Transcript array Hybridization  
All reagents were thawed at room temperature. The hybridization oven was preheated at 45°C 
and the rotation set to 60rpm. The hybridization controls were preheated for 5 min at 65°C in 
a thermal cycler. The hybridization master mix was prepared for all fragmented and biotin-
labelled ss-cDNA samples, 1.7µl control oligo, 5µl hybridization controls (bioB, bioC, cre), 50µl 
hybridization mix, 7µl dimethylsulfoxide (DMSO) and 9.3µl nuclease-free water. A total of 73µl 
of hybridization master mix was added to 27µl of each fragmented and biotin-labelled ss-cDNA 
sample in a 96 well plate. The plate was then incubated for 5 min at 95°C, then for 5 min at 
45°C in a thermal cycler. Thereafter, the plate was centrifuged briefly to collect the contents 
at the bottom of the wells. A total of 80µl of sample was loaded onto a Genechip cartridge 
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array, 1 sample/cartridge and placed into hybridization oven trays, loaded into the 
hybridization oven and incubated with rotation at 60rpm for 16hr at 45°C.  
Wash and staining of Arrays 
The arrays were removed from the hybridization oven and the samples removed. The arrays 
were then filled with wash buffer A. A total of 3 vials containing 600µl stain cocktail 1, 600µl 
stain cocktail 2 and 800µl stain cocktail 3, respectively, were placed into sample holders on 
fluidics stations. The arrays were then washed according to the fluidics protocol FS450_0007. 
Thereafter, the arrays were scanned by the GeneChipTM scanner 3000 7G (Thermofisher, 
USA).  
 
Appendix VI: Illumina data analysis R script  
#import illumina data into R 
my_data <- read.table(file.choose(),header=T,sep="\t")  
 
#load the library: 
library(lumi) 
 
#Read beadstudio output file and create lumiBatch object: 
my_data <- lumiR('microarray data 2010.txt') 
#summary of data: 
my_data 
#summary of quality control information: 
summary(my_data, 'QC') 
 
#preprocessing and quality control: 
lumi.N <- lumiExpresso(my_data) 
#Plot the density: 
density(my_data) 




#plot pairwise sample correlation  
#plot the pair plot: 
pairs(my_data) 
#pairwise scatter plot with smoothing: 
pairs(my_data, smoothScatter=T) 




# estimate the coefficient of variance and plot the density plot of it 
cv <- estimateLumiCV(my_data, ifPlot = TRUE) 
 
#Plot sample relation with hierarchial clustering: 
plotSampleRelation(example.lumi, method='cluster') 
# plot the sample relations with MDS: 
plotSampleRelation(example.lumi, col=c(..)) 
 
#perform quantile between microarray normalization 
lumi.T<- lumiT(my_data)  
lumi.N <- lumiN(lumi.T) 
 
#qualtity control estimation after normalization: 
lumi.N.Q <- lumiQ(lumi.N) 
#Summary of the quality control: 
summary(lumi.N.Q, 'QC') 









#Plot samplesRlation using hierachical clustering: 
plotSampleRelation(lumi.N.Q, method='cluster') 
#plot sample relation using MDS: 
plotSampleRelation(lumi.N.Q, method='mds', col=c(…) 
#DEG list generation  
#Identify differentially expressed genes 
library(limma) 
dataMatrix <- exprs(lumi.N.Q) 
presentCount <- detectionCall(my_data) 
selDataMatrix <- dataMatrix[presentCount > 0,] 
probeList <- rownames(selDataMatrix) 
 
## Specify the sample type 
Treatment <- factor(rep(c('CMC', 'PBMC'),5)) 
###  compare 'cmc' and 'pbmc' 
design <- model.matrix(~Treatment) 
fit <- lmFit(selDataMatrix, design) 
fit <- eBayes(fit) 
####Save to CSV 
Toplist<-(topTable(fit, coef = c(1-2), adjust='fdr', number=10000)) ###or  
write.csv (Toplist, file="Toplistadj.csv") 
 
Appendix VII: R script for Cytokine PCA and heatmap generation  
#Load library for mixOmics package 
library(mixOmics) 
 
#Import cytokine data 
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my_data<-  read.table(file = "clipboard", sep = "\t", header=TRUE) #to copy from excel 
X<-my_data[,2:ncol(my_data)] #x variables from column 2 
Y<-my_data$Samples #identify y variable 
 
#PCA 
pca.res <- pca(X, ncomp = 5, scale = TRUE) 
plot(pca.res) #plot variance per PC 
print(pca.res) #shows eigenvalues 
mycols <- c("blue3", "coral1","firebrick3","cadetblue2","dodgerblue", "magenta", "deeppink", 
"darkviolet", "darkorange", "brown1") #to change plot colours 
plotIndiv(pca.res, group = my_data$samples, ind.names = FALSE, ellipse = TRUE, legend = TRUE, 
col=mycols, title = 'PCA') 
plotIndiv(pca.res, group = my_data$samples, ind.names = FALSE, ellipse = TRUE, legend = TRUE, 
col=mycols, title = 'PCA', style='3d') 
head(selectVar(pca.res, comp = 1)) #show loadings for PC1 
head(selectVar(pca.res, comp = 2)) #show loadings for PC2 
pca.res$rotation #see loadings for all PCs 
#heatmap 
my_data<-  read.table(file = "clipboard", sep = "\t", header=TRUE) #to copy from excel 
rnames <- my_data[,1] #where the name for each row is 
mat_data <- data.matrix(my_data[,2:ncol(my_data)]) #labeling numerical data as matrix 
rownames(mat_data) <- my_data[,1] #assigns the row names to the matrix 
col<- colorRampPalette(c("blue", "white", "red"))(256) 
heatmap(scale(as.matrix(mat_data)), scale = "none", col =  col, RowSideColors = c(rep("dodgerblue", 
142), rep("darkmagenta", 142), rep("coral1", 142), rep("darkorange"))) 
 
Appendix VIII: Affymetrix microarray data analysis R script  
#set working directory 
#load oligo package 
library(oligo) 
#Importing cel files: 
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celpath = "C:/Users/27812/Desktop/Masters 2019/Results/Affymetrix/1213AFM/1213AFM" 
celFiles <- list.celfiles(full.names=TRUE) 
rawdata <- read.celfiles(celFiles) 
#Quality control of raw data:  
exp_raw <- log2(Biobase::exprs(rawdata)) #log2 transform data 
 
#PCA to view clustering and potential outliers:  
PCA_raw <- prcomp(t(exp_raw), scale = FALSE)  
percentVar <- round(100*PCA_raw$sdev^2/sum(PCA_raw$sdev^2)) 
sd_ratio <- sqrt(percentVar[2] / percentVar[1])  
dataGG <- data.frame(PC1 = PCA_raw$x[,1], PC2 = PCA_raw$x[, 2], SAMPLES = 
sampleNames(rawdata)) 
ggplot(dataGG, aes(PC1, PC2)) + geom_point(aes(colour = SAMPLES)) +  ggtitle("PCA plot of the log-
transformed raw expression data") +   xlab(paste0("PC1, VarExp: ", percentVar[1], "%")) +   
ylab(paste0("PC2, VarExp: ", percentVar[2], "%")) +   theme(plot.title = element_text(hjust = 0.5))+   
coord_fixed(ratio = sd_ratio) +   scale_shape_manual(values = c(4,15)) +  scale_color_manual(values 
= c(…) 
#boxplot of probe intensities (1 box/individual array): 
oligo::boxplot(rawdata, target = "core", main = "Boxplot of log2-intensitites for the raw data", las = 
2, cex.axis = 0.7, col = cols1) 
cols1 <- colours(c(…)) 
 
#ArrayQuality Metrics: 
arrayQualityMetrics(expressionset = rawdata, outdir = tempdir(), force = TRUE, do.logtransform = 
TRUE) 
 
#Applying full Robust Multichip Average (RMA) normalization: 
affy_eset_norm <- oligo::rma(rawdata) 
write.exprs(affy_eset_norm, file="affy_array.txt") #extract normalized data 
 
#PCA plot of normalized data 
exp_affy <- Biobase::exprs(affy_eset_norm)  
PCA <- prcomp(t(exp_affy), scale = FALSE)  
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percentVar <- round(100*PCA$sdev^2/sum(PCA$sdev^2),1)  
sd_ratio <- sqrt(percentVar[2] / percentVar[1]) 
dataGG <- data.frame(PC1 = PCA$x[,1], PC2 = PCA$x[,2], SAMPLES = sampleNames(rawdata)) 
ggplot(dataGG, aes(PC1, PC2)) + stat_ellipse() + geom_point(aes(colour = SAMPLES)) +  ggtitle("PCA 
plot of normalized data") +   xlab(paste0("PC1, VarExp: ", percentVar[1], "%")) +   ylab(paste0("PC2, 
VarExp: ", percentVar[2], "%")) +   theme(plot.title = element_text(hjust = 0.5))+   coord_fixed(ratio = 
sd_ratio) +   scale_shape_manual(values = c(4,15)) +  scale_color_manual(values = c(…) 
PCA$rorotation #loadings for PCs 
#Boxplot of normalized data 
oligo::boxplot(affy_eset_norm, target = "core", main = "Boxplot of normalized data", las = 2, cex.axis 
= 0.7, col = cols1) 
 
#DEG list generation 
library(limma) 
 
#Import array.txt file 




#Detect differentially expressed genes 
#Design model and applying it to data columns 
design <- model.matrix(~ 0+factor(c(1,1,1,2,2,2,3,3,3,4,4,4,5,5,5,6,6,6,7,7,7,8,8,8,9,9,9,10,10,10))) 
colnames(design) <- c("group1", "group2", "group3", "group4", "group5", "group6", "group7", 
"group8", "group9", "group10") 
fit <- lmFit(affy_eset_norm, design) 
contrast.matrix <- makeContrasts(groupB-groupA,levels=design) 
fit2 <- contrasts.fit(fit, contrast.matrix) 
fit2 <- eBayes(fit2) 
Toplist <-  topTable(fit2, coef=1, adjust="fdr") 
#Extract DEG list 
write.csv(Toplist, file="Toplistadj.csv")  
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Appendix IX: RNA yield and quality for Illumina microarray data 
 
 
Figure 50 RNA yield and quality for Illumina microarray data.  Bar graphs showing A) RNA yield and B) RNA integrity numbers 
(RINs) for 5 cervical mononuclear cells (CMC) and matched peripheral blood mononuclear cells (PBMC) samples. Each bar 
represents a separate RNA sample extracted from CMC and matched PBMC for each participant denoted by the y axis. Red 
dotted lines indicate the recommended 100ng RNA input for microarray and 7.0 RIN lower limit for “good” RNA integrity. 
RNA was extracted from matched CMCs and PBMCs isolated from cervical cytobrush and blood samples obtained from 
chronically HIV-infected women. RNA quality and quantity were assessed using an Agilent 2100 Bioanalyzer and NanoDrop 

































































































































Figure 51 Illumina data post-normalization quality control figures. A) Density of normalized expression values for arrays of 
5 cervical mononuclear cells (CMC) and matched peripheral blood mononuclear cells (PBMC) samples and indicates the signal 
intensity distribution for all samples.  B) Multidimensional scaling (MDS) plot of 5 CMC and matched PBMC sample 
relationships based on normalized expression of 48664 genes. RNA was extracted from matched CMCs and PBMCs isolated 
from cervical cytobrush and blood samples obtained from chronically HIV-infected women. RNA quality and quantity were 
assessed using an Agilent 2100 Bioanalyzer and NanoDrop 8000 spectrometer. Gene expression analysis of RNA samples was 
evaluated using Illumina Human HT-12 V3 Gene Expression Beadchip. Quantile normalization was performed on raw data 
and quality control figures were generated using the lumi R package.  
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Appendix XI: Upregulated and downregulated genes in CMCs compared to 
PBMCs 







133 ADM adrenomedullin 
220 ALDH1A3 aldehyde dehydrogenase 1 family member A3 
301 ANXA1 annexin A1 
302 ANXA2 annexin A2 
390 RND3 Rho family GTPase 3 
445 ASS1 argininosuccinate synthase 1 
481 ATP1B1 ATPase Na+/K+ transporting subunit beta 1 
595 CCND1 cyclin D1 
629 CFB complement factor B 
718 C3 complement C3 
1087 CEACAM7 carcinoembryonic antigen related cell adhesion molecule 7 
1356 CP ceruloplasmin 
1476 CSTB cystatin B 
1514 CTSL1 cathepsin L 
1893 ECM1 extracellular matrix protein 1 
2012 EMP1 epithelial membrane protein 1 
2139 EYA2 EYA transcriptional coactivator and phosphatase 2 
2152 F3 coagulation factor III, tissue factor 
2215 FCGR3B Fc fragment of IgG receptor IIIb 
2564 GABRE gamma-aminobutyric acid type A receptor epsilon subunit 
2568 GABRP gamma-aminobutyric acid type A receptor pi subunit 
3099 HK2 hexokinase 2 
3303 HSPA1A heat shock protein family A (Hsp70) member 1A 
3304 HSPA1B heat shock protein family A (Hsp70) member 1B 
3310 HSPA6 heat shock protein family A (Hsp70) member 6 
3553 IL1B interleukin 1 beta 
3557 IL1RN interleukin 1 receptor antagonist 
3576 IL8 C-X-C motif chemokine ligand 8 
3853 KRT6A keratin 6A 
3854 KRT6B keratin 6B 
3880 KRT19 keratin 19 
3914 LAMB3 laminin subunit beta 3 
3934 LCN2 lipocalin 2 
4070 TACSTD2 tumor-associated calcium signal transducer 2 
4071 TM4SF1 transmembrane 4 L six family member 1 
4072 TACSTD1 tumor-associated calcium signal transducer 1 
4082 MARCKS myristoylated alanine rich protein kinase C substrate 
4118 MAL mal, T-cell differentiation protein like 
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4487 MSX1 msh homeobox 1 
4582 MUC1 mucin 1, cell surface associated 
4585 MUC4 mucin 4, cell surface associated 
4680 CEACAM6 carcinoembryonic antigen related cell adhesion molecule 6 
4792 NFKBIA NFKB inhibitor alpha 
5055 SERPINB2 serpin family B member 2 
5209 PFKFB3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 
5266 PI3 peptidase inhibitor 3 
5284 PIGR polymeric immunoglobulin receptor 
5507 PPP1R3C protein phosphatase 1 regulatory subunit 3C 
5743 PTGS2 prostaglandin-endoperoxide synthase 2 
5768 QSOX1 quiescin sulfhydryl oxidase 1 
6278 S100A7 S100 calcium binding protein A7 
6279 S100A8 S100 calcium binding protein A8 
6280 S100A9 S100 calcium binding protein A9 
6284 S100A13 S100 calcium binding protein A13 
6286 S100P S100 calcium binding protein P 
6288 SAA1 serum amyloid A1 
6289 SAA2 serum amyloid A2 
6303 SAT1 spermidine/spermine N1-acetyltransferase 1 
6372 CXCL6 C-X-C motif chemokine ligand 6 
6446 SGK serum/glucocorticoid regulated kinase 1 
6590 SLPI secretory leukocyte peptidase inhibitor 
6648 SOD2 superoxide dismutase 2, mitochondrial 
6696 SPP1 secreted phosphoprotein 1 
6700 SPRR2A small proline rich protein 2A 
6703 SPRR2D small proline rich protein 2D 
6704 SPRR2E small proline rich protein 2E 
6705 SPRR2F small proline rich protein 2F 
6707 SPRR3 small proline rich protein 3 
7033 TFF3 trefoil factor 3 
7082 TJP1 tight junction protein 1 
7132 TNFRSF1A TNF receptor superfamily member 1A 
7851 MALL mal, T-cell differentiation protein like 
8842 PROM1 prominin 1 
8857 FCGBP Fc fragment of IgG binding protein 
8870 IER3 immediate early response 3 
9123 SLC16A3 solute carrier family 16 member 3 
9245 GCNT3 glucosaminyl (N-acetyl) transferase 3, mucin type 
9528 TMEM59 transmembrane protein 59 
9982 FGFBP1 fibroblast growth factor binding protein 1 
10079 ATP9A ATPase phospholipid transporting 9A 
10135 NAMPT nicotinamide phosphoribosyltransferase 
10170 DHRS9 dehydrogenase/reductase 9 
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10205 MPZL2 myelin protein zero like 2 
10221 TRIB1 tribbles pseudokinase 1 
10276 NET1 neuroepithelial cell transforming 1 
10409 BASP1 brain abundant membrane attached signal protein 1 
10562 OLFM4 olfactomedin 4 
10653 SPINT2 serine peptidase inhibitor, Kunitz type 2 
11005 SPINK5 serine peptidase inhibitor, Kazal type 5 
23589 CARHSP1 calcium regulated heat stable protein 1 
25878 MXRA5 matrix remodeling associated 5 
26298 EHF ETS homologous factor 
26353 HSPB8 heat shock protein family B (small) member 8 
29949 IL19 interleukin 19 
30001 ERO1A endoplasmic reticulum oxidoreductase 1 alpha 
49860 CRNN cornulin 
50848 F11R F11 receptor 
54544 CRCT1 cysteine rich C-terminal 1 
54869 EPS8L1 EPS8 like 1 
57162 PELI1 pellino E3 ubiquitin protein ligase 1 
57447 NDRG2 NDRG family member 2 
58489 FAM108C1 abhydrolase domain containing 17C  
60675 PROK2 prokineticin 2 
65009 NDRG4 NDRG family member 4 
65249 ZSWIM4 zinc finger SWIM-type containing 4 
79689 STEAP4 STEAP4 metalloreductase 
83959 SLC4A11 solute carrier family 4 member 11 
84419 C15orf48 chromosome 15 open reading frame 48 
84518 CNFN cornifelin 
84659 RNASE7 ribonuclease A family member 7 
132724 TMPRSS11
B 
transmembrane protease, serine 11B 
144568 A2ML1 alpha-2-macroglobulin like 1 
150696 PROM2  prominin 2 
196374 KRT78 keratin 78 
646786 LOC646786 PREDICTED: similar to Afadin (AF-6 protein) 
649768 LOC649768 PREDICTED: mucin MUC5B 
653108 CXADRP1 coxsackie virus and adenovirus receptor pseudogene 1 
653381 SORD2P sorbitol dehydrogenase 2, pseudogene 
727897 MUC5B mucin 5B, oligomeric mucus/gel-forming 
Downregulated genes 
678 ZFP36L2 ZFP36 ring finger protein like 2 
894 CCND2 cyclin D2 
919 CD247 CD247 molecule 
994 CDC25B cell division cycle 25B 
1043 CD52 CD52 molecule 
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1901 EDG1 endothelial differentiation, sphingolipid G-protein-coupled receptor, 
1 
2113 ETS1 ETS proto-oncogene 1, transcription factor 
2219 FCN1 ficolin 1 
2534 FYN FYN proto-oncogene, Src family tyrosine kinase 
2999 GZMH granzyme H 
3021 H3F3B H3 histone family member 3B 
3040 HBA2 hemoglobin subunit alpha 2 
3043 HBB hemoglobin subunit beta 
3148 HMGB2 high mobility group box 2 
3702 ITK IL2 inducible T-cell kinase 
3945 LDHB lactate dehydrogenase B 
4050 LTB lymphotoxin beta 
5295 PIK3R1 phosphoinositide-3-kinase regulatory subunit 1 
5551 PRF1 perforin 1 
6139 RPL17 ribosomal protein L17 
6143 RPL19 ribosomal protein L19 
6144 RPL21 ribosomal protein L21 
6156 RPL30 ribosomal protein L30 
6188 RPS3 ribosomal protein S3 
6189 RPS3A ribosomal protein S3A 
6194 RPS6 ribosomal protein S6 
6206 RPS12 ribosomal protein S12 
6208 RPS14 ribosomal protein S14 
6209 RPS15 ribosomal protein S15 
6210 RPS15A ribosomal protein S15a 
6218 RPS17 ribosomal protein S17 
6232 RPS27 ribosomal protein S27 
6233 RPS27A ribosomal protein S27a 
6235 RPS29 ribosomal protein S29 
6352 CCL5 C-C motif chemokine ligand 5 
8367 HIST1H4E histone cluster 1 H4 family member e 
8473 OGT O-linked N-acetylglucosamine (GlcNAc) transferase 
8905 AP1S2 adaptor related protein complex 1 sigma 2 subunit 
9452 ITM2A integral membrane protein 2A 
9806 SPOCK2 SPARC/osteonectin, cwcv and kazal like domains proteoglycan 2 
10235 RASGRP2 RAS guanyl releasing protein 2 
10578 GNLY granulysin 
25777 UNC84B Sad1 and UNC84 domain containing 2 
51176 LEF1 lymphoid enhancer binding factor 1 
53637 S1PR5 sphingosine-1-phosphate receptor 5 
54504 CPVL carboxypeptidase, vitellogenic like 
54855 FAM46C family with sequence similarity 46 member C 
83888 FGFBP2 fibroblast growth factor binding protein 2 
128346 C1orf162 chromosome 1 open reading frame 162 
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149628 PYHIN1 pyrin and HIN domain family member 1 
286530 P2RY8 purinergic receptor P2Y8 
400963 LOC400963 ribosomal protein S2 pseudogene 17 
401019 LOC401019 ribosomal protein S15 pseudogene 4 
402057 LOC402057 ribosomal protein S17 pseudogene 16 
439949 LOC439949 PRKCQ antisense RNA 1 
647361 LOC647361 PREDICTED:similar to 40S ribosomal protein S29 
649821 LOC649821 PREDICTED: similar to 60S ribosomal protein L14 (CAG-ISL 7), 















































Figure 52 Immune cell populations in CMC and PBMC samples. Bar graph shows absolute abundances of immune cells in 
CMC and PBMC samples. Microarray data were used for A) CIBERSORT and B) xCell analyses to detect cell populations in 
each sample type. A paired t test was used to statistically test the differences in predicted cell populations in CMCs compared 
to PBMCs, p-value < 0.05 was considered significant. A false discovery rate step down procedure was used to adjust for 
multiple comparisons, adj. p-value < 0.05 was considered significant. CMC: cervical mononuclear cells, PBMC: peripheral 
















































































































































































































































































































































































































































































































































































































































Appendix XIII: Electropherograms of RNA extracted from VK2 cells stored in 























Figure 53 Electropherograms of total RNA extracted from VK2 cells stored in RNALater and RLT buffer. VK2 cells were 
cultured in 24mm transwell inserts with 0.4µm pores, at 37°C, 5% CO2 for 7 days, with media changed every 2-3 days. The 
cells were harvested and stored in either RNALater or RLT lysis buffer, at -80°C. RNA was extracted using the Qiagen RNeasy 
Mini kit. RNA integrity was assessed using an Agilent 2100 Bioanalyzer. RIN: RNA integrity number.  
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Appendix XIV: Culture pH of VK2 cells co-cultured with Lactobacillus spp. and 
G. vaginalis in combination in 24 well cell plates 
 





Appendix XV: Electropherograms of RNA extracted from unstimulated and 













Figure 54 Electropherograms of RNA extracted from stimulated VK2 cells and unstimulated cells. VK2 cells were seeded into 24 
well plates (0.5x106 cells/well) and grown to confluence. Monolayers were stimulated with each Lactobacillus isolate 
(4.18x106CFU/well) in 500µl media and incubated for 6 hours at 37°C, 5% CO2. Thereafter, G. vaginalis (4.18x107 CFU/well) in 
500µl was added to the Lactobacillus-VK2 cell cultures and incubated for an additional 6 hrs at 37°C, 5% CO2. Triplicate 
independent assays were performed. VK2 cells only and G. vaginalis only stimulated VK2 cells were included as controls, in 
duplicate for each independent assay. VK2 cells were harvested following the stimulation assay and stored in RLT lysis buffer at -
80°C. RNA was extracted using the Qiagen RNeasy mini kit and RNA integrity assessed using an Agilent 2100 Bioanalyzer. RIN: 
RNA integrity number.  
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Appendix XVI: Upregulated genes in G. vaginalis-stimulated VK2 cells 
compared to unstimulated cells  
 
Table 6: Upregulated genes in G. vaginalis-stimulated VK2 cells compared to unstimulated cells 
Entrez gene 
ID 
Gene symbol DAVID Bioinformatics resources gene name 
4312 MMP1 matrix metallopeptidase 1 
3624 INHBA inhibin beta A subunit 
629 CFB complement factor B 
3569 IL6 interleukin 6 
3659 IRF1 interferon regulatory factor 1 
83666 PARP9 poly(ADP-ribose) polymerase family member 9 
8995 TNFSF18 tumor necrosis factor superfamily member 18 
634 CEACAM1 carcinoembryonic antigen related cell adhesion molecule 1 
55966 AJAP1 adherens junctions associated protein 1 
50486 G0S2 G0/G1 switch 2 
3552 IL1A interleukin 1 alpha 
1594 CYP27B1 cytochrome P450 family 27 subfamily B member 1 
6515 SLC2A3 solute carrier family 2 member 3 
3553 IL1B interleukin 1 beta 
330 BIRC3 baculoviral IAP repeat containing 3 
3433 IFIT2 interferon induced protein with tetratricopeptide repeats 2 
80149 ZC3H12A zinc finger CCCH-type containing 12A 
2919 CXCL1 C-X-C motif chemokine ligand 1 
10318 TNIP1 TNFAIP3 interacting protein 1 
6352 CCL5 C-C motif chemokine ligand 5 
3431 SP110 SP110 nuclear body protein 
54739 XAF1 XIAP associated factor 1 
9966 TNFSF15 tumor necrosis factor superfamily member 15 
2247 FGF2 fibroblast growth factor 2 
162394 SLFN5 schlafen family member 5 
205860 TRIML2 tripartite motif family like 2 
54498 SMOX spermine oxidase 
9582 APOBEC3B apolipoprotein B mRNA editing enzyme catalytic subunit 3B 
64135 IFIH1 interferon induced with helicase C domain 1 
22822 PHLDA1 pleckstrin homology like domain family A member 1 
200315 APOBEC3A apolipoprotein B mRNA editing enzyme catalytic subunit 3A 
7128 TNFAIP3 TNF alpha induced protein 3 
6737 TRIM21 tripartite motif containing 21 
8843 HCAR3 hydroxycarboxylic acid receptor 3 
5791 PTPRE protein tyrosine phosphatase, receptor type E 
219285 SAMD9L sterile alpha motif domain containing 9 like 
3665 IRF7 interferon regulatory factor 7 
12 SERPINA3 serpin family A member 3 
168 
 
81848 SPRY4 sprouty RTK signaling antagonist 4 
3656 IRAK2 interleukin 1 receptor associated kinase 2 
101730217 SPECC1L-
ADORA2A 
SPECC1L-ADORA2A readthrough (NMD candidate) 
3434 IFIT1 interferon induced protein with tetratricopeptide repeats 1 
55332 DRAM1 DNA damage regulated autophagy modulator 1 
5971 RELB RELB proto-oncogene, NF-kB subunit 
10221 TRIB1 tribbles pseudokinase 1 
79689 STEAP4 STEAP4 metalloreductase 
4973 OLR1 oxidized low density lipoprotein receptor 1 
5744 PTHLH parathyroid hormone like hormone 
3627 CXCL10 C-X-C motif chemokine ligand 10 
4599 MX1 MX dynamin like GTPase 1 
5743 PTGS2 prostaglandin-endoperoxide synthase 2 
51561 IL23A interleukin 23 subunit alpha 
129607 CMPK2 cytidine/uridine monophosphate kinase 2 
4688 NCF2 neutrophil cytosolic factor 2 
3669 ISG20 interferon stimulated exonuclease gene 20 
85480 TSLP thymic stromal lymphopoietin 
2113 ETS1 ETS proto-oncogene 1, transcription factor 
5270 SERPINE2 serpin family E member 2 
2635 GBP3 guanylate binding protein 3 
8482 SEMA7A semaphorin 7A (John Milton Hagen blood group) 
7127 TNFAIP2 TNF alpha induced protein 2 
27071 DAPP1 dual adaptor of phosphotyrosine and 3-phosphoinositides 1 
3604 TNFRSF9 TNF receptor superfamily member 9 
6648 SOD2 superoxide dismutase 2, mitochondrial 
5329 PLAUR plasminogen activator, urokinase receptor 
10561 IFI44 interferon induced protein 44 
51191 HERC5 HECT and RLD domain containing E3 ubiquitin protein ligase 
5 
51458 RHCG Rh family C glycoprotein 
6364 CCL20 C-C motif chemokine ligand 20 
374 AREG amphiregulin 
91543 RSAD2 radical S-adenosyl methionine domain containing 2 
7097 TLR2 toll like receptor 2 
5055 SERPINB2 serpin family B member 2 
115019 SLC26A9 solute carrier family 26 member 9 
4953 ODC1 ornithine decarboxylase 1 
3576 CXCL8 C-X-C motif chemokine ligand 8 
5265 SERPINA1 serpin family A member 1 
3038 HAS3 hyaluronan synthase 3 
85441 HELZ2 helicase with zinc finger 2 
51312 SLC25A37 solute carrier family 25 member 37 
25841 ABTB2 ankyrin repeat and BTB domain containing 2 
115361 GBP4 guanylate binding protein 4 
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7378 UPP1 uridine phosphorylase 1 
23586 DDX58 DExD/H-box helicase 58 
597 BCL2A1 BCL2 related protein A1 
24145 PANX1 pannexin 1 
341208 HEPHL1 hephaestin like 1 
84419 C15orf48 chromosome 15 open reading frame 48 
11274 USP18 ubiquitin specific peptidase 18 
10964 IFI44L interferon induced protein 44 like 
6288 SAA1 serum amyloid A1 
9636 ISG15 ISG15 ubiquitin-like modifier 
2069 EREG epiregulin 
27074 LAMP3 lysosomal associated membrane protein 3 
56937 PMEPA1 prostate transmembrane protein, androgen induced 1 
338442 HCAR2 hydroxycarboxylic acid receptor 2 
4600 MX2 MX dynamin like GTPase 2 
10346 TRIM22 tripartite motif containing 22 
7130 TNFAIP6 TNF alpha induced protein 6 
6373 CXCL11 C-X-C motif chemokine ligand 11 
2633 GBP1 guanylate binding protein 1 
6289 SAA2 serum amyloid A2 
134285 TMEM171 transmembrane protein 171 
1969 EPHA2 EPH receptor A2 
7039 TGFA transforming growth factor alpha 
3437 IFIT3 interferon induced protein with tetratricopeptide repeats 3 
3561 IL2RG interleukin 2 receptor subunit gamma 
6523 SLC5A1 solute carrier family 5 member 1 
26525 IL36RN interleukin 36 receptor antagonist 
8061 FOSL1 FOS like 1, AP-1 transcription factor subunit 
113277 TMEM106A transmembrane protein 106A 
220 ALDH1A3 aldehyde dehydrogenase 1 family member A3 
3383 ICAM1 intercellular adhesion molecule 1 
9175 MAP3K13 mitogen-activated protein kinase kinase kinase 13 
4938 OAS1 2'-5'-oligoadenylate synthetase 1 
9674 KIAA0040 KIAA0040 
1847 DUSP5 dual specificity phosphatase 5 
57458 TMCC3 transmembrane and coiled-coil domain family 3 
114770 PGLYRP2 peptidoglycan recognition protein 2 
6705 SPRR2F small proline rich protein 2F 
5017 OVOL1 ovo like transcriptional repressor 1 
1839 HBEGF heparin binding EGF like growth factor 
4322 MMP13 matrix metallopeptidase 13 
1848 DUSP6 dual specificity phosphatase 6 
4319 MMP10 matrix metallopeptidase 10 
8638 OASL 2'-5'-oligoadenylate synthetase like 
3575 IL7R interleukin 7 receptor 
2643 GCH1 GTP cyclohydrolase 1 
170 
 
4939 OAS2 2'-5'-oligoadenylate synthetase 2 
11254 SLC6A14 solute carrier family 6 member 14 
91351 DDX60L DEAD-box helicase 60-like 
8676 STX11 syntaxin 11 
30844 EHD4 EH domain containing 4 
10125 RASGRP1 RAS guanyl releasing protein 1 
4940 OAS3 2'-5'-oligoadenylate synthetase 3 
56300 IL36G interleukin 36, gamma 
639 PRDM1 PR/SET domain 1 
85463 ZC3H12C zinc finger CCCH-type containing 12C 
10468 FST follistatin 
 


















































































Figure 55 Housekeeping gene Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression in unstimulated and 
stimulated VK2 cells. VK2 cells were seeded into 24 well plates (0.5x106 cells/well) and grown to confluence. Monolayers 
were stimulated with each Lactobacillus isolate (4.18 X 106CFU/well) in 500µl media and incubated for 6 hours at 37°C, 5% 
CO2. Thereafter, G. vaginalis (4.18x107 CFU/well) in 500µl was then added to the Lactobacillus-VK2 cell cultures and 
incubated for an additional 6 hrs at 37°C, 5% CO2. Triplicate independent assays were performed. VK2 cells only and G. 
vaginalis only stimulated VK2 cells were included as controls, in duplicate for each independent assay. VK2 cells were 
harvested following the stimulation assay and stored in RLT lysis buffer at -80°C. RNA was extracted using the Qiagen RNeasy 
mini kit and RNA integrity assessed using an Agilent 2100 Bioanalyzer. RNA was extracted using the Qiagen RNeasy mini kit 
and gene expression analysis was then performed using microarray Affymetrix GeneChip whole transcript array platform. 
The R Studio Bioconductor Oligo package was used to normalize raw data using Robust MultiChip Average (RMA) 
normalization. Genes were annotated using the Clariom S Human annotation file. GV: G. vaginalis, LJ3: L. jensenii 3, LV3: L. 
vaginalis 3, LC3: L. crispatus 3, LM2: L. mucosae 2, LC1: L. crispatus 1, LJ2: L. jensenii 2, LM4: L. mucosae 4. LV4: L. vaginalis 
4.  
